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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Overview 
 
Plant-derived compounds have always been an important source of medicines for 
various diseases and have received considerable attention in recent years due to their 
diverse pharmacological properties including cytotoxicity and cancer preventive effects 
(Gonzales and Valerio, 2006). Recently there is considerable scientific and commercial 
interest in the continuing discovery of novel anticancer agents of plant origin (Cragg 
and Newman, 2005) and such investigations targeting plant products have recently 
regained prominence with the increasing understanding of their biological significance 
and increasing recognition of the origin and function of their structural diversity 
(Conforti et al., 2008).  
 
Cancer is the second leading cause of death and its incidence has increased dramatically 
worldwide (Madhusudan and  Middleton, 2005). Cancer is the uncontrolled growth and 
spread of abnormal cells, associated with dysregulatin of apoptosis, a programmed cell 
death. Most of the current anticancer drugs are derived from plant sources, which act 
through different pathways converging ultimately into activation of apoptosis in cancer 
cells leading to cell cytotoxicity. 
 
The plant Swetenia macrophylla (Family: Meliaceae), commonly known as “sky fruit”, 
because its fruits seem to point upwards to the sky, is a beautiful, lofty, evergreen large 
tree usually 30-40m in height and 3-4m in girth. This tropical timber tree grows natively 
throughout the tropical region of the America, especially in Central America, Mexico 
and Bolivia. In Malaysia, the seeds are used traditionally to treat diabetes, hypertension 
and also to relieve pain. 
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The seeds of S. macrophylla have been previously reported to have, anti-inflammatory, 
anti-mutagenecity and antitumor activity (Guevera et al., 1996), anti-malaria (Soediro et 
al., 1990), anti-microbial (Maiti et al., 2007), in vivo anti-diarrheal activity (Maiti et al., 
2007), and antinociceptive activity (Das et al, 2009). The seeds have been used 
commercially in healthcare products to improve blood circulation and skin condition. 
 
Phytochemical investigation has identified limonoids and it derivatives as the major 
constituents of this plant (Chen et al., 2010). The limonoid compounds that have been 
isolated are swietenine, swietenolide (Guha & Chakraborty, 1951), diacetylswietenolide, 
6-Oacetylswietonolide (Goh et al., 2010a, 2010b) swietemahonin, khayasin, andirobin, 
augustineolide, 7- deacetoxy-7- oxogedunin, proceranolide, and 3β,6- 
dihydroxydihydrocarapin (Mootoo et al., 1999). These limonoids were claimed to be 
responsible for its bioactivities. 
 
However, the effect of S. macrophylla seeds on human cancer cell lines in vitro has 
hitherto not been reported. Thus, study was designed to investigate the cytotoxic 
properties of extract and factions of S. macrophlla seeds followed by elucidation of 
bioactive compound(s) which responsible for the activation of apoptosis mechanisms 
and the specific objectives of the study were listed as below: 
 
1. To investigate the in vitro cytotoxic activity of the crude extract and fractions of 
Swietenia macrophylla King seeds against selected cancer lines (Ca Ski, MCF 7, 
KB, HEP G2 and HCT 116) using MTT assay. 
2. To isolate, purify and elucidate the structures of the compounds responsible for 
the detected cytotoxic activity by fractionation using different chromatography, 
nuclear magnetic resonance spectroscopy (NMR) and mass spectrometry (MS).   
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3. To enhance the cytotoxic activity of swietenine through chemical modification. 
4. To evaluate the modulation of the intracellular oxidative homeostasis exerted by 
SMEAF and swietenine acetate in HCT116 cells by detection of intracellular 
ROS and glutathione level. 
5. To investigate the apoptosis inducing effects of SMEAF and swietenine acetate 
assessed by using Hoechst/PI staining and flow cytometric analysis by TUNEL, 
Annexin-V and JC-1 binding.  
6. To determine the Bax and Bcl-2 expression level by SMEAF and swietenine 
acetate on HCT 116 in relation to mitochondrial-mediated apoptosis 
accompanied by a concomitant activation of down stream caspases. 
7. To investigate the effects of SMEAF and swietenine acetate on cell cycle 
progression by flow cytometry analysis of PI binding and the expression level of 
core regulatory proteins including p53, p21 and cyclic dependent kinases. 
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1.2 Literature review 
1.2.1 Cancer 
The term ‘cancer’, which means “crab” in Latin, was described by Hippocrates in the 
fifth century BC to describe a family of diseases in which tissues grow and spread 
uncontrollably throughout the body, eventually lead to death (Lewis, 2006). There are 
different categories of cancer depending on the origin of cells, namely carcinomas, 
sarcomas, lymphomas and leukemia. Cancer cells can grow and divide autonomously 
leading to a progressive increase in the number of dividing cells. Tumor or neoplasm is 
referred to a resultant mass of growing tissue. The replication rate of tumor cells is not 
neccessarily faster than normal cells, but rather the crucial issues rely on the balance 
between cell division and cell differentiation (Becker, 2009). 
 
Cancer development or carcinogenesis is a complex multi-sequence process that leads a 
cell from health stage to a precancerous state and finally followed by the entry into an 
early cancer stage. In general there are three stages of carcinogenesis which started with 
initiation followed by promotion and progression. Initiation stage involves DNA 
mutation which is a non-lethal form that subsequently produces an altered cell. As an 
example, initiation can proceed through oxidative stress. The increase of free radicals 
induced change in intracellular Ca (II) level. The high level of Ca (II) may cause 
unspecific activation of calcium-dependent endonucleases and lead to miss-cleaving of 
the DNA backbone (Wiseman et al., 1995) and give rise to mutated cells. Besides, an 
initiating genetic alteration may have been introduced by a long list of factors, including 
exposure to radiation or certain chemicals, insertion of retrovirus, generation of random 
mutations during replication, random DNA amplication or random loss of a DNA 
segment. In certain cases, the initial changes may also be inherited. Genetic 
predisposition accounted for about 5% of total cancer cases (Wolfe, 1993).  
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Promotion stage involves induction of cell proliferation and results in the formation of 
identifiable focal lesion. During this stage, there is a need for a continuous supply of the 
tumor promotion stimulus to maintain or bring the mutated cell to progression stage and 
therefore it is a reversible process. Additional gene conversion to oncogenic form can 
also occur at this stage. Further alteration to the initial and succeeding gene activation 
also occurs at this stage. For an example, initial conversion of a proto-oncogene to an 
oncogene by translocation may be compounded at successive steps by sequential 
changes and amplification. As the first change may have induced an increase in the rate 
of DNA replication and cell division, opportunities for additional changes are likely to 
come more frequently as progression advances (Wolfe, 1993). There are wide varieties 
of promoting agents and not all tumor promoters are foreign substances. Even the 
growth factors or hormones can act as tumor promoter if they exert the proliferation 
effect on a cell that has already sustained an initiating mutation (Becker, 2009).  
 
Progression is known as the third or final stage in carcinogenesis. During this stage, 
tumor gradually gains aberrant characteristics and become more aggressive. The 
characteristics include, increased growth rate, invasiveness, ability to survive in blood 
stream, immune killing resistance, drug resistance, apoptosis evasion etc. In general, 
cell entry into progression stage is believed to be irreversible. Long term accumulation 
of genetic changes can lead the cell to go through the transition stage, from benign to 
malignant. Transformation includes, cell surface molecule alteration, connection break 
between neighbourigng cells or molecules on malignant cells are normally associated 
with metastasis. The acquired traits enable tumor cells to break loose from the tumor, 
evaded immune attack and eventually will lodge and grow in new locations of the body 
(Wolfe, 1993). 
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1.2.1.1 Hallmarks of Cancer 
Evidences showed that changes in normal cell in terms of various combinations of 
mutations and epigenetic changes involving tumor suppressor genes and oncogenes can 
lead to cancer; however there is a need in common principles that would help simplify 
the picture.  In year of 2000 Douglas Hanahan and Robert Weinberg  (Hanahan and 
Weinberg, 2000) have proposed a series of six required traits in the development of 
cancer. 
 
1. Self-sufficient in growth signals 
Generally, it is believed that normal cells proliferate under stimulation of 
appropriate growth factors. Apparently, cancer cells are less dependent on 
exogenous growth stimulation. Studies have shown that through the action of 
oncogenes that produce excessive quantities or mutant version of proteins enable 
the cancer cells to self-sustain on prolonged stimulation (Slamon, 1987; Yarden 
and Ullrich, 1988). 
 
2. Insensitivity to anti-growth signals 
The existence of growth-inhibiting mechanisms is necessary in preventing 
excessive cell proliferation in normal tissues. Cancer cells must evade or acquire 
anti-growth signal mechanisms to continue proliferating. As an example, Rb 
protein responsible in inhibiting cell proliferation at end of G1 phase. Mutation 
of RB gene made cells insensitive to TGFβ growth inhibitory (Dyson et al., 
1989; Fynan and Reiss, 1993). 
3. Evasion of apoptosis 
The programmed cell death or apoptosis plays a major role in cell attrition. 
Principle studies and observations accumulated over the past indicate that 
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apoptosis is present in latent form in virtually all cell types throughout the body 
(Hanahan and Weinberg, 2000). The impairment of p53 pathway enables the 
cells to evade apoptosis (Zusman, 1997). As an example, overexpression of Bcl-
2 gene which encodes for an inhibitor of apoptosis known as Bcl-2 protein 
affects the ability of p53 pathway to trigger apoptosis (Apakama et al., 1996). 
 
4. Limitless replicative potential 
The overall effect of the preceding three traits is to uncouple cancer cells from 
the mechanisms that maintain normal cell replication. However, this will not 
ensure unlimited proliferation as telomere sequences are gradually lost from the 
end of each chromosome during DNA replication. A few of the cancer cells are 
able to activate an alternative mechanism for maintaining telomere length above 
a critical threshold and thereby retain the ability to divide indefinitely (Bryan 
and Cech, 1999; Bryan et al., 1995; Shay and Bacchetti, 1997; Wright et al., 
1989). 
 
5. Sustained angiogenesis 
Blood supply is needed for tumors to survive or grow beyond a few milimeters 
in size. Thus, angiogenic activation is a must in a certain stage of tumor 
development. A common strategy involves the activation of genes coding for 
angiogenesis stimulators combined with the inhibition of genes coding for 
angiogenesis inhibitors. For example, p53 protein activates the gene coding for 
angiogenesis inhibitor thrombospondin; hence the loss function of p53 function 
will eventually cause thrombospondin levels to decrease (Dameron et al., 1994). 
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6. Tissue invasion and metastasis 
Invasion or metastasis by tumor has been categorized based on its ability to 
invade surrounding tissues and spread to distant sites. Three major traits 
possessed by this type of cancer cells include decreased cell-cell adhesion, 
increased motility and production of proteases that can degrade extracellular 
matrix and basal lamina. The mechanisms underlying these molecular changes 
differ among tumor types and tissue environments, but they commonly involve 
activation of genes normally intended for use in embryonic development or 
wound healing (Becker, 2009). 
 
Apart from the six biological capabilities acquired during the multiple step development 
of human tumors, based on the observations made through the last decade (Hanahan and 
Weinberg, 2011),  two high potential and promising hallmarks were added to this list. 
 
7. Deregulation of cellular energetics 
The adjustments of energy metabolism occur in neoplastic disease in order to 
sustain cell growth and proliferation. An anomalous cancer cell energy 
metabolism known as “aerobic glycolysis” was firstly described by Otto 
Warburg (Warburg, 1956; Warburg et al., 1927). Observation of cancer energy 
metabolism resulting in counterintuitive situation, as cancer cells would prefer 
undergo glycolysis rather than mitochondrial oxidative phosphorylation 
although have to compensate for almost 18-fold lower efficiency in term of ATP 
production. In some cases, tumors contain two subpopulations differing in 
energy-generation pathways, as both of them evidently function symbiotically: 
the hypoxic cancer cells rely mainly on glucose for survival and secrete lactate 
as waste, whereas the better-oxygenated neighbour cells imported and 
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preferently used lactate as fuel (Feron, 2009; Kennedy and Dewhirst, 2010; 
Semenza, 2008, 2009), forming a lactate-secreting and lactate-ultilizing cells. 
 
8. Avoiding immune destruction 
It is the fact that immune system plays a vital role in eradicating or resisting the 
formation and progression of cancer. Thus, is a must for tumor cells to evade 
immune surveillance through certain means to limit or prevent immunological 
killing. Immunological monitoring defects in immunocompromised individual 
have shown striking increase of certain cancers (Vajdic and Leeuwen, 2009). 
Besides, studies have shown that cancer cells that originated from 
immunodeficient mice are often inefficient at initiating secondary tumors in 
syngeneic immunocompetent hosts, whereas cancer cells from tumors arising in 
immunocompetent mice are equally efficient at initiating transplanted tumors in 
both types of hosts (Teng et al., 2008). 
 
With this holistic clarity of mechanism, cancer prognosis and treatment will become a 
rational science. It will surely help to understand with precision, how and why treatment 
regimens and specific antitumor drugs succeed or fail eventually help to develop or use 
appropriate combinations of drugs to gain better outcomes in treatment. 
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Adapted from (Hanahan and Weinberg, 2000) 
Figure 1.1 Hallmarks of cancer. 
 
1.2.1.2 Treatment of cancer 
There are several treatment options available for patients diagnosed with cancer. 
Depending on both types and stage of the cancer, appropriate or combinatory treatment 
would be selected to suit the conditions. One of the most common approaches involves 
surgical removal of primary tumor followed by radiation or chemotherapy to destroy 
remaining cancer cells. The radiation therapy employs high-energy X-rays or other 
forms of ionizing radiation to kill cancer cells. The principle of this treatment relies on 
the ionizing radiation to destroy DNA content of cancer cells to the extent that the cells 
are unable to undergo mitosis or trigger apoptosis through p53 pathway and therefore 
die while trying to divide (Hamada et al., 1996; Swisher et al., 2003). 
 
Chemotherapy is another mean to kill dividing cancer cells. Such drugs are subdivided 
into four major categories: 1. Antimetabolites that are able to inhibit metabolic 
pathways required for DNA synthesis. Example of this class of drug is fluorouracil 
(Peters et al., 2000); 2. Alkylating agents that inhibit DNA function by chemically 
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crosslinking the DNA double helix. Example of a drug from this family is cisplatin 
(Comis, 1994; Gately and Howell, 1993); 3. Antibiotics where the substances made by 
microorganism that are able to bind to DNA or inhibit the topoisomerases activities in 
DNA replication. Example of an antibiotic is bleomycin produced by the bacteria 
Streptomyces verticillus (Blum et al., 1973; Umezawa et al., 1967);  4. Plant-derived 
drugs that either inhibit topoisomerases or disrupt formation or disintegration of mitotic 
spindle, for example, taxol (Schiff et al., 1979; Schiff and Horwitz, 1980).  
 
Other alternative treatments include immunotherapy that exploits the ability of the 
immune system to recognize cancer cells. For an example, the utilization of a special 
strain of bacillus Calmette-Guerin (BCG) bacteria to trigger localized immune response 
success in treating early stage of bladder cancer (Alexandroff et al., 1999; Lamm et al., 
1981). Anti-angiogenic treatment is another means of treatment (Boehm et al., 1997; 
Folkman, 1998a, 1998b). In 2004, Avastin was the first anti-angiogenic drugs approved 
for routine use in cancer patient. 
 
1.2.2 Cell death 
Cell death research has fascinated scientists of different disciplines for more than a 
century. The term “cell death” in general can be defined as an irreversible loss of 
plasma membrane integrity (G. Kroemer et al., 2005). Researchers have classified the 
cell death into three main types of cell death by distinguishing them through 
morphological features in mammalian cell. Type I cell death or commonly known as 
apoptosis, is defined by characteristic changes in nuclear morphology with DNA 
fragmentation (karyorrhexis) or chromatin condensation (pyknosis); cytoplasmic 
organelles changes; cell shrinkage followed by plasma membrane blebbing and 
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formation of apoptotic bodies that contain nuclear or cytoplasmic material. All named 
changes occur before plasma membrane integrity is lost.  
 
Type II cell death is commonly characterized by a massive accumulation of two-
membrane bounded autophagic vacuoles in the cytoplasm. Type III cell death or better 
known as necrosis is often defined in a negative manner as death lacking the 
characteristics of type I and type II processes, with only a classical definition based on 
morphological criteria: early rupture of plasma membrane, occurrence of cytoplasmic 
organelles dilation particularly mitochondria (Edinger and Thompson, 2004; Golstein 
and Kroemer, 2007; Kroemer et al., 2005).  
 
The nomenclature of the cell death is important, as good distinct features between 
different types enable appropriate diagnostic and medical treatment can be done on the 
patients. As an example, occurrence of necrosis is quite common with association with 
unwarranted cell loss in human pathologies (Festjens et al., 2006; Yuan, 2006; Zong 
and Thompson, 2006), and can lead to local inflammation which required immediate 
proper treatment. 
 
1.2.2.1 Autophagy 
Autophagy, which has been proposed as a second mode of cell death, is a general term 
for the degradation of cytoplasmic components within lysosomes whereas require cells 
generate energy and metabolites by digesting their own organelles and macromolecules 
(Cuervo, 2004; Klionsky, 2007; Levine and Klionsky, 2004; Shintani and Klionsky, 
2004). Autophagic process is mediated by a unique organelle called the autophagosome, 
a two-membrane vesicle containing cytoplasmic organelles or degenerating cytosol. 
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Autophagy is generally thought to be a non-selective degradation system, as 
autophagosomes can engulf a large portion of cytoplasm.  
 
Autophagy is involved in numerous important processes in cell, one of the most typical 
role in cell allows a starving cell, or a cell that is deprived of growth factors, to survive. 
In this sense, lack of any type of essential nutrient can induce autophagy. For example, 
yeast undergoes nitrogen starvation can induce autophagy (Takeshige et al., 1992). 
Insufficient supply of nitrogen or carbon can also trigger autophagy in plant cells 
(Moriyasu and Ohsumi, 1996; Yoshimoto et al., 2004). In mammals, depletion of total 
amino acids can induces autophagy and it has been shown in many types of cultured 
cells. However the effects of individual amino acids differ, as it depends on cell type 
because the amino acid metabolism differs greatly among tissues (Lardeux and 
Mortimore, 1987).  
 
Autophagy induction through starvation is greatly depending on the period of exposure. 
As a very short period of starvation, the cell would trigger ubiquitin-proteasome system 
rather than autophagy to maintain the amino acid pool (Vabulas and Hartl, 2005). 
Persistent starvation period up to several hours which acts as an adaptive response 
would eventually leading to up regulation of autophagy to occur in order to produce 
necessary amino acids to maintain the cells (Kuma et al., 2004; Onodera and Ohsumi, 
2005). In general, autophagy allows a starving cell, or a cell that is deprived of growth 
factors, to survive. However, if the cells do not receive nutrients for extended periods 
ultimately digest all available substrates and die (autophagy-associated cell death) 
(Klionsky, 2007; Kroemer and Jaattela, 2005; Levine and Abrams, 2008; Levine and 
Deretic, 2007).  
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In addition to this role in the starvation response, autophagy has also been implicated in 
other physiological processes. Autophagy machinery may be used in recycle damaged 
organelles, thereby contributing to maintain cellular integrity. For example damaged 
mitochondria resulting from an incomplete apoptotic event are sequestered by 
autophagosomes to prevent cellular damage caused by uncontrolled release of reactive 
oxygen species (Xue et al., 2001).  
 
1.2.2.2 Necrosis 
Necrosis has been defined as a type of cell death that lacks the features of apoptosis and 
autophagy, and is usually considered to be uncontrolled. Morphological observation 
revealed necrosis occurred with the swelling of organelles, an increased cell volume, 
disruption of the plasma membrane followed by rupture of the plasma membrane with a 
consequent localized inflammatory response and damage to surrounding cells and 
tissues (Kroemer et al.,1998). It is originally thought as a “nonspecific” form of cell 
death or in other terms an accidental and unregulated cell death event. Recent research 
provided a mounting evidence that the execution of necrotic cell death is also regulated 
by a set of signalling pathways (Golstein and Kroemer, 2007; Vanlangenakker et al., 
2008) this might facilitate a shift from the negative definition of necrosis to a more 
positive definition of this particular modality of cell death. 
 
Studies showed necrosis can be induced through receptor induction. By utilizing L929 
mouse fibrosarcoma cell line, necrosis can be induced by treated with TNFα. In this 
model, cells will eventually undergoes a complex multi-step signalling transduction in 
which Fas-associated death domain (FADD) is recruited to the TNF receptor 1 (TNF-
R1) and induces necrosis, presumably through its death domain (Festjens et al., 2006). 
In addition, TNFα-induced necrosis is accompanied by a rapid increase of 
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mitochondrial ROS production that can be dampened by rotenone, an inhibitor of the 
respiratory chain complex I. The addition of rotenone (Schulze-Osthoff et al., 1993) and 
lipophilic antioxidants are shown be able to prevent necrotic cell death in this model 
(Sanchez-Alcazar et al., 2003). Besides, research have shown that the elevation level of 
Bcl-2 can eventually reduce TNFα induced necrosis (Denecker et al., 2001; Hennet et 
al., 1993). As there is no involvement early release of cytochrome c in necrosis 
(Denecker et al., 2001), Bcl-2 must exert its protective effect by another molecular 
mechanism. There are even more evidence supports a ‘sequence’ of events that 
characterize necrotic cell death at both the phenomenological and biochemical level, 
thereby reflecting a programmed course of events in the dying necrotic cell and 
contributing to a definition of necrotic cell death. 
 
1.2.2.3 Apoptosis 
Apoptosis or programmed cell death is an important component of the development and 
health of multicellular organisms that regulate and allows the wounded cell to commit 
suicide (Duprez et al., 2009; Hotchkiss et al., 2009; Wyllie, 2010). It is essential in 
granting the survival of multicellular organisms by selectively and orderly getting rid of 
old, mutated, damaged or infected cells that may interfere with normal function. There 
are two major well studied types of apoptosis pathways, extrinsic and intrinsic (Duprez 
et al., 2009). 
i) Extrinsic pathway 
Extrinsic pathway is always related to the triggers of cell surface receptors 
by extracellular ligands. Examples of death receptors mediated activities 
include Tumor Necrosis Factor receptors (TNFR) superfamily namely, 
TRAIL FAS and TNFR. Death receptors activation leads to the recruitment 
and activation of initiator caspases such as caspase -8 and -10 followed by 
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the assembly of the death inducing signaling complex (DISC). The initiation 
and activation of caspase-3 which is effector caspase followed after DISC 
formation (Pan et al., 1997; Sheridan et al., 1997). 
 
ii) Intrinsic pathway 
The cell autonomous or intrinsic pathway is largely centred around and/or 
regulated by the mitochondria (Brunelle and Letai, 2009; Galluzzi et al., 
2010; Gupta et al., 2009). Well studied form of intrinsic apoptosis is initiated 
by the stress-mediated release of cytochrome c from the mitochondria that 
results in the formation of apoptosome. The apoptosome then activates the 
initiator caspase, typically caspase -9, which leads to the activation of the 
exercutioner caspase -3. Normally, the activation of intrinsic pathway is 
related to pro- and anti-apoptotic Bcl-2 family proteins. The ratio between 
the pro- and anti-apoptotic proteins in cell will eventually determine fate of 
cell’s survival. 
 
Even though the apoptotic pathways are well defined into two distinct pathways, 
namely, extrinsic and intrinsic pathway, the evidences have shown the greater 
complexity and diversity in apoptosis as it involves interconnection and cross-activation 
of two apoptotic pathways such as the extrinsic and intrinsic pathways or even together 
with necrotic sub-pathways activation (Wu et al., 2011). 
 
1.2.3 Tumor suppressor p53 protein 
Tumor suppressor protein p53 was firstly described in 1979 (DeLeo et al., 1979; Lane 
and Crawford, 1979; Linzer and Levine, 1979) and is encoded by TP53 gene (Isobe et 
al., 1986). It is probably the most popular molecule in the field of cellular biology as the 
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biological consequences of p53 activity include cell-cycle regulation, induction of 
apoptosis, development, differentiation, gene amplification, DNA recombination, 
chromosomal segregation, and cellular senescence (Oren and Rotter, 1999). As a tumor 
suppressor, p53 is essential for preventing inappropriate cell proliferation especially 
cells with damaged DNA and maintaining genome integrity following genotoxic stress 
(Vogelstein et al., 2000; Vousden and Lu, 2002). Various intracellular and extracellular 
stimuli can cause DNA damage (namely, ionizing radiation, UV radiation and virus 
infection), heat shock, hypoxia and oncogene over-expression, wild-type p53 is 
activated and emerges as a pivotal regulatory protein which triggers diverse biological 
responses, both at the level of a single cell as well as in the whole organism (Vousden 
and Lu, 2002; Levine, 1997; Vogelstein et al., 2000).  
 
Since the discovery of the p53 tumor suppressor gene has been found to be mutated in 
more than 40% of human cancers (Cheah and Looi, 2001; Hernandez et al., 1999). 
Mutation at TP53 gene will eventually disrupted the function of translated p53 tumor 
suppressor protein activities by various mechanisms, including activation of DNA 
damage check point and p53-mediated apoptosis pathway consequently formation of 
cancer (Bartkova et al., 2005; Kastan and Bartek, 2004). Example, the patients with the 
Li–Fraumeni syndrome, who have an inherited germline mutation in one of the two p53 
alleles, are at very high risk of developing cancer throughout their lifetimes (Srivastava 
et al., 1990; Malkin et al., 1990).  
 
In many cancer cases, p53 is not functionally inactive but the function of p53 is 
impaired owing to mutations in proteins operating either upstream or downstream of 
p53 targets, such as MDM2 or the E6 protein of HPV, or deletion of key p53 co-
activators such as the ARF gene (Hollstein et al., 1991; Sherr, 1998; Vogelstein et al., 
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2000). The p53 inactivation without p53 mutation also leads to cancer development as 
functional p53 is not working as it is supposed to, this clearly demonstrated inactivation 
of p53 is a key event in carcinogenesis. An example of p53 inactivation is Burkitt’s 
lymphoma, where the cells are under overexpression of MDM2 protein due to enhanced 
translation (Capoulade et al., 1998). As MDM2 is an ubiquitin ligase, it promotes 
ubiquitination of p53 (Meulmeester et al., 2003) for degradation, this would mean that 
if there is more MDM2 around, it would stimulate more p53 degradation and keep p53 
levels low.  
Evidence has shown that, this small 53-KDa tumor suppressor is a molecular node at the 
crossroads of an extensive and complex network of stress response pathways. This 
opened a new prospect in developing p53-based cancer therapy (Stoklsa and Golab, 
2005), includes, gene therapy through reconstitution of wild-type p53 (Swisher et al., 
2003) , or restoration of p53 function-targeting mutant p53 by using small molecules 
like styrylquinazoline that is capable to interfere with mutant p53 and restore wild type 
function (Foster et al., 1999) followed by mean of wild type p53-directed approaches 
like nutlins that can bind to p53 and prevent MDM2 targeting p53 degradation 
(Galimard et al., 2004). 
 
1.2.4 BCL2 proteins family 
There are at least 15 Bcl-2 family member proteins have been identified in mammalian 
cells (Gross et al., 1999).The Bcl2 family members responsible in controlling apoptosis 
process and are generally separated into pro-apoptotic (promote apoptosis) and anti-
apoptotic (inhibit apoptosis) (Adams and Cory, 2007; Danial and Korsmeyer, 2004; 
Hotchkiss et al., 2009). The Bcl-2 family members have been classically been grouped 
into three classes. The first class inhibits apoptosis (Bcl-2, Bcl-XL, Bcl-W, Mcl1, Bcl-B 
or Bcl-2L10 and A1 or Bcl-2A1) whereas the second class promotes apoptosis (Bax, 
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Bak and Bok). The third class known as BH3-only protein (Bad, Bik, Bid, Hrk, Bim, 
Bmf, NOXA and PUMA) as they have a conserved BH3 domain that can bind and 
regulate the anti-apoptotic Bcl-2 proteins to promote apoptosis. The pro-apoptotic 
family members of Bcl-2 namely Bax and Bak are crucial in inducing permeabilization 
of the outer membrane of mitochondria. Subsequently release of apoptogenic molecules 
such as cytochrome c and SMAC which lead to caspase activation. Studies indicated 
that, the anti-apoptotic family members, such as Bcl-2 and Bcl-XL able to inhibit Bax 
and Bak while the BH3 only proteins de-repress Bax and Bak by direct binding and 
inhibit Bcl-2 and other anti-apoptotic family members (Willis et al., 2007; Youle and 
Strasser, 2008).  
 
Overexpression Bcl-2 members family of pro-survival proteins is commonly associated 
with unfavourable pathogenesis in cancer (Chipuk et al., 2010). In colon, Bcl-2 protein 
is normally expressed only in the lower half of crypts of the colon, corresponding to the 
stem cell compartment, where Bcl-2 is believed to be responsible in protecting stem 
cells from apoptosis (Merritt et al., 1995). Most colonic adenomas express Bcl-2 protein 
at high levels throughout the neoplastic epithelium (Kinzler and Vogelstein, 1996; 
Nakamura et al., 1995; Baretton et al., 1996), while non-neoplastic polys have a normal 
pattern of Bcl-2 expression (Bronner et al., 1995; Flohil et al., 1996; Nakamura et al., 
1995). Overexpression of Bcl-2 may therefore contribute to the transition between 
hyperplastic epithelium and adenomas. However, Bcl-2 is probably is not the only one 
of the genes that contributed to the colorectal neoplasms. Indeed, changes in the 
expression of other members of the Bcl-2 family have been shown during progression 
of colorectal tumors, such as the anti-apoptotic proteins Bcl-Xl, Mcl-1 and pro-
apoptotic protein Bak, which may be more important than Bcl-2 (Krajewska et al., 
1996). 
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1.2.5 Heat shock proteins (HSP) 
The heat shock response was first discovered in 1962 by Ritossa (1962), who observed 
response pattern of Drosophila salivary gland chromosome puffs towards transiently 
elevated temperature. Since then, investigators have proved that the heat shock response 
is ubiquitous and highly conserved in all organisms. The importance of HSPs include 
acting as an defense mechanism to protect cells from different range of harmful 
exposure such as alcohols, heat shock, heavy metals, inhibitors of energy metabolim, 
oxidative stress, inflammation and fever (Lindquist, 1986; Morimoto, 1993). 
Hsps have been classified into six major families according to their molecular size: Hsp 
100, Hsp 90, Hsp 70, Hsp 60, Hsp 40 and small heat shock proteins. Within each gene 
family are members that are constitutively expressed, inducibly regulated, and/or 
targeted to different compartments. For example, Grp 94 performs an analogous 
function in endoplasmic reticulum, whereas Hsp 90 functions in both the cytosolic and 
nuclear compartments. Likewise, members of the Hsp 70 family exhibit complex 
patterns of growth-regulated and stress-induced gene expression and are targeted to 
different subcellular compartments.  
 
Studies have shown  that the stress response and apoptosis pathway are linked. Intensity 
and duration of heat shock responses resulting from stressful conditions and heat shock 
can also trigger apoptosis or necrosis (Barry et al., 1990). However, the exposure of 
cells to mild or little stress conditions that are sufficient to cause expression and 
accumulation of HSPs would eventually exert the protective effects on cell. This cell-
protective process is known as thermotolerance or cytoprotection, (Parsell et al., 1993). 
Since survival and death correspond to opposing cellular events, there should be 
multiple checkpoints and points of regulatory cross-talk to ensure that cells sustaining 
reparable molecular damage survive and that cells damaged beyond repair undergo cell 
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death. There is increasing evidence that Hsps may function at multiple points in the 
apoptotic signalling pathway and exert their protective effects to apoptosis. For example, 
high level of Hsp 70 reduce or block caspase activation and supress mitochondrial 
damage, nuclear fragmentation (Buzzard et al., 1998; Mosser et al., 1997), prevent 
recruitment of procaspase 9 and 3, to the apoptosome formation (Beere et al., 2000). 
Meanwhile Hsp 27 has been shown to block apoptosis induced by heat, Fas ligand, 
H2O2, and anticancer drugs (Richards et al., 1996; Trautinger et al., 1997).  
 
1.2.6 Characteristics of apoptosis 
1.2.6.1 Ca
2+
 influx 
Apoptotic cells acquired characteristic morphological and cytological changes while 
progressing through programmed cell death. The process of cellular suicide includes 
membrane modifications such as changes in membrane fluidity where involvement of 
Ca
2+
 influx. Whereas in studies conducted by Kim and coworkers indicated the Ca
2+
 
occurs through the activation of voltage-sensitive Ca
2+
 permeable non-selective cation 
channels. (Kim et al., 2000). Marked elevation of Ca
2+
 activate hydrolytic enzymes, 
lead to exaggerated energy expenditure, impair energy production, initiate cytoskeletal 
degradation, and ultimately resulting in cell death (Nicotera and Orrenius, 1998). 
 
1.2.6.2 Externalization of phosphatidylserine 
Most of the cell would maintain the asymmetric distribution of phospholipids between 
their cytoplasmic and exoplasmic membrane leaflets (Bretscher, 1972). However, the 
phosphatidylserine which belongs to component of phospholipid would be externalized 
to the outer membrane when a cell undergoes apoptosis (Mirnikjoo et al., 2009) 
especially in the early phase of apoptosis (Castegna et al., 2004). Externalization of 
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phosphatidyserine will eventually will act as phagocytic recognition and attract the 
phagocytes uptake and kill the apoptotic cells (Hoffmann et al., 2005).  
 
1.2.6.3 Membrane Blebbing and formation of apoptotic bodies 
Research showed that membrane blebbing may due to the level changes of cytoskeleton 
protein (Mills et al., 1998). In tumor cells which are lacking in the binding protein 
(ABP)
1
 bleb extensively under normal conditions (Cunningham, 1992). Peroxide-
induced blebbing is shown to be caused by the cleavage of actin binding proteins talin 
and α-actinin (Miyoshi et al., 1996). Membrane bledding can also occur when actin-
binding cytoskeleton protein which known as fodrin being cleaved by caspases during 
apoptosis (Cryns et al., 1996; Vanags et al., 1996). F actin was shown to be necessary in 
formation of blebbing and eventually apoptotic bodies (Cotter et al., 1992), besides the 
concentration of F actin is showed to be correlated to bleb size (Cunningham, 1995). 
Several groups have suggested the cleavage of actin by activated caspases during 
apoptosis contribute to membrane blebbing (Kayalar et al., 1995; McCarthy et al., 
1997). Other than actin, myosin was also shown to be involved in membrane blebbing 
formation (Mills et al., 1998). 
 
1.2.6.4 Chromatin condensation and DNA fragmentation 
During apoptosis, pro-apoptotic proteins such as AIF, endonuclease G and CAD are 
released from mitochondria. AIF would translocate to the nucleus and cause DNA 
fragmentation into ~50-300 kb pieces and condensation of peripheral nuclear chromatin 
(Joza et al., 2001). This early form of DNA condensation is referred to as “stage I”  
condensation (Susin et al., 2000). Meanwhile, translocation of endonuclease G to 
nucleus will cause the cleavage of nuclear chromatin to produce oligonucleosomal DNA 
fragmentation (Li et al., 2001). Both AIF and endonuclease G functioning in caspase-
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independent manner. The subsequent release of CAD protein from mitochondria during 
apoptosis would cleaved by activated caspase-3 and further translocate to nucleus where 
subsequently leads to oligonucleasomal DNA fragmentation or a more pronounced and 
advanced chromatin condensation (Enari et al., 1998). This later and more pronounced 
chromatin condensation is referred to as “stage II” condensation (Elmore, 2007; Susin et 
al., 2000). 
 
1.2.7 Oxidative stress 
Oxidative stress is generally defined as an imbalance that favours the production of 
ROS over antioxidant defences (Ott et al., 2007). In humans, oxidative stress has been 
implicated in a wide variety of pathologies, including cancer, type II diabetes, 
arteriosclerosis, chronic inflammatory processes, ischemia/reperfusion injury, and 
various neurodegenerative diseases (Droge, 2002). In the cell, the major reactive oxygen 
species (ROS) is produced through mitochondrial respiration. The ROS would be 
countered by the intracellular antioxidant defense systems including the glutathione 
peroxidase (Gpx)  (Han et al., 2003), SOD, catalase (Michiels et al., 1994) (Gus'kova et 
al., 1984), and most importantly tripeptide glutathione (GSH) molecules to prevent the 
interaction with various macromolecules in cells. 
 
1.2.7.1 Consequences of oxidative stress 
Damage to DNA 
Increase of intracellular ROS level would cause the oxidative damage to the DNA 
content, especially through the modification of the purine and pyrimidine bases of the 
deoxyribose backbone. An important target of ROS is the mitochondrial DNA 
(mtDNA), which encodes polypeptides, transfer RNAs (tRNAs) and ribosomal RNAs 
(rRNAs) which are all essential for electron transport and ATP generation by oxidative 
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phosphorylation (Anderson et al., 1981). As the major locus for free radical generation 
is inside the mitochondria, mtDNA is very susceptible to the attack by ROS. For 
example, ROS can trigger the formation of 8-hydroxydeoxyguanosine which is a 
modified base in mtDNA and probably leads to the respiratiory dysfunction followed by 
cell death (Anderson et al., 1981; Ott et al., 2007). 
 
Damage to proteins 
An important mechanism of O2
-
 toxicity is directly causing oxidation and inactivation of 
iron-sulfur (Fe-S) proteins, such as aconitases (Fridovich, 1997). The existence of 
aconitase in mitochondria plays a key role in the Krebs cycle, as it is responsible in 
catalysing the conversion of citrate to isocitrate. Partial or full inhibition of aconitase 
could result in Krebs cycle dysfunction and would cause an impact on energy 
production subsequently affecting the viability of the cell (Chen et al., 2005).  
 
Damage to lipids 
High level of ROS formation can stimulate lipid peroxidation in mitochondria and lead 
to suppression of mitochondrial metabolism. Mitochondrial functions such as 
respiration and oxidative phospholrylation, inner membrane barrier properties, 
maintenance of mitochondrial membrane potential (Δψ), and mitochondrial Ca2+ 
buffering capacity would be affected by lipid peroxides (Zhang et al., 1990; Albano et 
al., 1991; Bacon et al., 1993). The deleterious effect on mitochondrial Ca
2+
 permeability 
plays the key role in the activation modes of cell death (Chen et al., 1995). 
 
1.2.8 Caspases 
Caspases or cysteine-dependent aspartate-specific proteases, are a family of cysteine 
proteases that play essential roles in apoptosis, necrosis and inflammation (Alnemri et 
 
 
25 
 
al., 1996). In human, twelve caspases belonging to apoptotic and inflammatory 
subfamilies of caspases have been described. Apoptosis caspases can be further 
subdivided into initiator (caspase-2, -8, -9, -10) and executioner (caspase-3, -6, -7) 
caspases. Available crystal structures demonstrate that caspase zymogens are single-
chain proteins, with N-terminal prodomains preceding the conserved catalytic domains 
as shown in Figure 1.2.  They occur either as monomers or dimers, a crucial property 
that defines their activation mechanism. During activation and/or maturation, the 
catalytic domain is cleaved to a large (α) and a small (β) subunit that interact intimately 
with each other. The active form of a caspase is a dimer of catalytic domain of α β β’α’ 
symmetry, with two active sites per molecule (Denault et al., 2006; Pop and  Salvesen, 
2009). 
 
Adapted from (Pop and Salvesen, 2009) 
Figure 1.2 [A] caspase organization. A prodomain precedes the catalytic domain, 
composed of two covalently linked subunits. Sites for (auto) proteolysis at Asp residues 
are indicated. [B] activation mechanisms. Initiators are monomers that activate by 
prodomain-mediated dimerization. Executioners are dimers that activate by cleavage of 
intersubunit linkers. Following activation, additional proteolytic events mature the 
caspases to more stable forms, prone to regulation. 
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1.2.8.1 Types of caspases 
Initiator caspases, present in the cell as inactive or inert monomers. Its activation is by 
dimerization process where those monomers recruited to platform molecules via these 
protein-protein interaction domains and are subsequently activated by oligorization and 
proximity-induced autoproteolysis. Short prodomain caspases exist as preformed dimers 
in the cell and their enzymatic activity requires proteolytic maturation by the action of 
upstream caspases (Salvesen and Riedl, 2008).  
 
Executioner caspases or downstream caspase group are thought to be responsible for the 
actual destruction of the cell. This group of caspases occur as inactive dimers that 
require cleavage of catalytic domain to become active (Figure 1.2). When compared to 
initiator caspases, the first step of activation namely dimerization has already occurred 
shortly after their synthesis. The large and small subunits of catalytic domain are 
restrained by a short linker. The crystal structure of the zymogen form of caspase-7 
revealed clearly the molecular details of the catalytic groove formation upon activation 
(Chai et al., 2001; Chai et al., 2001). Proteolytic processing of the linker allows 
rearrangement of mobile loops equivalent to the initiator caspases, favouring formation 
of the catalytic site (Prior and Salvesen, 2004). 
 
Generally, there are two pathways in which the caspase family proteases can be 
activated, namely, extrinsic or death receptor-mediated pathway and also intrinsic 
mitochondrial-mediated pathway. Commonly, the death receptor-dependent procaspase-
activattion pathway involved caspase-8 and caspase-10. Whereas the activation of the 
death receptor by Fas ligand (FasL) and tumor necrosis factor (TNF)-2 signaling 
molecules occurs at outer plasma membrane of cell (Lu et al., 2003; Wang et al., 2005).  
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1.2.8.2 Caspase activation in extrinsic and intrinsic apoptotic pathway 
The binding of the signalling molecules will eventually activate the death receptor. The 
binding of Fas to Fas associated death domain (FADD) (or TNFR-associated death 
domain, TRADD) will cause FADD aggregation followed by the emergence of death 
effector domains (DEDs). Interaction of DEDs with prodomain of procaspase-8 induces 
the oligorization of procaspase-8 followed by formation of a massive molecule complex 
known as the death-inducing signal complex (DISC). In DISC, two linear subunits of 
procaspase-8 are compacted together followed by procaspase-8 autoactivation to 
caspase-8 (Wang et al., 2005).  
 
The following downstream effects of caspase-8 can be divided into two types. The first 
type involves direct vigorous activation of the procaspase-3 by caspase-8. It can be 
found in certain types of the lymphoid cell lines. Opposed to first type, the activated 
caspase-8 can be either mildly activated or totally unable to activate procaspase-3 
directly. However, it can activate the mitochondrion-mediated pathway by truncating 
Bid (a pro-apoptotic Bcl-2 family member) in cytosol of cell and activated it to become 
tBid which can trigger the activation of the mitochondrion pathway (Arnoult et al., 
2003). 
 
The activation pathway mediated by procaspase-10, with a DED-containing prodomain, 
is similar to that mediated by procaspase-8. It can function independently of caspase-8 
in initiating Fas- and TNF-related apoptosis. Moreover, Fas crosslinking in primary 
human T cells leads to the recruitment and activation of procaspase-10. Although 
caspase-8 and caspase-10 both interact with the DED of FADD in death receptor 
signalling, they may have different apoptosis substrates and therefore potentially 
function distinctly in death receptor signalling or other cellular process (Wang, 2001 ). 
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The intrinsic apoptosis pathway involves mitochondrion-mediated procaspase-
activation of caspase-9. The activation of the mitochondrion-mediated pathway 
normally occurs when cell is under stress (e.g. DNA damage) which in turn will cause 
the activation of the proapoptotic protein in cytosol. Next, it induces the opening of 
mitochondrion permeability transition pores (MPTPs). As a result, cytochrome c that is 
localized in the mitochondria will be released to the cytosol. 
 
The presence of the cytosolic dATP (deoxyadenosine triphosphate) or ATP, cytochrome 
c, apoptotic protease activation factor (Apaf-1) oligomerizes together with cytosolic 
procaspase-9 can result in the formation of a massive complex known as apoptosome. 
The N-terminal of Apaf-1 and the prodomain of procaspase-9 both have caspase 
recruitment domains (CARDs) and form a complex in the proportion of 1:1 (Arnoult et 
al., 2003; Fan et al., 2001). Activated caspase-9 can in turn activate procaspase-3 and 
procaspase-7. The activated caspase-3 will then activate procaspase-9 and form a 
positive feedback activation pathway to further enhance the apoptotic effects (Fan et al., 
2005). Figure 1.3 and 1.4 summarized the caspase-8 and caspase-10 activation and 
downstream of executioner caspases activities mentioned above. 
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Adapted from (Fan et al., 2005) 
Figure 1.3 Caspase -8/caspase -10 dependent procaspase-activation 
 
 
Adapted from (Fan et al., 2005) 
Figure 1.4 Downstream substrates of apoptosis executioner caspases. 
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1.2.9 Possible intervention of apoptosis and chemoprevention in cancer 
Of all the forms of cell death,  apoptosis is the best characterized and its highly 
regulated nature makes it an attractive target for therapeutic intervention. Apoptosis is 
highly conserved throughout evolution (Lockshin and Zakeri, 2007; Samali et al., 1996) 
and plays a major physiological role in both embryonic development and aging 
(Lockshin and Zakeri, 2007; Samali et al., 1996). Thus, the therapies designed to 
stimulate apoptosis in target cells play an increasing central role in the prevention and 
treatment of both hereditary and non-hereditary types of cancer (Hawk et al., 1999). 
Chemoprevention in colorectal cancer is defined as the use of pharmacological agents to 
prevent or reverse the development of adenomatous polyps and subsequent progression 
to colorectal cancer (Plummer et al., 2001; Sharma et al., 2001). 
 
Among these agents, curcumin (diferuloylmethane) a naturally occuring yellow 
phenolic chemical substance derived from the root of plant Curcuma longa is currently 
widely used as chemopreventive agent (Cheng et al., 2001; Rao et al., 1995). This 
major pigment in turmeric, possesses both anti-inflammatory (Srimal and Dhawan, 
1973) and antioxidant properties (Motterlini et al., 2000; Sharma, 1976) and studies 
have shown that curcumin inhibits growth of cultured colon HCT-15 and HT-29 human 
cancer cell lines (Hanif et al., 1997), and also prevents the development of skin cancer 
in in vivo models (Huang et al., 1992). There are even more reports (Skommer et al., 
2007; Yang et al., 2012; Yang et al., 2012) showing curcumin-induced apoptosis in 
numerous types of cancer cell lines, one of the apoptotic pathways is through generation 
of reactive oxygen species, down regulation of Bcl-XL and IAP followed with release 
of cytochrome c and inhibition of AKT (Woo et al., 2003). 
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As an important and common food coloring and flavouring agent (Kawamori et al., 
1999), dietary administration of curcumin significantly suppresses development of 
chemically induced forestomach, duodenal and colon tumors in mice model (Huang et 
al., 1994). Reduction in formation of focal areas of dysplasia and aberrant crypt foci in 
the colon that are early preneoplastic lesions in rodents was detected with curcumin 
administration (Huang et al., 1992; Rao et al., 1993). Report (Pereira et al., 1996) has 
shown that, continuous administration of 0.8% and 1.6% curcumin during initiation and 
postinitiation phase significantly inhibited development of colonic adenomas in rats.  
Moreover, phase I clinical trial studies conducted by Cheng et al. (2001) in patients 
with high-risk or pre-maglinant lesions demonstrated that curcumin possesses 
chemoprevention activities. Results supported that curcumin is not only able to exert its 
effect in early stage of cancer-initiation stage, but also either in cancer promotion or 
may be progression stage. In addition, a high dose of curcumin up to 8 g/day could be 
administrated orally on daily mode to patients with premalignant lesion for 3 months 
without overt toxicity (Cheng et al., 2001).  
 
A critical issue in chemoprevention is in the relative sensitivity of cells at different 
stages of neoplastic progression (Koornstra et al., 2003).  It is generally believed that, 
the apoptotic inducers that can directly induce apoptosis may provide less opportunity 
for cancer cells to acquire drug resistance traits and decrease mutagenesis and reduce 
toxicity on normal cells. It is for these reasons that researchers have a general interest in 
identifying compounds that possess apoptosis-inducing capabilities (Essack et al., 2011). 
As discussed earlier, curcumin is definitely a good example of plant-derived compound 
that complies to all necessary criteria and features mentioned. In the coming years, it 
seems likely that rational strategies to manipulate apoptotic mechanisms will produce 
new therapies that are less toxic than current chemoprevention strategies.  
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1.2.10 Cell Cycle 
The cell cycle is a series of events that take place in a cell leading to its replication. 
There are two important phases in cell cycle where S phase is the chromosome 
duplication (synthesis) phase and M phase stands for mitotic phase, in which the cell’s 
chromosomes are divided between two daughter cells. These two important phases are 
separated by G1 phase and G2 phase (interphase) making up the sequence M-G1-S-G2 
as shown in Figure 1.5 (Kathleen, 1997). Regulation of the cell division cycle is an 
essential process by which the cell monitors its fidelity of cell division through several 
cell cycle checkpoints. The main function for the existence of checkpoints is to assess 
DNA damage and make sure the correct replication of DNA sequences. Scientists have 
identified several checkpoints along the cell cycle namely G1 checkpoint (located in G1 
phase), G2 checkpoint (located in G2 phase) and so on (Anne, 2006; Julie and Jane, 
2005).  
 
Generally, the cell cycle progression relies on cyclin dependent kinases (cdks) and their 
inhibitors. If there are any DNA damages on the chromosomes, it will cause the absence 
or presence of certain regulators that can stop the cells from passing through their 
checkpoint and subsequently leading to cell cycle arrest or apoptosis (Alberson et al., 
2005). 
                                         
Figure 1.5 The different phases in cell cycle. 
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1.2.10.1 Early cell cycle progression: G1/S-phase 
Cell cycle progression involves expression and/or activation of numerous regulatory 
proteins. The regulatory proteins include cyclin-dependent kinases (Cdk’s) and holo-
enzymes formed from complex of cyclins and the cyclin. Accumulation of D-type 
cyclins (D1, D2, and D3), Cdk’s (Cdk4 and Cdk6) and proliferating cell nuclear antigen 
(PCNA) that occur during the early entry of G1-phase would promote DNA-polymerase 
activity (Stillman, 1994). PCNA is capable of forming complexes with cyclin D/Cdk4 
complexes to regulate the cell cycle progression (Sherr, 1994). In fact, increased levels 
of the cyclin-dependent kinase inhibitor (CKI) typically p27
Kip1
 will prevent the cell 
cycle entry into mitogen deprived (G0) phase (Sherr and Roberts, 1995) as p27
Kip1
 is 
able to bind and cause deactivation of G1-phase cyclin/Cdk complexes. It is counter- 
balanced by increased level of activated D/Cdk4/PCNA complexes, as high level of 
D/Cdk4/PCNA compared to p27
Kip1 
will allow an enzymatic activation of Cdk2. In late 
G1-phase, expressed cyclins E and A will form complexes with the activated Cdk2 
together assisting in progression of cell through the cell cycle phase. 
 
Retinoblastoma gene product (Rb) which is responsible as a timer of transcriptional 
events will be activated through phosphorylation process by activated G1-phase Cdk 
complexes (Weinberg, 1995). Hyper- or hypo-phosphorylated Rb would either inhibit 
or release different isoforms of E2F in late G1-phase. The primary isoform of E2F, 
E2F-1 regulates number of genes which are required for progression of cells in different 
phases including, S, G2 and M. The genes under regulation by E2F1 include PCNA, 
dihydrofolate reductase, cyclin E, Cdk1 and cyclin A (Gregori et al., 1995). 
 
Regulation of early phases of cell cycle also involves a 21-KD protein, p21
Cip1
. As 
another CKI, p21
Cip1
 is thought to act as a cyclin-Cdk assembly and a regulatory factor 
 
 
34 
 
(Sherr and Roberts, 1995). The importance of p21
Cip1
 can be seen where a single p21
Cip1
 
molecule may be required for Cdk activation, whereas complexes are inactivated if 
bounded by multiple p21
Cip1
 subunits. p21
Cip1
 protein levels remained low in G0-phase 
cell, but an upsurge of this protein can be observed in late G1-phase. The increased 
level of this Cdk inhibitor is important as it can regulate or counterbalance the increased 
accumulation and enzymatic activity of cyclin/Cdk complexes (Sherr and Roberts, 
1995).  
 
Protein 53 (p53) or known as “the guardian of the genome” is a vital transcription factor 
that regulates the expression of a number of important genes. This protein has also been 
shown to be involved in cell cycle regulation (Levine, 1997). One example of the 
involvement of p53 in the cell cycle is through the response to DNA damage that leads 
to an arrest in G1-phase. It serves to provide the primary mechanism of the 
antiproliferative effect on cells that suffer from irradiation by stimulating the 
accumulation of p21
Cip1
 (Deiry et al., 1993; Levine, 1997). Accumulation of p21
Cip1
 will 
thereby directly block the ability of PCNA and suppress the processing ability of DNA 
polymerase. Consequently, it can cause the arrest of DNA replication and thus allows 
DNA repair to take part (Waga et al., 1994).  In fact, besides acting as a transcription 
factor, p53 can also act through direct protein-protein interactions with E2F1 as an 
alternative preventive measure to promote apoptosis on the damaged DNA cells (Lowe 
et al., 1993). Indeed, studies have suggested that p53 plays a role in regulating the 
transition of G0-G1-S and also completion of G2/M-phase in cell cycle progression 
(Cross et al., 1995; Del Sal et al., 1995). 
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1.2.10.2 Late cell cycle progression: G2/M-phase 
DNA replication process is completed at G1 phase and the cell is expected to progress 
further through the G2-phase with marked increase of cyclin B protein. The complex 
known as “mitosis-promoting factor” (MPF) would be formed when cyclin B protein 
interacts with Cdk1 with the presence of cell division cycle 2 (Cdc 2) kinase. 
Phosphorylation of Cdk1 on a threonine residue (Thr161) by Cdc25 phosphatase 
activates MPF (King et al., 1994). The activated MPF will then be able to induce the 
ubiquitin proteasome pathway that subsequently causes cyclin B degradation and the 
initiation of anaphase (King et al., 1996). Eventually, the reset of cell cycle clock is 
through dephosphorylation of Cdk 1 at Thr161. 
 
Besides that, proto-oncogenes especially c-fos is believed to play a significant role in 
the completion of progression through the cell cycle. As it has been suggested c-fos is 
required for all phases of cell cycle (Pai and Bird, 1994). C-myc is able to increase Cdk 
activity, resulting in upregulation of cyclin level and further induces Cdc25 phosphatase 
activation in which it causes a rapid hyperphosphorylation of pRb at G1/S (Galaktionov 
et al., 1996). C-myc can also cooperate with activated H-ras to upregulate the Cdk1 
protein level, an interaction that is further correlated with its ability to promote 
progression into M-phase (Born et al., 1994). Meanwhile, C-myb regulates the 
transcription level of Cdk1 (Ku et al., 1993) and increases the expression of IGF-1 
(Travali et al., 1991), indicating a bidirectional regulation of prooncogene and growth 
factor expressions in cell (Pardee, 1989). Figure 1.6 summarized the regulatory proteins 
involved in cell cycle regulation.  
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Figure 1.6 Involvement of cell cycle regulatory proteins in cell cycle regulation. 
 
1.2.11 Cancer and Natural Products 
In recent years, oriental medicinal herbs have aroused scientific interest as 
complementary or alternative medicines (Lee, 2000). The utilization of modern 
analytical and chemical purification techniques has resulted in the discovery of novel 
natural compounds from herbs, a step further and easier than before. Intensive scientific 
studies are being conducted in search for new drugs or chemicals from natural sources 
as there are 250,000 species of plant in the world and most of them are in wait to be 
discovered (Cragg and Newman, 1999; Cragg et al., 1997).  Furthermore, the 
uniqueness and diversity of chemical compounds in natural products intensify the 
identification and mechanistic investigation in natural product field. These lead to the 
discovery of novel lead compounds acting on newly discovered therapeutic targets 
(Harvey, 1999).  Besides, the synthetic analogs of natural products as potential cancer 
chemopreventive agents has also become an important issue in current public health-
related research (Steele et al., 1998; Alberts et al., 1995). 
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Today, naturally derived products play an important role as a source of medicine and 
many pharmaceutical agents have been discovered (Harvey, 1999). Several important 
chemotherapeutic drugs derived from plants have been discovered, such as 
podophyllotoxin, vinblastine, camptothecin and Taxol, and are widely used in tumor 
medical treatment (Raskin et al., 2002). One of the most noteworthy examples of the 
plant-derived anticancer agent is the vinca alkaloids vincristine isolated from periwinkle 
Catharanthusroseus, which is endemic in Madagascar rain forests. Plant-derived 
vincristine is known as mitotic inhibitor which is commonly used in cancer 
chemotherapy. It acts through binding to tubulin and depolymerize the microtubules 
(Okouneva et al., 2003), leading to cell cycle arrest in mitosis especially in the 
metaphase (Gidding et al., 1999). Besides the interaction with tubulins, its efficacy 
toward cancer cells is also due to other mechanisms such as membrane-bound drug 
efflux transporters, signal transduction pathways and programmed cell death. 
 
1.2.12 Limonoids 
Limonoids are found most abundant in Meliaceae and Rutaceae Families. Natural 
occurring citrus limonoids contain a furan ring attached to the D-ring, at C-17. The 
oxygen containing functional groups occur at C-3, C-4, C-7, C-16 and C-17 of the 
structure of citrus limonoids. On the other hand, the structural variations of limonoids 
found in Rutaceae are lesser compared to Meliaceae as there are generally due to 
limitation of the modification at ring A and B. Limonoids found in the family of 
Meliaceae are far more complex as their structures have higher number of oxygen 
molecules and far more types of rearrangement are exhibited in the parent limonoid 
structure (Roy and Saraf, 2006). 
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Due to commercial reasons, limonoids were discovered way back when researchers 
started looking for the factor responsible for the bitterness in citrus as it created a 
negative impact on the fruit and juice industry. The ability of some limonoids to 
produce an extremely bitter taste in these products has provided much impetus to the 
study of their structural makeup and characteristics. Eventually limonin was the first 
tetranortriterpenoid to be discovered from citrus which is responsible for its bitterness, 
consequently contributed to the derivation of the term limonoids (Roy and Saraf, 2006). 
Scientific studies of this group of compounds have been shown to exhibit a wide range 
of biological activities including antifungal, antibacterial, antimalaria, anticancer, 
antiviral and also a number of pharmacological activities on humans (Saraf, 2006).  
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1.2.12.1 Structure-related activities 
According to studies conducted by Govindachari and coworkers (1999) limonoids 
namely, swietenine, 3-tigloylswietenolide and 6-acetylswietenine were evaluated for  
antifungal activity and  the results have revealed that the double bond position in these 
compounds at 8, 30 and 8, 14 did not play a role  in the antifungal activity. However, it 
was proposed that functional group substitutions at C-6 may be important in increasing 
the antifungal effect as the 3-tigloylswietenolide and 6-acetylswietenine compounds 
with acetoxy group at C-6 possessed stronger bioactivity. This concluded the C-6 
substitution is crucial for antifungal activity. 
 
Comparison between 3,6-Di-O-acetylswietenolide and swietenolide has resulted in the 
conclusion that C-3 substitution with a tigloyl group possessed the strongest activity 
followed by hydroxyl and acetyl group. Meanwhile, mexicanolide derivatives such as 
2,3 dihydroxymexicanolide, 3-hydroxymexicanolide and 3-acetoxymexicanolide with 
carbonyl group substitution at C-3 and 2α-hydroxymexicanolide (A-hydroxyl 
substitution at C-2 and a carbonyl functional group at C-3) showed limited activity .    
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1.2.13 Swietenia macrophylla 
[A] 
 
[B]     [C] 
   
 
Figure 1.7 The view of [A] whole tree, [B] Fruit and [C] seeds of Swietenia 
macrophylla King. 
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The existing study is to focus on the seeds of Swietenia macrophylla as shown in Figure 
1.7. The details of this plant are listed as below. 
A) Scientific classification of Swietenia macrophylla. 
Kingdom : Plantae 
Order: Sapindales 
Family: Meliaceae 
Genus: Swietenia 
Species: S. macrophylla 
B) Common name: 
Sky fruit, Coaba (throughout Latin America), Acajou (French-speaking areas), Tunjuk 
Langit (Malay). 
C) Physical Characteristic: 
They are medium-sized to large trees growing to 20-45 m tall, and up to 2 m trunk 
diameter. The leaves are 10-30 cm long, pinnate, with 3-6 pairs of leaflets, the terminal 
leaflet absent; each leaflet is 5-15cm long. The leaves are deciduous to semi-evergreen, 
failing shortly before the new foliage grows. The flowers are produced in loose 
fluorescence, each flower small, with five white to greenish-yellowish petals. The fruit 
is a pear-shaped five-valved capsule 8-20 cm long, containing numerous winged seeds 
about 5-9 cm long (Brown et al., 2003). 
D) Traditional usage 
The seeds of Swietenia macrophylla are used in traditional medicine to improve blood 
circulation or hypertension, diabetes, skin condition (Tan et al., 2009) and as 
antimalarial (Munoz et al., 2000). 
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E) Previous works on Swietenia macrophylla 
i) Phytochemicals 
Previous phytochemical investigations have revealed the present of limonoids such as 
swietenin, swietenolide, 8,30-epoxyswietenine acetate, swietenine acetate, swietenolide 
diacetate, swietenolide tiglate, augustineolide and 3β, 6-dihydroxydihydrocarapin in the 
seeds (Anne, 1983; Chakravarty, and Chatterjee , 1955; Chakravarty et al., 1957; Chan 
et al., 1976; Connolly, 1964; Mootoo et al., 1999). On the other hand, its leaves have 
been reported to yield essential oils which contain himachalene, germacrene D, 
germacrene A, cadina-1,4-diene, hexadecanoic acid, and ethyl hexadecanoate (Soares, 
2010). Besides that, the most recent finding reported that four new phragmalin-type 
limonoids were successfully isolated out, named swietephragmin H-J and 
swietemacrophine from dichloromethane extract of Swietenia leaves (Tan et al., 2009). 
 
ii) Bioactivity 
Several bioactivities works have been done by scientists around the world on this 
particular plant. The limonoids of this tree have been shown to exhibit antimalarial 
(Soediro et al., 1990) insect anti-feedant (Nsiama, 2008), anti-inflammatory (Chen et al., 
2010), antimicrobial (Maiti et al, 2007), oral hypoglycemic (in vivo) (Dewanjee et al., 
2009a) and antioxidant activities (Tan et al., 2009) and the essential oil of S. 
macrophylla have been shown able to induce electrophysiological responses to Zeller 
(Soares et al., 2003). 
 
 
 
 
 
 
43 
 
CHAPTER 2 
MATERIAL AND METHODS 
2.1 Material 
2.1.1 Solvents 
Acetone, chloroform, ethanol (95%), absolute ethanol, ethyl acetate, hexane, methanol 
and sulphuric acid were purchased from Merck. 
 
2.1.2 Cell lines 
The cell lines namely Ca Ski (Human Caucasoid cervical carcinoma cells, CRL1150), 
KB (Human Negroid cervical carcinoma cells, HeLa derivative, CCL-17), MCF-7 
(Human breast carcinoma cell, HTB-22), Hep G2 (Human hepatocellular carcinoma cell, 
HB-8065), HCT116 (Human colorectal carcinoma cell , CCL-247) and MRC-5 (Human 
fibroblast cell, CCL-17) were procured from American Type Culture Collection. 
 
2.1.3 Growth medium 
The growth medium namely EMEM (Eagle’s Minimum Essential Medium), DMEM 
(Dulbecco’s Modified Eagle’s Medium), Medium 199 and RMPI (Roswell Park 
Memorial Institute) 1640 were purchased from Sigma. 
 
2.1.4 Drugs, chemicals and reagents 
The following purchased items are listed according to manufacturer: 
Sigma: Bovine Serum Albumin (BSA), HEPES, Hoechts 33342, camphothecin (CPT), 
dimethyl sulfoxide (DMSO), ethylene diamine tetrachloroacetic acid 
(EDTA.4Na.4H2O), paraformaldehyde (PFA), PBS, propidium Iodide, RNase A, 
sodium azide, trypan blue, DCFH-DA (6-carboxy-2’, 7’-dichlorodihydrofluorescein 
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diacetate), Copper sulphate, N,N’-Methylethylenediamine (TEMED), ammonium 
persulfate, acrylamide and sodium dodecyl sulphate. 
Merck: Thin Layer Chromatography (TLC) plate silica gel 60 F254, Silica gel F254 
(0.063-0.200 mm), Trixon X-100, sodium carbonate, potassium sodium tartarate, 
hydrochloric acid, Folin-Ciocalteu reagent, bromophenol blue, Tris (hydroxymethyl)-
aminomethane, glycerol, glycin and acetic acid. 
PAA Lab: Amphotericin B, Fetal bovine serum and penicillin-streptomycin (liquid). 
BD-Bioscience: Annexin V FITC, Annexin V binding buffer and Cytofix/Cytoperm. 
Innovative Cell Technologies: Accutase  
Bio-Rad: Coomassie brilliant blue R-250. 
  
2.1.5 Kits 
The following purchased kits are listed according to manufacturer: 
Immunochemistry technologies, LLC: FAM-FLICA Caspase 3/7, FAM-FLICA Caspase 
8, FAM-FLICA Caspase 9 and FAM-FLICA Caspase 10. 
Qiagen: QIAamp RNA Blood Mini Kit, Qiagen SA Biosciences PCR array and First 
Strand kit. 
Stratagene: Mitochondrial membrane potential detection kit. 
Ambion: RNAqueous-4PCR kit. 
Quantace: SensiMix One-Step Kit. 
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2.1.6 Oligonucleotides 
Table 2.1: The different primers used in this study are listed as below. 
Target Genes Function Sequence 
Bcl-2 Forward primer 5’-TTGGCCCCCGTTGCTT-3’ 
Reverse primer 5’-CGGTTATCGTACCCCGTTCTC-3’ 
Bax Forward primer 5’-GTCGCCCTTTTCTACTTTGCCAG-3’ 
Reverse primer 5’-TCCAGCCCAACAGCCGCTCC-3’ 
PBGD Forward primer 5’-ACCATCGGAGCCATCTGCAAG-3’ 
Reverse primer 5’-CCCACCACACTCTTCTCTGGCA-3’ 
PCNA Forward primer 5’-GCCTGCTGGGATATTAGCTC–3’ 
Reverse primer 5’-CATACTGGTGAGGTTCACGC–3’ 
GADPH Forward primer 5’-CCAGGGCTGCTTTTAACTCTG–3’ 
Reverse primer 5’-CGTTCTCAGCCTTGACGGTG–3’ 
 
 
2.1.7 Instrumentation/ Equipment 
Instruments and equipment used including Nanodrop (Thermo Scientific), Centrifuge 
(Eppendorf), CO2 incubator (RS biotech), Microplate reader Asys UVM 340 (Biochrom 
Ltd), Flow Cytometer (FACSCalibur) and CellQuest software (Becton Dickinson), 
Leica Fluorescent microscope (Leica),Liquid nitrogen storage Dewar (MVE), pH meter 
(Jenway), RotorGene-6000 System (Qiagen), Rotary evaporator with vacuum & water 
bath (Buchi), NMR Spectrometer 400MHz (JEOL), LC-MS (Fisher Scientific), LC-
MS/MS-TOF (Agilent), SDS-PAGE system (Bio-Rad), BD-C6 Accury Flow cytometer 
(Becton Dickinson) and High performance liquid chromatography (Shimadzu). 
 
2.1.8 Miscellaneous 
Items listed according to manufacturer: 
Orange Scientific: cell culture flasks (25 and 75 cm
2
), cell culture dishes (60 mm) and 
cell culture multiwall plate (96 well, flat bottom). 
DB Biosciences: conical centrifuge tubes (15 and 50ml). 
Nalge Nune International: Cryovials. 
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Becton Dickinson: falcon round bottom tubes (5ml). 
Pyrex Co.: glassware. 
Fisher Scientific: glass slides and cover glass slips and haemocytometer and cover slips. 
Sartorius: sterile syringe and syringe filters (0.2 µm). 
 
2.2 Methods 
2.2.1 Plant material 
The dried seeds of Swietenia macrophylla (600 g) were purchased from local market 
and were identified by Professor Dr. Ong Hean Chooi, a botanist from Institute of 
Biological Sciences, Faculty of Science, University of Malaya, Malaysia. A voucher 
specimen (No. KLU46901) is on deposit at Herbarium of Institute of Biological 
Sciences, Faculty of Science, University of Malaya, Malaysia. 
 
2.2.2 Extraction and Fractionation of S. macrophylla 
Seeds of S. macrophylla were extracted to obtain the crude ethanolic extract 66.6 g out 
of 600 g of sample (11.1 g per 100g of dry weight) and further fractionation to yield 
fractions with different polarities. 
 
2.2.2.1 Solvent extraction 
The dried, ground seeds powder was then soaked for 3 days in ethanol at room 
temperature. The extract was then filtered from the residue by using filter paper and the 
residue was re-extracted with ethanol again for two times. By using a rotary evaporator, 
the ethanol solvent was evaporated under reduced pressure at a temperature of 45 °C to 
give a dark yellow crude ethanolic extract. 
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2.2.2.2 Solvent-solvent partitioning of the crude extract  
A solvent-solvent partitioning step was employed to separate the extract based on 
polarities (Figure 2.1). The use of solvents with varying polarities ensures that a wide 
polarity range of compounds could be extracted in the process. 30 g of the ethanolic 
extract was partitioned with hexane to yield a 4.28 g hexane soluble fraction. The 
resultant hexane-insoluble residue was further partitioned with ethyl acetate and water 
(1:1) in a separating funnel. The bottom aquoeus layer was collected and concentrated 
by evaporation under vacuum and freeze-dried to yield a water fraction of 2.48g. The 
upper ethyl acetate layer was evaporated under pressure to give an ethyl acetate fraction 
of 23.1g. This afforded another three fractions from the crude plant extract, namely, S. 
macrophylla ethanol extract (SMEE) , S. macrophylla hexane fraction (SMHF), S. 
macrophylla ethyl acetate fraction (SMEAF) and S. macrophylla water fraction 
(SMWF). 
 
 
Figure 2.1 Extraction and fractionation procedures. 
i. Ethanol extraction 
i. Hexane extraction 
ii. Concentrated under 
reduced pressure 
Dried and ground sample 
Ethanol extract 
Hexane-soluble fraction Hexane-insoluble fraction 
Ethyl acetate-soluble 
fraction 
Aqueous fraction 
Partition (v/v) ethyl 
acetate: water (1:1) 
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2.2.3 Cell culture 
2.2.3.1 Maintenance of cells 
HCT116, Ca Ski, MCF-7, KB, Hep G2 cells were cultured in RPMI (Roswell Park 
Memorial Institute) 1640 Medium. The MRC-5 cells were cultured in MEM medium 
which supplemented with sodium pyruvate. Both type of medium were further 
supplemented with 10% (v/v) heat-deactivated fetal bovine serum, 100 µg/ml 
streptomycin, 100 unit/ml penicillin and 50 µg/ml amphotericin B. All the media were 
filter-sterilized by using a membrane filter with pore size of 0.22 µm. the cells were 
cultured as monolayers and maintained in 5% CO2 incubator at 37 °C in a humidified 
atmosphere. 
 
2.2.3.2 Cryopreservation of cells 
For cryopreservation, the cells were first viewed using an inverted microscope to assess 
the degree of cell density and confirm the absence of contamination. The confluent cells 
were harvested and centrifuged at 1000 rpm for 5 min and the cell pellet was washed 3 
times with PBS and resuspended at a concentration of 1 x 10
6
 cells per ml in a freezing 
medium. Since the formation of ice crystals during the freezing process could rupture 
the cells, a special feezing medium consisting of 70% of respective culture medium, 20% 
of FBS and 10% of DMSO was used. Then 1 ml aliquot of the cell suspension was 
transferred into sterile cryovial and labelled with the cell-line name, date, passage 
number and user name. To ensure successful cryopreservation, gentle freezing method 
was used whereby the temperature was decreased gradually. The vials were first frozen 
at -20 °C for 6 h and then transferred to -80 °C for 2 h before placed in the vapour phase 
of liquid nitrogen storage vessel for long-term storage.  
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2.2.3.3 Reviving of cells  
For resuscitation of cells, cryovials were removed from the liquid nitrogen storage and 
quickly defrosted by immersed in a 37 °C water bath and gently shaken until thawed. 
Once fully thawed, the cells were pipetted into 15 ml conical centrifuge tube containing 
warmed medium. After centrifugation at 1000 rpm for 5 min, the supernatant was 
removed and the pellet was resuspended in fresh warm medium. The cells were then 
pipetted into 25 cm
2
 cell culture flask and incubated inside CO
2
 incubator overnight to 
allow cells to adhere. The medium was removed the next day to remove traces of 
DMSO and replaced with fresh medium. The cells were culture for at least 3 passage 
before use for any experiment. 
 
2.2.3.4 Subculturing the cells 
When the cell growth reached confluency, the cells were subcultured/ passaged in order 
to prevent the cells from dying by providing spaces for continuous growth and supply of 
fresh nutrients. To subculture the cells, the medium was removed and the cells were 
washed twice with phosphate buffer saline (PBS) by gently swirling the flask. After 
discarding the PBS, 2ml of Accutase solution was added to cover the adhering 
monolayer cells and the flask was returned to the incubator and left for 3~8 min. During 
the incubation period, the flask was examined under an inverted microscope to ensure 
that all the cells were detached and floating. The bottom of the flask was gently tapped 
to dislodge any remaining attached cells. When the cells were rounded up and detached 
from the surface, medium was added into the flask. The cell suspension was transferred 
into a 15ml conical centrifuge tube and centrifuged at 1000 rpm for 5min. After 
discarding the supernatant, the pellet was resuspended in the medium and diluted to 
appropriate concentration before transferred to new flasks for further incubation. 
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2.2.3.5 Counting the cells 
A trypan blue exclusion assay was performed to count the viable cells using a 
haemocytometer. Trypan blue is a dye that excludes viable cells but selectively stains 
dead cells with damaged plasma membrane. To count the cells, adherent cells were 
harvested and resuspended in a volume of medium. Then 100 µl of 4% (w/v) trypan 
blue solution was added (dilution factor=2). The cells were mixed and left for 2 min at 
room temperature. Then 20 µl aliquots of cell mixtures were pipetted into each of the 
two haemocytometer chambers covered with a coverslip and the chamber was filled by 
capillary action. The haemaocytometer was viewed under an inverted phase contrast 
microscope using 10x or 20x magnifications to focus on the grid lines of the chamber. 
The number of viable cells were counted in the five large squares. Non-viable cells 
(stained blue) were not included in the cell counts. The number of viable cells per ml 
was calculated by the equation: total number of viable cells/ml = the average count per 
square x dilution factor x 10
4
, where the dilution factor = 2 (if volume of cell suspension 
and trypan blue = 1:1) and 10
4
 = correction factor (supplied by haemocytometer 
manufacturer). To obtain the total viable cell number in the original suspension, the 
viable cell number/ml was multiplied by the total volume (ml) in the original suspension. 
 
2.2.3.6 Treatment of cells 
Stock solution (20mg/ml) of the plant extract/ fractions and isolated pure compounds 
were prepared by dissolving them in DMSO. These solutions were filter-sterilized and 
stored in lightly sealed dark glass container in at -20 °C. For the experimental 
procedures, the stock solutions were serially diluted by using medium and added to the 
cells. Exponentially growing cells were then treated with the vehicle DMSO. The final 
concentration of DMSO was 0.5% (v/v). Cells were harvested at the appropriate time 
points, and were then subjected to various processing procedures accordingly.  
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2.2.4 Evaluation of cytotoxic effect of extract and fraction of S. macrophylla 
The crude ethanolic extract and fractions from S. macrophylla were evaluated their 
cytotoxic effect using MTT cell viability assay. 
2.2.4.1 MTT cell viability assay 
3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide or known as  MTT assay 
has been routinely used to assess cell growth/ inhibition and cell viability and compared 
well with other available assays  (Alley et al., 1988; Hansen et al., 1989; Mosmann, 
1983; Rubinstein et al., 1990). The assay is based on the reduction of yellow water 
soluble tetrazolium MTT by mitochondrial dehydrogenase to a purple water insoluble 
formazan cystal. the reduction takes place only in metabolically active cells and 
therefore, the generated formazan product is proportional to the number of viable cells 
(Liu et al., 1997). The amount of MTT formazan produced can be dissolved in a 
suitable solvent and determined spectrophotometrically. The reaction is shown in Figure 
2.2. 
 
Figure 2.2 Principle of MTT chemical reaction. 
 
The effect of Swietenia macrrophylla extracts on cell viability was assessed using the 3-
(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT) assay according to 
Mosmann (1983) with some modifications.  A total of 5 x 10
3
 cells were seeded at a 
density of 5 X 10
3
 cells/well into a sterile flat bottom 96-well plate and allowed to 
adhere overnight.  After 24 h, 20 µl of the appropriate extract solution in the 
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concentration range of 10 to 200 µg/ml was added. For untreated cells (control), vehicle 
DMSO was added instead of the sample. The cells were then incubated at 37 °C in a 
humid atmosphere with 5% CO2, 95% air for 24, 48 or 72h.  After the indicated period 
of exposure, 20 µl of MTT solution (5mg/ml, in PBS) was pipetted into each well of the 
plate. The plates were protected from light and further incubated for another 4h at 
37  °C. Following 4 h of incubation, the medium was removed by gentle aspiration and 
the crystal formazan formed was dissolved in 150 µl of DMSO. The amount of 
formazan product was measured at 570 nm against the reference wavelength of 650 nm 
using a microplate reader. The effect of various treatments on cell growth was expressed 
as percentage of cell viability of the treated cells compared to that of the untreated 
control cells set at 100%. Cell viability (%) = (absorbance of treated cells/ absorbance 
of untreated cells) x 100%. The results obtained from MTT assay were presented as 
dose-response curves (percentage of cell viability vs the concentration of the sample in 
µg/ml) for each cell line. The 50% inhibitory concentration (IC50) is the concentration 
that reduces cell viability to 50% and is obtained from dose-response curves.   
 
2.2.4.2 Total Cell Count 
Briefly, 1x10
6 
of cells were plated into 60 mm dish and incubated 24 hours to let the 
cells to adhere. After 24 hours, the medium of the cell were replaced with the fresh 
medium containing different concentrations of extract ranging from 50μg/ml to 1mg/ml. 
The cells were further incubated either for 24, 48 or 72 hours. After incubation period, 
the cells were detached by accutase and pelleted for 5 minutes at 1000rpm 
centrifugation. The cell pellets were diluted with the desired dilution factor in 0.4% of 
trypan blue solution and the viable cells were counted by using a haematocytometer. 
Figure 2.3 shown distribution quadrants of haematocytometer and the formula used for 
cells count. 
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Figure 2.3 Major quadrates view of haematocytometer under light microscope. 
 
The cell number of treated samples was counted by using formula as below:      
(A+C+E+G+I) / 5 x Dilution factor  x 10
4
. 
 
2.2.5 Evaluation of apoptotic effect of the most active fraction of S. macrophylla 
Based on the MTT assay, the most active fraction of S. macrophylla was determined. 
The apoptotic-inducing effects were further evaluated using the following methods and 
elucidation of the apoptotic pathways. 
 
2.2.5.1 Hoechst-propidium iodide  staining and morphological observation 
Hoechst 33342 (2'-[4-ethoxyphenyl]-5-[4-methyl-1-piperazinyl]-2,5'-bi-1H-
benzimidazole trihydrochloride trihydrate) is a cell-permeable DNA stain that is excited 
by ultraviolet light and emits blue fluorescence at 460-490nm. Hoechst 33342 binds 
preferentially to adenne-thyymine (A-T) regions of DNA. Combination of Hoechst 
33342/PI stains provides a rapid and convenient assay for apoptosis based upon 
fluorescent detection for the compacted stage of the chromatin in apoptotic cells.  As 
Hoechst33342 (Figure 2.4) is a vital blue fluorescing DNA stain that is 
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membrane permeable, it brightly stains the condensed chromatin of apoptotic cells, 
whereas nuclei of live cells exhibit lower fluorescence. The red propidium iodide 
(Figure 2.5) is another DNA staining dye that only stains nuclei of cells with 
compromised plasma membrane and thus does not stain normal cells (Vanderlaag et al., 
2006).  The morphological signs of apoptosis in HCT 116 cells were evaluated by 
monitoring the nuclear changes using the named assay. The cells were grown in 60 mm 
culture dish and after 24 h of incubation and the cells were treated with 50 µg/ml of the 
active fraction for different time periods. After treatment, the cells were subjected to 
analysis using inverted microscope (Leica, Germany) and photographs of the cells were 
captured using camera (Leica, Germany).  
The cells were then rinsed with PBS and harvested by using accutase. The suspension of 
the cells was collected by centrifugation and stained with Hoechst 33342 (10µM) and 
propidium iodide (10µM) for approximately 10 min while protected from light. 
Observation was made by using inverted fluorescent microscope and photographs were 
taken using camera. 
 
Figure 2.4 Chemical structure of Hoechst 33342. 
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Figure 2.5 Chemical structure of propidium iodide (PI). 
 
2.2.5.2 Examination of intracellular reactive oxygen species (ROS) 
Various techniques can be used to determine ROS production including 
chemiluminescense (Briheim, 1989), fluorescence (Rest, 1994) or even cytochrome c 
reduction (Smith and Weidemann, 1993). The use of DCFH-DA as a fluorometric assay 
was first described for hydrogen peroxide detection (Keston, 1965), since then the use 
of dichlorofluorescin (DCFH) became popular as a probe to evaluate intracellular 
hydrogen peroxide formation by flow cytometry (Wang and Joseph, 1999).  The 
principle for the experiment using DCFH-DA is that nonfluorescent fluorescin emitted 
fluorescence that is directly proportional to the concentration of hydrogen peroxide. 
However, when applied to intact cells, the non-ionic, non-polar DCFH-DA can cross 
cell membranes and is hydrolysed enzymatically by intracellular esterases into 
nonfluorescent DCFH. The presence of ROS would oxidize DCFH into highly 
fluorescent dichlorofluorescein (DCF) (LeBel et al., 1992).  Therefore, the intracellular 
DCF fluorescence can be used to determine the oxidative stress condition in cells. 
 
In this experiment, 1x10
6
 of HCT116 cells were grown on 23cm
3
 dishes and allowed to 
attach overnight and subsequently treated with 0.05mg/ml of SMEAF or DMSO for 4h. 
After the incubation period the cells were washed twice with PBS and 100 µM of DCF-
 
 
56 
 
DA dye was added to each of the samples and incubated for 1h in darkness. The cells 
were harvested by using accutase and washed with ice-cold PBS. Florescence intensity 
was monitored using BD Accuri C6 flow cytometer. The mean of DCFH florescence 
was obtained from 10, 000 cells with excitation wavelength of 488 nm and emission 
wavelength of 525 nm. 
 
2.2.5.3 Measurement of intracellular total glutathione (GSH) content 
Glutathione (GSH) is a tripeptide (γ-gluyamylcysteinglycine) and major thiol 
antioxidant. Glutathione is a multifunctional intracellular non-enzymatic antioxidant. It 
is highly abundant in the cytosol, nuclei and mitochondria and is the major soluble 
antioxidant in these cell compartments. The reduced form of glutathione is GSH 
(glutathione) and the oxidized form is GSSG (glutathione disulphide) (Strużyńska et al., 
2005). Generally the antioxidant capacity of thiol compounds is due to the sulfur atom 
which can easily accommodate the loss of a single electron (Karoui et al., 1996). 
Reaction with radicals oxidized glutathione, but the reduced form is regenerated in a 
redox cycle involving glutathione reductase and the electron acceptor NADPH. 
 
The presence of intracellular GSH provides protection for damage induced by 
antineoplastic agents, free radicals, reactive oxidant species (ROS) and other stress-
induced conditions (Arrick and Nathan, 1984; Sies, 1999). It has been reported that 
intacellular level of GSH offered protective effect against apoptotic cell death and 
depletion of GSH was found in pre-apoptotic cells (Fernandes and Cotter, 1994; Macho 
et al., 1997a). The experiment is based on the reaction between GSH and 5,5’-dithio-bis 
(2-nitrobenzoic acid  or TNB) (DTNB, Ellman’s reagent) to produce a yellow colored 2-
nitro-5-thiobenzoic acid (TNB). The generated glutathione disulphide (GSSG) is 
reduced by glutathione reductase (GR) to GSH in the presence of coenzyme 
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nicotinamide adenine dinucleotide phosphate (NADPH). Since GR was used in this  
assay, total glutathione (GSH and GSSG) was measured in this assay (Figure 2.6) 
(Baker et al., 1990; Eyer and Podhradsky, 1986; Griffith, 1980). 
 
Figure 2.6 Principle of total glutathione assay. 
 
The assay was started by seeding 1 x 10
6
 of HCT116 cells in 60 mm dishes and after 24 
h of incubation; the cells were harvested, collected by centrifugation (1000 rpm, 5min) 
and washed with ice-cold PBS. The cells were adjusted to 1 x 10
6 
cells per sample. 
Samples were mixed with 250 µl, 5%  5-sulfosalicylic acids (SSA) and vortexed. The 
samples were further subjected to freeze and thaw process for 3 times and proceeded to 
centrifugation at 10,000 rpm, 4 °C for 15 min. The supernatant was collected and 
glutathione assay was performed in a 96-well plate. Each well consisted of GSH 
standards, DTNB and NADPH in phosphate buffer and the reaction was initiated by 
addition of glutathione reductase (GR). The final concentrations were 0.031 mg/ml 
DTNB, 0.038 mg/ml (48 µM) NADPH, 95 mM potassium phosphate buffer (pH 7.0), 
0.95 mM EDTA, 0.115 units/ml GR and 0.24% SSA. The absorbance was read at 405 
nm and measurements were taken every 1min interval for 10 min. For each sample, the 
rate of TNB production (change in absorbance/min) was calculated and the total GSH 
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concentration was determined based on a linear regression curve obtained from the GSH 
standard curve. 
 
2.2.5.4 Analysis of cell cycle distribution 
The HCT 116 cells were seeded in 60 mm culture dishes (1 x 10
6
) and left for 24 h for 
attachment. The cells were then treated without or with desired concentration of sample 
and incubated for indicated time period in CO2 incubator. The cells were harvested and 
rinsed with ice-cold PBS. After centrifugation at 1000 rpm for 5 min, the supernatant 
was removed and the cell pellets were resuspended in 100 µl of ice-cold PBS. Cells 
were fixed by adding dropwise into 1 ml of 70 % (v/v) ethanol (in PBS) while vortexing 
the cells. Cells were gently mixed to prevent clumping of cells. The fixed cells were 
stored at -20 °C for 24 h, followed by centrifugation (15000 rpm, 5 min) to discard the 
ethanol. Fixed cells were washed with PBS thoroughly to discard the ethanol. After 
washing and centrifugation, cells were resuspended in 500 µl of hypotonic staining 
solution containing 50 µg/ml PI, 0.1 % (w/v) sodium citrate, 0.1 % (v/v) Triton-X-100 
and 100 µg/ml RNase A. After incubation for 1 h in the dark at room temperature, the 
cells were immediately subjected to analysis by flow cytometer at excitation 488 nm 
and emission 620 nm. 10,000 cells were analysed and the cell-cycle distribution was 
calculated by using CellQuest software.  
 
2.2.5.5 Assessment of DNA fragmentation using TUNEL assay 
During apoptosis, the DNA strands are cleaved or nicked by endonucleases, generating 
DNA fragments with abundance of exposed 3’-OH ends. These DNA strand breaks 
(DSBs) induced by apoptosis can be detected using terminal deoxynucleotidyl 
transferase (TdT) dUTP nick end labelling (TUNEL) assay (Darzynkiewicz et al., 
2008a; Darzynkiewicz et al., 2006; Jiang et al., 1995; Li et al., 1995). A TUNEL assay 
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kit (Apo-BRDU, Sigma) was used for this purpose according to the manufacturer 
protocol. The assay relies on the incorporation of bromo-deoxyuridine triphosphate (Br-
dUTP) into fragmented DNA at the 3’-OH ends, catalysed by Tdt. FITC-conjugated anti 
BrdU antibody then binds to the incorporated Br-dUTP residues and labelling the 
apoptotic cells. The principle of TUNEL assay is illustrated in Figure 2.7. 
 
A total of 1 x 10
6 
of HCT116 cells were seeded in 60 mm culture dishes and after 24 h 
of incubation, the attached cells were treated with 500µg/ml of the active faction for 24 
h.  After designated treatment hours, cells were harvested, washed with PBS and 
centrifuged at 1000 rpm for 5 min. After resuspending the pellets in 500 µl of PBS, the 
cell suspensions were added into 5 ml of 1% (w/v) paraformaldehyde in PBS and 
incubated on ice for 15 min. This was followed by washing twice with PBS and the 
pellets were fixed in 5 ml of ice-cold 70% (v/v) ethanol at -20 °C for 24 h. The ethanol-
fixed cells were centrifuged at 1800 rpm for 5 min to pellet the cells and the ethanol was 
discarded. The washed cell pellets were then incubated in 50 µl of buffer containing 
TdT enzyme and Br-dUTP at 37 °C.  After 60 min of incubation, the cells were then 
added to 400 µl of PBS and the FITC signal was detected and analysed by FACSCalibur 
flow cytometer using CellQuest software. 
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Figure 2.7 Principle of TUNEL assay. 
 
2.2.5.6 Measurement of mitochondrial membrane potential using JC-1 
Mitochondrial dysfunction during apoptotic process is often associated with loss of the 
mitochondrial membrane potential (Δψm), which is one of the characteristics of 
apoptosis (Green and Reed, 1998). This event can be monitored by using a liphophilic 
cationic fluorochrome, 5,5’,6,6’-tetrachloro-1,1’,3,3’ tetraethylbenzimidazolyl- 
carbocyanine iodide (strans for 1
st
 J-aggregate-forming cationic dye, JC-1) (Smiley et 
al., 1991).  The JC-1 (Figure 2.8) is commonly used to detect mitochondrial 
depolarization that occurs during early apoptosis (Cossarizza et al., 1993; Reers et al., 
1995). In healthy cells, JC-1 accumulates in the mitochondria as JC-1 aggregates (which 
fluoresce red) and also in the cytoplasm as JC-1 monomers (which fluorescence green). 
In apoptotic cells, the Δψm collapses. Consequently, JC-1 aggregates cannot 
accumulate within the mitochondria and dissipate into JC-1 monomers leading to loss of 
red fluorescence. Therefore, Δψm collapse is signified by the decrease of the red to 
green ratio fluorescence indicating the loss of mitochondrial membrane potential 
(Cossarizza et al., 1993; Reers et al., 1995). 
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This assay started by seeding1 x 10
6 
 of HCT116 cells in 60 mm dishes and treated  with 
desired sample concentration and incubated in CO2 incubator for indicated exposure 
periods.  After exposure to the sample and centrifugation, the cell pellets were 
resuspended in JC-1 solution and further incubated at 37°C in the CO2 incubator for 15  
min. Cells were then washed twice and  resuspended in fresh medium. Analysis was 
carried out using a  FACSCalibur flow cytometer and CellQuest software. 10,000 
events were examined for each sample. The JC-1 aggregates (red fluorescence) were 
detected in the FL-2 (620 nm) channel, while the JC-1 monomers (green fluorescence) 
were detected in FL-1 (520 nm) channel. 
 
 
Figure 2.8 Chemical structure of JC-1 dye. 
 
2.2.5.7 Detection of phosphatidylserine using Annexin V-FITC/ PI staining 
Multiple alterations of the plasma membrane occur during apoptosis (Morris et al., 
1984). This includes the loss of membrane asymmetry, where phosphatidylserine (PS) is 
externalized to the outer leaflet of the membrane (Martin et al., 1995). The mechanism 
that underlies the loss of membrane asymmetry remains unclear. Some studies 
suggested the involvement of downregulation of an ATP-dependent aminophospholipid 
translocase and upregulation of ‘flippase’ in this event (Bratton et al., 1997; Savill, 
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1997). Annexin V/ PI assay was performed using flow cytometry to measure the 
externalization of PS during early apoptosis (Koopman et al., 1994; Olie et al., 1996; 
Vermes et al., 1995). The assay relies on the fact that annexin V binds to exposed PS in 
early and late apoptotic cells, while PI is excluded from cells with intact and 
uncompromised plasma membrane such as the viable and early apoptotic cells. As a 
result, viable cells (with no stain), early apoptotic cells (with annexin V stain only) and 
late late apoptotic (with both annexin V and PI stain) or necrotic cells or deadscells 
(with PI only) can be discriminated by quantitatively estimate the relative amounts of 
the annexin V/ PI-stained cells in population.  
 
In this assay 1 x 10
6
 of HCT 116 cells were plated in 60 mm dishes and were allowed to 
attach to the surface. After 24 h of incubation, the cells were exposed to the bioactive 
fractions for different range of concentrations for indicated time periods. After treatment, 
both floating and attached cells were collected into 15 ml centrifuge tubes and washed 
with PBS. After centrifugation at 1000 rpm for 5 min, the pellets were resuspended in 1 
ml of annexin V binding buffer (10 mM HEPES, 140 mM NaCl, 5mM CaCl2, pH 7.4). 
This was followed by the transfer of 100 µl of the cell suspensions into 5 ml falcon 
round bottom tubes. The cells were added with 5 µl of FITC-conjugated annexin V and 
10 µl of PI (50 µg/ml). The cells were gently mixed by pipetting, and incubated for 30 
min in the dark at room temperature. Afer staining, 400 µl of binding buffer was added 
to the tubes and mixed again by gentle pipetting. The cells were then analysed by 
FACSCalibur flow cytometer and CellQuest software whereby 10,000 events were 
acquired for each analysis. After excitation at 488 nm, the green fluorescent intensity of 
annexin V-FITC was measured at 520 nm in the FL-1 channel while the red fluorescent 
intensity of PI was measured at 620 nm in FL-2 channel. The results were represented 
as quadrants in the bivariate PI versus annexin V-FITC fluorescence plot. 
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2.2.5.8 RNA isolation and real-time PCR (Q-PCR) 
In this study, we applied real-time quantitative polymerase chain reaction (Q-PCR) 
analysis to investigate the effect of sample on gene expression of PCNA (proliferating 
cell nuclear antigen), Bcl-2 (B-cell CLL/ lymphoma 2) and Bax (BCL-2 associated X 
protein). HCT 116 cells were plated into 60 mm dishes at a density of 1 x 10
6
 cells/ dish. 
After 24 h of incubation for attachment, exponentially growing cells were treated with 
samples for indicated time frames. After designated exposure times, cells were 
harvested and total RNA was extracted using a commercial kit, QIAamp RNA Blood 
Mini Kit (Qiagen).The procedures were according to manufacturer guidelines. In brief, 
the cells were lysed by vortexing the pellets in 600 µl of RLT buffer. The lysate was 
transferred directly into a QIAshredder spin column in a 2ml collection tube (provided),  
centrifuged and homogenized for 2 min at maximum speed. The spin column was 
discarded. 600 µl of 70% ethanol was added into the lysate and homogenized by gentle 
pipetting. The sample was carefully pipetted into a new QIAamp spin column in a 2 ml 
collection tube without moistening the rim. After centrifugation for 15 s at 10, 000 rpm, 
the flow-through was discarded. On-column DNase digestion treatment was conducted 
according to the kit. RW1 buffer (350 µl) was added to QIAampspin column and 
centrifuged for 15 s at 10,000 rpm to wash the spin column membrane. The flow 
through was then discarded. 80 µl of DNase (10 µl DNase plus 70 µl RDD buffer) was 
added on the membrane of the spin column and left for 15 min. 350 µl of buffer RW1 
was added to the spin column, centrifuged and the flow through was discarded. The spin 
column was then transferred to a new 2 ml collection tube. The procedures were 
followed with washing twice with 500 µl of buffer RPE each time. Approximately 30 µl 
of RNase-free waster was directly added on the QIAamp membrane and centrifuged for 
1 min at 10,000 rpm to elute out the RNA. The quantity and quality of the RNA was 
measured at 260 nm and 280 nm using Nanodrop and bioanalyzer.  
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The target genes (PCNA, Bax and Bcl-2) expression was assessed using one-step SYBR 
Green relative Q-PCR protocol performed on RotorGene 600 real-time amplification 
instrument. The gene expression of PCNA was normalized to GADPH (Glyceraldehyde 
3- phosphate dehydrogenase) reference gene, while Bax and Bcl-2 were normalized to 
PBGD (porphobilinogen deaminase) reference gene. The primer sequences were based 
on literature (Kralovcova et al., 2008; Truong et al., 2007) and were shown in Table 2.1. 
 
Real-time Q-PCR was performed in (0.2 ml flat-cap microcentrifuge tubes. For each 
sample, a PCR mixture was prepared using SensiMix SYBR One-Step kit. A total 
volume of 25 µ reaction mixture were created with the following reagents (Table 2.2). 
The tubes were then transferred to the Rotor-Gene 6000 (36-well rotor) and cycling 
conditions for real-time QPCR experiment are shown in Table 2.3. At the end of the 
reaction, the cycle threshold (Ct) values were determined using Rotor-Gene software 
and the ΔCt = Ct target gene – Ct reference gene. The expression of target gene in the treated 
cells relative to untreated cells was quantitated using the formula 2
–ΔΔCT
  (Livak and 
Schmittgen, 2001), by calculating the ∆∆CT (∆∆CT = ∆CT sample - ∆CT untreated ). 
 
Table 2.2: The reaction mixtures of Q-PCR. 
Reagents 1 reaction (total volume 25 µl) Final concentration 
Water (H2O) 4.5 µl - 
Sensimix SYBR One-Step 12.5 µl 1x 
SYBR green 0.5 µl 1x 
MgCl2 - 3mM 
Forward primer 1 µl 200 nM 
Reverse primer 1 µl 200 nM 
RNase inhibitor 0.5 µl 10units 
RNA 5 µl 20 ng/ml 
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Table 2.3 The cycling conditions for real-time Q-PCR. 
Target gene Reference gene Denaturation Annealing Extension 
PCNA GAPDH 95 °C 
45 seconds 
56 °C 
45 seconds, 
30 cycles 
72 °C 
120 seconds 
Bax PBGD 95 °C 
20 seconds 
60 °C 
40 seconds, 
45 cycles 
72 °C 
10 seconds 
Bcl-2 PBGD 95 °C 
20 seconds 
42 °C 
40 seconds, 
45 cycles 
72 °C 
10 seconds 
 
 
2.2.5.9 Flow cytometric immunofluorescence staining of Bax and Bcl-2 
The expression level of protein Bax and Bcl-2 were determined by immunofluorescence 
staining using flow cytometry. This method was based on Roussi et al (Roussi et al., 
2007) with some modifications. Following the sample treatment, the cells were  
harvested and washed twice in PBS and the fixed and permeabilized using Cytofix/ 
Cytoperm
TM 
 kit (BD Biosciences). The kit consisted of two solution: Cytofix/Cytoperm 
solution (1x) and perm/Wash buffer solution (10x). The Cyto/Perm solution was used 
for fixation and permeabiliztion of the cells before staining with antibody. The 
Perm/Wash buffer solution was used to permeabilize the cells before staining, 
antibodies dilution and also used as washing buffer. A total of 1x 10
6
 cells were 
resuspended in 500 µl of fixation/ permeabilization solution and incubated for 20 min at 
4ºC. The cells were washed twice with Perm/Wash buffer and incubated for 15min in 
1ml of Perm/Wash
TM
 buffer to detect Bax or Bcl-2. The fixed and permeabilized cells 
were incubated with 100 µl of Perm/ Wash
TM
 buffer containing antibodies. For Bcl-2 
protein, the cells were stained directly for 30 min with 20 μl FITC-conjugated mouse 
anti-human Bcl-2 monoclonal antibody (clone 124) or IgG1 isotype control (BD 
Biosciences) at 4°C. For indirect Bax staining, the cells were incubated for 30 min with 
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either rabbit anti-human Bax polyclonal antibody or IgG1 isotype control (BD 
Biosciences) at 4°C. After washing, the cells were further incubated for 30 min with 
FITC-conjugated goat anti-rabbit F(ab')2 polyclonal secondary antibody (Abcam) at 
4°C. The cells were then washed with Perm/WashTM buffer and analyzed using BD 
Accuri C6 flow cytometer. 
 
2.2.5.10 Determination of Caspase -3/7 and -9 activities 
This assay was performed using the protocol recommended by the manufacturer 
(Immunochemistry technologies, LLC). The HCT 116 cells were seeded in 60 mm 
dishes and treated with the desired concentration of samples. After the indicated 
treatment periods, the cells were harvested and counted using haemocytometer. The cell 
suspension in 290 µl (~5 x 10
5 
cells per 100 µl) was suspended in a new 1.5 ml 
centrifuge tube, 10µl of 30X FAM-DEVD-FMK (Caspase -3/7), FAM-LETD-FMK 
(Caspase -8), FAM-LEHD-FMK (Caspase -9) or FAM-AEVD-FMK (Caspase -10) 
solution was directly added into the cell suspension. After gentle tapping,  followed by  
1 hour  incubation at 37ºC under 5% CO2, the cells were washed twice by using 1X 
washing solution (provided) and further suspended in 400 µl of washing solution. The 
cells were analysed by using BD Accury C6 flow cytometer. 
 
2.2.5.11 Protein extraction 
The cells treated with sample for indicated treatment period were then harvested and 
appropriate amounts of Cytobuster containing protease inhibitors was added into the 
pellet of the cells. The mixture was then vortexed and stored for about 10 min before 
subjected to centrifugation at 12,000 x g for 10 min. The supernatant was transferred 
into a new tube and kept in -20 freezer for further processing.  
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2.2.5.12 Protein estimation 
The protein concentration of the cell lysates was determined by using Bradford Kit 
(Biorad) BSA was used as the standard. 
 
2.2.5.13 Protein array 
Protein array was conducted according to the procedures recommended RayBio Human 
Apoptosis Antibody Array kit. After 24 hour exposure of SMEAF on HCT116, the cells 
were harvested and lysed using the lysis buffer (provided), priorly added with protease 
inhibitors. The protein content was determined as described in Materials and Methods 
(Section 2.2.5.12).  After quantification, the working concentration of the sample 
protein was adjusted to 500 µg/ml.  100 ul of blocking buffer was added into each well 
of pre-assembled array and incubated at room temperature for 30 min. Then, the 
blocking buffer was discarded and 100 µl of each sample was added to the array wells. 
The arrays containing the sample were incubated overnight at 4 °C. 
 
After the incubation period, the samples were removed and washed 5 times with 150 µl 
of wash buffer I at room temperature with gentle shaking. The slides was then washed 2 
times by using 150 µl of wash buffer II.  Biotin-conjugated antibodies (70 µl) were 
added to each corresponding well and subjected to 2 hours incubation at room 
temperature. The wells were further washed 5 times and 2 times by using wash buffer I 
and wash buffer II, respectively. After the washing steps, 70 µl of HiLyte Plus- 
conjugated streptavidin was added into each well and incubated in the dark room for 2 
hours. Finally, the array was washed twice using wash buffer I. 
 
The array was disassembled from its incubation chamber and placed in a 50 ml 
centrifuge tube, followed by the addition of 45 ml of washing buffer I and gently shaken 
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for 10 min at room temperature. Washing buffer I was decanted and replaced with wash 
buffer II for 10 min incubation. After removal of wash buffer II the slide was rinsed 
using distilled water. The slides were centrifuged at 1,000 rpm for 3 min to remove any 
water droplets remaining on the slides. Images were captured using laser scanner Axon 
GenePi using cy3 channel and analysed by GenePixPro 6.1 software. 
 
2.2.5.14 PCR array analysis 
The RNA of HCT116 cells that treated with 0.05 mg/ml of SMEAF for 12 h was lysed 
and performed on PCR Array Kit (PAH-033, Human Cancer PathwayFinder PCR Array, 
Qiagen) and data analysis according to protocol provided. 
 
2.2.6 Isolation and purification of chemicals 
There are hundreds or even thousands of chemical compounds as a mixture in plant 
extracts (Hamburger and Hostettmann, 1991). In order to discover the bioactive 
compounds from S. macrophylla, a bioassay-guided isolation was employed, which is 
considered the most efficient method of searching for active plant-derived anticancer 
agents (Pezzuto, 1997). In this study, MTT cell viability assay was used to guide the 
isolation process and was performed as described in Section 2.2.4.1 The fractions and 
sub-fractions obtained from each separation step were tested at the final concentration 
of 6.25-200 µg/ml. In addition to the bioassay-guided procedures, further steps were 
taken to purify other chemicals constituents for characterization.  
 
2.2.6.1 Analysis by Thin Layer Chromatography (TLC) 
Thin layer chromatography (TLC) was normally used to detect and separate compounds. 
In this study, it was used to determine the suitable solvent system for the isolation of 
chemical compounds from the bioactive fraction. Silica gel 60 F254 TLC plates (plastic) 
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from Merck were chosen for TLC analysis.  Generally, the soluble sample was spotted 
about 1.0 cm from the bottom of the TLC plate by using a fine capillary tube and 
allowed to dry. The TLC plate is then placed into a TLC developing tank filled with 
premixed solvent system. When the TLC plate was fully developed to the solvent front 
the plate was removed from the developing tank. The TLC plate was dried by using air 
blower and was viewed under both short (254 nm) and long (365 nm) ultra violet (UV) 
visible light.  The TLC plate was then placed into an iodine vapour chamber to stain the 
separated chemical compounds. 
 
2.2.6.2 Fractionation of Ethyl Acetate Fraction 
The ethyl acetate fraction was subjected to column chromatography by using a glass 
column (60cm L X 6cm I.D.) and packed with stationary phase as Merk kieselgel 60 
(0.063-0.200 mm). Briefly, the silica gel was made into slurry with solvent before it was 
packed into the column and was allowed to equilibrate for at least an hour before use. 
The fraction was then introduced on top of the silica surface. The column was generally 
eluted with combinations of different solvents; with stepwise increase in the solvent 
polarities until flushed with methanol. Fractions were monitored by TLC and 
appropriate fractions were combined, dried and stored at -20 °C until further 
investigations. 
 
2.2.6.3 HPLC Analysis 
Purification of the compounds was performed by using Shimadzu HPLC system 
equipped with diode array detector (DAD) on a Chromolith reversed phase C18 HPLC 
column (100.0 x 10.0 mm). The mobile phase used for analysis was water (A) and 
HPLC grade methanol (B) with flow rate of 4.7 ml/min. Each sample (50 µl) was 
injected into HPLC column and their separation was detected at the wavelengths of 214 
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and 254 nm. The mobile phase of each collected fraction was evaporated with rotary 
evaporator, weighed and analyse with TLC. Fractions that contained pure compound 
were then analysed with GC-MS and NMR to determine their chemical structures and 
molecular weight. 
 
2.2.6.4 Structural elucidation 
2.2.6.4.1 NMR analysis 
For structural elucidation purposes, isolated compounds were subjected to Nuclear 
magnetic resonance (NMR) spectroscopy analysis at Chemistry Department, Faculty of 
Science, University of Malaya, Malaysia. The compounds were dissolved in deuterated 
chloroform (CDCl3) solvent and subjected to proton (
1
H), Carbon-13(
13
C), distortionless 
enhancement by polarization transfer (DEPT), heteronuclear multiple-bond correlation 
spectroscopy (HMBC) and heteronuclear single quantum coherence spectroscopy 
(HSQC), NMR analysis. The NMR spectra were recorded on a JOEL 400 MHz 
spectrometer. The internal reference standard used was tetramethylsilane (TMS).   
 
2.2.6.5 GC-MS Analysis 
GC-MS analysis was performed using Agilent Technologies 6980N equiped with 5979 
Mass Selective Detector, HP-5MS (5% phenyl methyl siloxane) capillary column of 
dimensions 30.0m x 250μm x 0.25 μm and used helium as carrier gas at 1 ml min-1. The 
column temperature was programmed with the desired condition after several tries. MS 
was operating at 70 eV. The constituents were identified by comparison of their mass 
spectral data with those from NIST 05 Spectral Library. Only mass spectral 
fragmentation pattern that gave greater than 90% match were accepted particularly 
applicable for SMHF analysis. GCMS analysis provides the molecular weight (MW) 
data for confirmation of isolated compounds.   
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2.2.7 Chemical modification of Swietenine 
The purified compound swietenine was subjected to acylation process as a solution to 
the solubility problem.  A solution of  swietenine ( 81mg, 0.55 mmol) was stirred, 
cooled (0–5 ◦C)in dry DMF (20 ml), sodium hydride (45 mg,  mmol) and acetic 
anhydride (0.2938ml, mmol) was added into the reaction flask. The ice bath was then 
removed and the mixture was allowed to stir overnight at room temperature. Saturated 
ammonium chloride was added to the reaction mixture followed by extraction with 
ethyl acetate. The combined ethyl acetate extracts were then washed with distilled water 
to remove DMF. The solution was then filtered and dried over anhydrous sodium 
sulfate.  The crude product obtained after evaporation under reduced pressure, was 
purified by column chromatography to yield the purified product in yellowish solid 
form. 
 
The structure elucidation of the modified compound was further subjected to NMR 
analysis as described in earlier section. The compound isolated was further subjected to 
additional correlation spectroscopy (COSY) and nucler overhauser effect spectroscopy 
(NOESY) NMR analysis. LC-MS/MS analysis was performed as well to obtain high 
resolution mass spectrometry (HRMS) data. 
 
2.2.8 Evaluation of the cytotoxic effect of swietenine derivative 
2.2.8.1 MTT cell viability assay 
The MTT cell viability assay was carried out as described in section 2.2.4.1. The pure 
compounds was tested at different final concentration for 72 h incubation period. 
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2.2.9 Evaluation of apoptotic effect of swietenine derivative 
After MTT assay, the swietenine derivative was further subjected to the bioassays as 
described earlier. The final concentration of the modified compound was 50 µM and 
subjected to different exposure times in HCT116. 
 
2.2.9.1 Hoechst-propidium iodide  staining and morphological observation 
The analysis was performed as described in section 2.2.5.1 except that the cells were 
treated with 50 µM of the modified compound for 48. 
2.2.9.2 Determination of intracellular reactive oxygen species (ROS) 
The analysis was performed as described in section 2.2.5.2 except that the cells were 
treated with 50 µM of the modified compound. 
 
2.2.9.3 Measurement of intracellular total glutathione (GSH) content 
The analysis was performed as described in section 2.2.5.3 except that the cells were 
treated with 50 µM of modified compound for 24-72 h. 
 
2.2.9.4 Analysis of cell cycle distribution 
The analysis was performed as described in section 2.2.5.4 except that the cells were 
treated with 50 µM of modified compound for 24-72 h. 
 
2.2.9.5 Measurement of mitochondrial membrane potential using JC-1 
The analysis was performed as described in section 2.2.5.6 except that the cells were 
treated with 50 µM of modified compound for 24-72 h. 
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2.2.9.6 Detection of phosphatidylserine using Annexin V-FITC/ PI staining 
The analysis was performed as described in section 2.2.5.7 except that the cells were 
treated with 50 µM of modified compound for 24-72 h. 
 
2.2.9.7 RNA isolation and real-time PCR (Q-PCR) 
The analysis was performed as described in section 2.2.5.8 except that the cells were 
treated with 50 µM of modified compound for 6-24 h. 
 
2.2.9.8 Flow cytometric immunofluorescence staining of Bax and Bcl-2 
The analysis was performed as described in section 2.2.5.9 except that the cells were 
treated with 50 µM of modified compound. 
 
2.2.9.9 Determination of Caspase -3/7, -8, -9 and -10 activities 
The analysis was performed as described in section 2.2.5.10 except that the cells were 
treated with 50 µM of modified compound for 3-24 h. 
 
2.2.9.10 PCR array analysis 
The analysis was performed as described in section 2.2.5.14 except that the cells were 
treated with 50 µM of modified compound for 24 h. 
 
2.2.9.11 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
The extracted crude protein was checked on 10% (w/v) polyacrylamide gel using tri-
glycin buffer containing 0.025 M tris and 0.192 M glycin, pH 8.3. Following solutions 
were used to prepare both stacking and resolving gels. 
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Solution A:  
29.2% (w/v) Acrylamide and 0.8% (w/v) N,N’- methylenebisacrylamide 
Solution B: 
1.5 M Tris-HCl buffer, pH 8.8 and 0.4 % (w/v) SDS 
Solution C: 
10% (w/v) Ammonium persulfate 
Solution D: 
0.5 M Tris-HCl buffer, pH 8.8, 0.4% SDS (w/v) 
Sample buffer: 
62 mM Tris-HCl buffer, pH 6.8 containing 2.3% (w/v) SDS, 5% mercaptoethanol, 10% 
(v/v) glycerol and 0.01% (w/v) bromophenol blue. 
Electrophoresis buffer: 
Tris-glycin bufeer containing 0.025 M tris, 0.1% SDS and 0.192 M glycin, pH 8.3 
Fixing solution: 
40% (v/v) Methanol and 10% (v/v) acetic acid in water 
Staining solution: 
0.2% (w/v) Coomassie brilliant blue R-250 in fixing solution 
Destaining solution: 
7% (v/v) Acetic acid and 5% (v/v) methanol in water. 
 
Resolving gel was prepared by sequential mixing of 6.0 ml of solution A,  6.0 ml of 
solution B, 6.0 ml of water, 0.1 ml of solution C and 10 µl of TEMED. This solution 
was poured gently into the space between the glass plates assembled in the gel casting 
unit up to 3/4
th
 of their height. Subsequently, a layer of water was added on top of the 
resolving gel solution and the gel was allowed to polymerize at room temperature for 40 
minutes. Meanwhile, stacking gel was prepared by mixing 1.4 ml of solution A, 2.5 ml 
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of solution D, 6.1 ml of water, 0.2 ml of solution C and 10 µl of TEMED. After 
polymerization of the resolving gel, water layer from its top was removed with the help 
of filter paper strips. Then stacking gel solution was poured gently at the top of the 
resolving gel up to a height of 2.0 cm with the help of a micropipette. A comb was 
inserted into it and left for 1 hour at room temperature for polymerization. After 1 hour, 
the comb was removed from the stacking gel and the newly-formed wells were rinsed 
three times with electrophoresis buffer. The glass plates with the polymerized gel were 
then fitted into the electrophoresis apparatus half-filled with the electrophoresis buffer. 
About 50 µg of crude protein dissolved in 50 µl of the sample buffer and 20 µl (10 µg) 
of each preparation was loaded into different wells. The remaining space of each well 
and the tank was filled with the electrophoresis buffer followed by covering of the tank 
with the lid containing electrode. The whole apparatus was connected to a power supply 
and a current of 60 V (6 V per well) was passed initially till all the protein bands had 
entered into the resolving gel. The voltage was increased to 120 V (12 V per well) and 
electrophoresis was continued for 1.5 hours till dye front reached near the bottom of the 
gel. Upon completion of the electrophoresis, the current was stopped; gel was gently 
removed from the glass plates and placed in the fixing solution overnight. It was stained 
with the staining solution for 2 hours and destained repeatedly with the destaining 
solution until the background was clear. 
 
2.2.9.12 LCMS protein analysis 
Protein samples were trysin digested and peptide extracted. Peptides were analysed by 
electrospray ionization mass spectrometry using the Ultimate 3000 nano HPLC system 
[Dionex] coupled to a 4000 Q TRAP mass spectrometer [Applied Biosystems]. Tryptic 
peptides were loaded onto C18 PepMap100, 3µm [LC Packings] and separated with a 
linear gradient of water/acetonitrile/0.1% formic acid (v/v). Spectra were analysed to 
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identify proteins using Mascot sequence matching software [Matrix Science] with 
taxonomy set to Homo sapiens (human). 
 
2.2.9.13 Protein array analysis 
The analysis was performed as described in section 2.2.5.13 except that the cells were 
treated with 50 µM of compound for 6-24 h. 
 
2.2.10 Statistical analysis 
All values are expressed as mean± standard deviation (S.D.) or means ± standard error 
(S.E.) of three independent experiments. Statistical analyst were performed by Student’s 
t-test to compare the difference between untreated and treated group and considered 
significant when p < 0.05. 
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CHAPTER 3 
RESULTS 
3.1 Biological evaluation of extract and fractions of S. macrophylla 
The extraction and fractionation of S. macrophylla yielded crude ethanolic extract 
(SMCE) and different polarity fractions, namely hexane (SMHF), ethyl acetate fraction 
(SMEAF) and water fraction (SMWF). All of the extract and fractions were subjected to 
cytotoxic screening to determine their cytotoxic effects on different cancer cell lines. 
3.1.1 MTT cell viability assay of extract and fractions of S. macrophylla 
The crude ethanol extract of Swietenia macrophylla demonstrated cytotoxic effect when 
screened against KB, CasKi, HCT 116, Hep G2 and MCF-7 cancer cell lines, especially 
HCT 116 cells (IC50 = 48.273 ± 1.649 μg/ml). Thus, the crude extract was further 
fractionated to yield hexane, ethyl acetate and aqueous fractions for further screening.  
Results are shown in Figure 3.1 (A-E) where the effect of cytotoxicity screening of the 
ethanol extract and fractions against five different human  cancer cell lines (HCT 116, 
Ca Ski, KB, MCF-7 and Hep G2) with increasing extract concentrations in the range of  
10 to 200 µg/ml. The IC50 values of S. macrophylla against KB, CasKi, HCT 116, Hep 
G2 and MCF-7 cancer cell lines are shown in Table 3.1. Among the five cancer cell 
lines, S. macrophylla ethyl acetate fraction (SMEAF) showed selective cytotoxic effect 
against HCT116 cells with lowest IC50 value recorded among all cell lines which is 
35.35 µg/ml at 72 h of incubation period. The effect of SMEAF on cell viability was 
further evaluated at 24 and 48 h by determining the percentage of MTT reduction upon 
incubation of HCT116 cells and the results are shown in Figure 3.1 (F). The values of 
IC50 decreased from 156.30 ± 10.25, 64.05 ± 7.45 to 35.35 ± 0.50 µg/ml after 
incubation  for 24, 48 and 72 h, respectively. Results showed that ethyl acetate fraction 
significantly reduced the cell viability in time- and dose-dependent manner.  
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In order to evaluate whether the SMEAF would causing any toxic effect on human 
normal cell line, MRC-5 cells were utilized for the experiment. A 72 h exposure of 
SMEAF with concentrations 6.25-200 µg/ml on MRC-5 was performed.  The results 
showing the SMEAF was less cytotoxic to the normal cells, as revealed by the relative 
higher IC50 value on MRC-5 cell line screening (187.82± 3.42 µg/ml). By dividing the 
IC50 value of MRC-5 cell line with the IC50 value of HCT116 cell line we obtained the 
selective index (SI) value of SMEAF (Wong et al., 2011). SMEAF was about 5 times 
more cytotoxic to HCT116 cells compared to MRC-5, indicated the specificity and a 
higher potency of inhibition effect on cancer cell line.
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Figure 3.1 The cytotoxicity effect of S. macrophylla ethanol extract and fractions 
against various cancer cell lines at 72h incubation time. The measurements were taken 
using MTT cell viability assay. The graphs in 16(A) – 16(E) represent the cytotoxicity 
effects against HCT 116, Ca Ski, KB, MCF-7 and Hep G2, respectively. Graph 16(F) 
represents the cytotoxic effect of S. macrophylla ethyl acetate fraction on HCT116 at 
24h, 48h and 72h of incubation period. The data represent mean ± S.E. of three 
independent experiments (n=9).
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Table 3.1: IC50values (μg/ml) of extract and fractions from S.macrophylla seeds against 
different cell lines, calculated after 72 h exposure. 
______________________________________________________________________ 
Cell Lines                                                              IC50(μg/ml)______________________ 
                                        Ethanol            Hexane             Ethyl acetate                 Aqueous         
 
MCF-7                       88.43± 1.17            >200                 116.43± 3.18                  >200 
 
KB                             106.72 ± 6.9            >200                 94.29 ± 2.18                   >200 
 
HepG2                       135.49± 4.01           >200                  92.52± 0.53                   >200 
 
CasKi                        115.89± 4.51            >200                170.08± 6.96                   >200 
 
HCT116                     48.27 ± 1.65            >200                 35.35 ± 0.50                   >200 
 
MRC-5                  N.A.                   N.A.                187.82± 3.42                    N.A. 
 
 
The data represent mean± S.E. of three independent experiments (n=9). 
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3.1.2 Trypan blue exclusion (TBE) assay 
The SMEAF was added to the cells as described above and its anti-proliferative effect 
was determined by using trypan blue exclusion assay. The 24 hour exposure of HCT116 
cells to various concentrations of SMEAF resulted in a marked increase in percentage 
inhibition of proliferation. The results are shown in Figure 3.2 A and B. This was 
evident when the degree of inhibition of proliferation was reduced with increasing 
concentrations of SMEAF. This provided evidences that SMEAF possessed dose-
dependent growth inhibitory effect on HCT116 cells. 
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                      [A]                                                                                            [B] 
 
 
 
 
 
 
 
 
Figure 3.2 [A] Effect of SMEAF on the viable cell count at different concentration of SMEAF treated HCT116 cells. [B] Percentage inhibition 
(%) on HCT116 cells after treatment with different concentration of SMEAF. Cells were treated without or with different concentration (0.05-1.0 
mg/ml) of SMEAF for 24h. The numbers of viable cells were counted using a hemocytometer as described in TBE assay in the methods. Each 
bar represents means ± S.E. from three experiments. Asterisks indicate a significant difference between untreated and treated cells (*P < 0.05). 
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3.2    Evaluation of apoptotic effect of SMEAF on HCT116 cells 
3.2.1 Morphological study 
A single dose of 0.05 mg/ml of SMEAF on HCT116 was evaluated at different time 
periods of 6, 12, 24, 48 and 72h. The nuclear changes of the cells exposed to SMEAF 
appeared to be shrunk with condensed chromatin which can be detected as early as 6h 
and 12h of SMEAF treatment which provide the morphological hallmark of apoptotic 
nuclei. Besides, the prolonged period of SMEAF exposed HCT116 cells tend to have 
higher number of the detached cells and membrane blebbing are clearly seen. 
 
 
Figure 3.3 Effect of SMEAF on the morphological changes of HCT116 cells.  
  
  
  
Control 6 h 
12 h 24 h 
48 72 h 
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3.2.2 Hoechst-propidium iodide staining  
To gain further insight on the effect of SMEAF on nuclear and membrane alteration, 
treated cells were stained with Hoechst-propidium iodide stains. As showed in Figure 
3.4, the cells underwent remarkable nuclear changes upon treatment. In the control 
untreated cells, the cells were uniformly stained with blue fluorescence Hoechst stain 
and not stained with red-fluorescence propidium iodide indicating the nuclei of cells 
and membrane of the cells were intact. However, after exposed to SMEAF, there was an 
increase of intensity captured on blue and red fluorescence signals where the cells 
manifested two apoptotic morphological changes, namely nuclear condensation and also 
alteration of cell membrane integrity.  
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Figure 3.4 Effect of SMEAF on HCT116 cells. Cells were incubated without or with 
0.05 mg/ml of SMEAF for different times and the cells were harvested and stained with 
Hoechst and Propidium iodide and visualized by fluorescence microscope. 
6 h 
12 h 
24 h 
48 h 
72 h 
Hoechst PI 
Hoechst/PI 
overlay 
Control 
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3.2.3 Reactive Oxygen Species (ROS) production is one of the mediators of 
SMEAF-induced   apoptosis. 
Endogenous and exogenous agents may cause formation of ROS such as hydrogen 
peroxide, hydroxyl radical, singlet oxygen peroxyl radical and superoxide anion inside 
the cells (Halliwell and Gutteridge, 1989). Elevation in the intracellular ROS levels was 
able to induce apoptosis in cells (Lu et al., 2011). The sensitive probe DCFH-DA was 
utilized to determine whether the ROS were involved in apoptotic inducing effects of 
SMEAF treated HCT116 cancer cells. Intracellular ROS levels increased (a shift of the 
histogram to right hand side) after SMEAF treatment for 4h (Figure 3.5). Further 
analysis revealed the SMEAF caused up to 259 ± 2.7 fold ROS level increase in treated 
cancer cells compared to control cells. The data suggested that the SMEAF exposed 
cells generated an increase intracellular ROS level which is a sign of cells undergoing 
oxidative stress.  
 
Figure 3.5 Effect of SMEAF on intracellular ROS level in HCT116 cells. After 
treatment with 0.05mg/ml of SMEAF for 4 h, the cells were harvested and 
intracellular levels of ROS were determined as described in methods. 
Representative overlay of histrograms showing ROS-associated fluorescence 
intensity. 
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3.2.4 Externalization of Phosphatidylserine 
Apoptosis is an active form of programmed cell death with several biochemical features 
(Jacobson et al., 1997; Nagata, 1997) and membrane-bound apoptotic bodies (Kidd, 
1998). Transverse redistribution of plasma membrane phosphatidylserine (PS) occurs 
during early apoptosis; thus, the annexin V binding assay was performed to detect the 
surface exposure of PS. Figure 3.6 [A] shows the FACS histograms with dual 
parameters including V-FITC and PI for different concentration of treatment (24h); 
Figure 3.6 [B] shows different hours of incubation period of 24, 48 and 72h for 
0.05mg/ml of ethyl acetate fraction. 
 
The dual parametric dot plots combining annexin V-FITC and PI fluorescence showed 
the viable cell population in the lower left quadrant (annexin V-negative/PI-negative), 
the early apoptotic cells in the lower right quadrant (annexin V-positive/PI-negative), 
and the late apoptotic cells in the upper right quadrant (annexin V-positive/ PI-positive). 
In untreated HCT116 cells, 3.23% of the cells were in the early apoptotic cells while  
6.20% were late apoptotic cells. The early and late apoptotic cells increased to 4.95% 
and 18.96%, respectively, after being treated with 1.0mg/ml of ethyl acetate fraction 
24h. Figure 3.6 (B) shows significant increase in the percentage of late apoptotic and 
dead cells throughout the increasing incubation period, with decreasing percentage of 
early apoptotic cells.  
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Figure 3.6 Effect of S. macrophylla ethyl acetate fraction on the induction of 
phosphatidylserine externalization and cell membrane integrity in HCT116 cells 
undergoing apoptosis, measured using flow cytometry analysis. Histogram in [A] shows 
induction with dual parameters including V-FITC and PI for different concentrations of 
treatment at 24h;  Histogram in [B] shows induction at different incubation periods of  
24, 48 and 72h for 0.05mg/ml of ethyl acetate fraction.  The data represent mean±S.D. 
of three replicates. (n=3). 
Control 0.05mg/ml 0.1mg/ml 
1.94±0.13% 6.20±1.22% 0.73±0.05% 4.57±0.12% 3.60±0.48% 9.34±0.95% 
87.45±0.93% 7.25±0.77% 75.00±1.22% 12.06±0.67% 89.62±1.35% 3.23±0.18% 
0.2mg/ml 0.5mg/ml 1.0mg/ml 
13.61±0.59% 13.61±0.59% 26.95±2.35% 16.32±1.23% 23.37±1.56% 18.96±1.83% 
64.74±1.18% 13.90±0.12% 50.56±2.02% 6.17±0.11% 52.72±0.85% 4.95±0.61% 
[A] 
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3.2.5 Induction of DNA fragmentation detected by TUNEL assay 
The induction of apoptosis was further studied and quantified by performing Terminal 
deoxynucleotidyl transferase-mediated d-UTP Nick End Labelling, utilizing APO-
BRDU kit. DNA breakage that occurred during late apoptosis was observed in Figure 
3.7 after treatment of ethyl acetate fraction. The apoptotic index was 0.12% in control 
cells, and it increased to 0.39%, 0.85%, 2.33%, 3.71% and 12.90% in cells treated with 
increasing concentrations ranging of S. macrophylla ethyl acetate fraction from 
0.05mg/ml to 1.0mg/ml.  
 
 
 
Figure 3.7 Effect of S.macrophylla ethyl acetate fraction on DNA fragmentation of 
HCT116 cells, measured by TUNEL assay using flow cytometry analysis, at increasing 
concentrations ranging from 0.05mg/ml to 1mg/ml, 24h following treatment. The data 
represent mean± S.D. of three replicates (n=3). 
 
 
Control 0.05mg/ml 0.1mg/ml 
99.51±0.57% 
0.12±5.77x10
-4
% 
98.29±0.03% 
0.39±0.08% 
97.19±0.52% 
0.85±0.07% 
0.2mg/ml 0.5mg/ml 1.0mg/ml 
95.15±0.65% 
2.33±0.34% 
95.09±1.25% 
3.71±1.15% 
85.83±2.85% 
12.90±2.00% 
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3.2.6 Alteration of intracellular total glutathione (GSH) level 
Impairment of mitochondrial function may lead to a decrease in cytosolic glutathione, 
as GSH synthesis required ATP and deficiency of energy supplied by mitochondria is 
likely to affect cellular turnover of GSH (Mithöfer et al., 1992). Eventually, changes in 
the level of glutathione in cells might eventually lead to apoptosis (Ratan et al., 1994). 
The results showed a significant dose-dependency in the drop of GSH level 
corresponding to the increase in ethyl acetate fraction concentrations (Figure 3.8). The 
lowest GSH level was established at 9.56±0.50nmoles when treated with 1.0mg/ml of 
ethyl acetate fraction. 
 
Figure 3.8 Effect of S.macrophylla ethyl acetate fraction on intracellular total 
glutathione level of HCT116 cells at 24 hours following treatment. The data represent 
mean± S.E. of three independent experiments (n=9). 
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3.2.7 Disruption of mitochondrial membrane potential (ΔΨm) 
Mitochondria play an important role in the apoptotic cascade by serving as a convergent 
center of apoptotic signals originating from both the extrinsic and intrinsic pathways 
(Kim et al., 2006). Depletion of ΔΨm caused the opening of the mitochondria 
permeability transition pore, eventually leading to apoptosis (Narita et al., 1998). The 
changes in mitochondrial membrane potential in HCT116 cell line with ethyl acetate 
fraction were measured by JC-1 dye. Results in Figure 3.9 showed that most of the JC-1 
fluorescence in the upper right quadrant of control untreated cells moved to the lower 
right quadrant after the treatment. The results indicated that the treatment has caused the 
depletion of ΔΨm in a dose-dependent manner. 
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Figure 3.9 Effect of S.macrophylla ethyl acetate fraction on the mitochondrial 
membrane depolarization of HCT116 cells at various concentrations ranging from 
0.05mg/ml to 1.0mg/ml. JC-1 intensity was measured using flow cytometry 
fluorescence pattern analysis. The data represent mean± S.D. of three replicates (n=3). 
 
 
 
 
 
 
 
 
90.62±0.17% 
9.26±0.17% 
88.93±0.15
% 
10.45±0.21% 
84.01±0.5% 
15.54±0.42% 
Control 0.05mg/ml 
0.1mg/ml 
76.59±0.15% 
23.53±1.76% 
63.24±0.46% 
36.45±0.42% 
0.2mg/ml 0.5mg/ml 
1.0mg/ml 
45.88±0.77% 
53.69±0.83% 
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3.2.8 Cell cycle distribution analysis 
To determine whether the HCT116 cells treated with SMEAF undergo the apoptosis 
accompanied by alteration in the cell cycle, the distribution index was examined by PI 
staining. The increasing accumulation of G1 phase of cell distribution was observed as 
low as concentration of 0.05mg/ml, and increased toward 1.0mg/ml at 24h incubation 
period (Figure 3.10 [A]). This was accompanied by an increase in sub-G1 population 
and concurrent decrease in G2/M phase cells with increasing hours of incubation at 
0.05mg/ml as shown in Figure 3.10[B]. 
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Figure 3.10 Effect of S.macrophylla ethyl acetate fraction on DNA distribution patterns of HCT116 cells. Propidium iodide (PI) fluorescent intensity 
was measured using flow cytometry.  (A) DNA distribution in different phases of cells following treatments ranging from 0.05mg/ml to 1.0mg/ml for 
24-hour incubation period. (B) DNA distribution in different phases of cells following treatment of 0.05mg/ml at 24h, 48h and 72h incubation periods. 
The data represent mean± S.D. of three replicates (n=3). 
 
 
95 
 
3.2.9 SMEAF-induced change in Bax and Bcl-2 ratio and inhibit the proliferation 
of HCT116 
Bax and Bcl-2 proteins are known to be involved in cell death mechanism. Specifically, 
increasing level of Bcl-2 was shown to promote cellular survival (Dohlman et al., 1988) 
and in contrast, the anti-apoptotic activity of Bcl-2 appears to be opposed by Bax 
(Oltval et al., 1993). It is generally thought that the ratio of Bcl-2 and Bax in a cell may 
determine the survival fate of the cell (Dohlman et al., 1988; Oltval et al., 1993). Since 
SMEAF is capable to induce apoptosis, therefore the investigation of gene expression 
level of Bax and Bcl-2 was performed by using Q-PCR. As depicted in Figure 3.11 [B], 
there is a slight decrease in Bcl-2 gene expression level and a significant concomitant 
increase of Bax expression detected after 6h and 12h of SMEAF treatment (Figure 3.11 
[A]). Taken together, the increase in Bax and decrease in Bcl-2 expression significantly 
elevated the Bax/Bcl-2 expression ratio (Figure 3.11 [C]). These results suggested that 
an increase level of Bax/Bcl-2 may sensitize the cells towards apoptotic stimuli. 
 
Further confirmation of the expression level of Bax and Bcl-2 was determined by using 
cytometric immunofluorescence staining method. As depicted in Figure 3.12, when 
compared to the untreated cells, the SMEAF-treated cell profiles shifted to the right in 
Bax histograms while there was no drastic shift in Bcl-2 histograms. This showed that 
the Bax protein level was increased after the treatment but no changes in Bcl-2 protein 
level was detected. This was consistent with the q-PCR results where no significant 
changes in Bcl-2 level was observed while increasing number of cells exhibited higher 
level of Bax expression upon the SMEAF treatment. Thus, these results supported the 
notion that SMEAF-induced apoptosis in HCT116 cells was mediated through the up 
regulation of Bax/Bcl-2 expression ratio. 
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Though the effect of apoptotic sensitizing effect was confirmed above, further 
investigation was focused on PCNA gene in determining the anti-proliferation effect of 
SMEAF. PCNA involves in vast number of cellular activities including cell cycle 
regulation, DNA synthesis and DNA repair and it is greatly expressed in most of the 
proliferating cancer cells (P. K. Chan et al., 1983). Thus PCNA is a well known marker 
for proliferating cells. Involvement of PCNA in SMEAF inhibitory effect was 
confirmed using Q-PCR showed Figure 3.13 the expression level of PCNA on SMEAF 
exposed cells gradually decreased throughout the treatment period. Reflecting the 
proliferation of the cells was halted upon the treatment. 
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 [A]                                                                          [B]                                                                             [C] 
                                         
 
Figure 3.11 Effect of SMEAF on gene expression level of Bax and Bcl-2 in HCT116 cells. Cells were treated with 0.05mg/ml of SMEAF for different 
times. After designed exposure times, cells were harvested and the total RNA was extracted. The RNA was subjected to q-PCR analysis as described in 
methods. [A] The relative gene expression level of Bax was compared to control, [B]The relative gene expression level of Bcl-2 was compared to 
control which were normalized against PBGD expression using the formula 2
-∆∆CT
. [C] Values are mean ± S.E. of three experiments. Asterisks indicate 
a significant difference between untreated and treated cells (*P < 0.05). 
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Figure 3.12 Effect of SMEAF on protein expression level of Bax and Bcl-2 in HCH116 
cells. After treatment with 0.05mg/ml of SMEAF for different time periods, the cells 
were harvested and intracellular levels of Bax and Bcl-2 were determined as described 
in methods. Representative overlay of histrograms [a] showing Bax-associated 
immunofluorescence, while [b] showing Bcl-2-assiociated immunofluorescence. 
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Figure 3.13 Effect of SMEAF on gene expression level of PCNA in HCT116 cells. 
Cells were treated with 0.05mg/ml of SMEAF for different times. After designated 
exposure times, cells were harvested and the total RNA was extracted. The RNA was 
subjected to q-PCR analysis as described in methods. The relative gene expresion level 
of PCNA expression was compared to control, which were normalized against GADPH 
expression using the formula 2
-∆∆CT
. Values are mean ± S.E. of three experiments. 
Asterisks indicate a significant difference between untreated and treated cells (*P < 
0.05). 
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3.2.10 Caspase -3/7 and -9 involved in SMEAF induced apoptosis 
Executioner Caspase -3/7 and initiator Caspase -9 were evaluated. The ability of 
SMEAF to activate the caspases was studied using fluorescence linked inhibitor of 
caspase -3/7 and -9. HCT116 were incubated with 0.05 mg/ml of SMEAF for 3, 6, 12 
and 24 hours followed by addition of the fluorescent inhibitor and results of flow 
cytometer analysis were showed in Figure 3.14 From the histograms (Figure 3.14 [A]), 
the intensity of fluorescence signal of caspase -3/7 increased after 3hours of incubation 
period and slight decrease was detected on 12h of incubation and resume higher level on 
24h. This may due to the nature different of cells reaction toward stimuli. Meanwhile, 
evaluation of initiator caspase -9 activity was showed of Figure 3.14 [B]. There were 
slight increase of activity of caspase -9 on 3 and 6h followed by bigger argument on 12 
and 24h of incubation period.  Therefore, the results suggested SMEAF able to induce 
apoptosis through execution by caspase cascade process especially through caspase -3/7 
and -9. 
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[A] 
 
[B] 
 
Figure 3.14 [A] Effect of SMEAF on caspase 3/7 and [B] caspase 9 activity level in 
HCH116 cells. After treated with 0.05mg/ml of SMEAF for different times, the cells 
were harvested and intracellular levels of caspase 3/7 were determined as described in 
methods. 
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3.2.11 SMEAF induced changes in cell cycle regulatory genes 
PCNA down regulation may exert its effect on cell cycle regulatory pathway, in effort 
to gain further insight into the molecular mechanisms affected by SMEAF in HCT116 
cells, we profiled the expression of key pathways involved in cell cycle using human 
cancer pathway finder PCR array with SMEAF treated cells and control cells. This PCR 
array contains 84 genes in different cancer related pathways (cell cycle, apoptosis, 
adhesion, angiogenesis, invasion and metastasis, signal transduction molecules and 
transcriptional factors (gene details on SABiosciences website, catalog PAH-033)). 
Numerous key genes involved in cell regulatory pathways were altered in its expression 
level, specifically CCNE1, CDC25A, CDK2, CDK4  and E2F1 were down regulated to 
identified and proved by real-time PCR as shown in Figure 3.15 In addition, the Q-PCR 
study showed the gene that encoded p21 and p53 protein which known as CDKN1A 
and TP53 respectively were up regulated. Besides, SMEAF exposure causing the down 
regulation of MDM2 gene which encoding the negative regulator of p53 was detected 
after the SMEAF treatment. The data indicating SMEAF may cause the p53-p21 
activation and subsequently leading to cell cycle arrest in HCT116 and apoptosis.  
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[A]   [B]  
                                                                                          
Figure 3.15 The cells were treated with 0.05 mg/ml of SMEAF, harvested after 12 h incubation and the total RNA was extracted. The RNA was 
subjected to Q-PCR analysis by using PCR array as described in methods. Analysis was done by using RT
2 
Profiler Data Analysis Excel platform. The 
genes expression was normalized against ACTB expression values. Values are mean ± S.D. of three experiments. [A] Effects of SMEAF treatment on 
cell cycle regulatory genes of HCT116 after 24h incubation period. [B] Effects of SMEAF on expression level of TP53 and MDM2 after 24h exposure 
period. Asterisks indicate a significant difference between expression level of TP53 and MDM2 of treated cells (*P < 0.05). 
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3.2.12 p53 and p21 proteins expression level detection by using protein array 
Proteins p53 and p21 play important roles in regulating the cell cycle progression. 
Protein array analysis was utilized in determination of protein expression of p21 and 
p53 proteins in HCT116 cells treated with SMEAF. Figure 3.16 [A] and Figure 3.17 [A], 
indicate the duplicates of experiments conducted on 0h (control) and 24 h exposure of 
SMEAF particularly on HCT116. The photographs clearly shown the treatment of 
SMEAF for 24 h caused the increase of p53 and p21 proteins level indicating by the 
sharper fluorescence signal. The fluorescent signal of each of the sample was subtracted 
with background fluorescent signal and further normalized against pre-coated positive 
control probes in arrays. Figure 3.16 [B] and Figure 3.17 [B] show mean fluorescent 
signals of its duplicates. The 0 h or control samples fluorescence intensity at 39.60 
while the treated group at 138.95 which indicating more than three folds increase in p21 
protein level. 
[A]                                                               [B] 
 
Figure 3.16 Protein expression level of p53 on 0h (control) and 24h exposure of 
SMEAF on HCT116 cell line. [A] RayBiotech protein array analysis on control and 
treated cells photographed by GenePix 4000B. [B] Means fluorescence of p21 of 
control (0h) and 24h SMEAF treated cells after subtracted with background and 
normalized against pre-coated positive control probes using Acuity 4.0 analysis 
software. 
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[A]                                                               [B] 
         
 
Figure 3.17 Protein expression level of p21 on 0h (control) and 24h exposure of 
SMEAF on HCT116 cell line. [A] RayBiotech protein array analysis on control and 
treated cells photographed by GenePix 4000B. [B] Means fluorescence of p21 of 
control (0h) and 24h SMEAF treated cells after subtracted with background and 
normalized against pre-coated positive control probes using Acuity 4.0 analysis 
software. 
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3.3 Chemicals purification and identification of SMEAF 
3.3.1 Cell viability evaluation of SMEAF chromatographed frations 
The previous results demonstred SMEAF possessed apoptotic inducing effects in 
HCT116 cells, therefore 3g of SMEAF was subjected for isolation of bioactive 
compounds through column chromatography. The isolation procedures were guided by 
MTT cell viability assay. As depicited in Figure 3.19  there are 11 fractions after 
chromatographed using mixture of solvents started with n-hexane followed by 
increasing proportions of chloform. Eleven fractions were obtained and all of them were 
subjected to biological screening against HCT 116 cells using MTT assay. The results 
show that, only five out of the eleven fractions were able to give IC50 with the range of 
screening concentration up to 200 µg/ml. The fractions were, EA 4 , EA 5, EA 7, EA 8 
and EA 11 with IC50 values 141.03 ± 2.16, 152.82 ± 3.19, 58.32 ± 5.02, 194.05 ± 4.44 
and 89.78 ± 4.72 µg/ml respectively (Figure 3.18). 
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Figure 3.18 MTT cell viability assay evaluation on different fractions of SMEAF after 
chromatograpy. The data represent mean ± S.E. of three independent experiments (n=9). 
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3.3.2 Identification of chemical constituents of EA 1, EA 2, EA 3 and EA 4 Fraction 
using GC-MS 
The named fractions were subjected to GC-MS anlysis and the results obtained are 
shown in Table 3.2, 3.3, 3.4 and 3.5 respectively. 
 
Table 3.2: Chemical constituents of EA 1 identified by GC-MS. 
Compounds Name Retention time Percentage (%) 
Pentadecanoic acid, metyl ester 19.526 5.97 
Hexadecanoic acid, ethyl ester 21.127 26.96 
Octadecanoic acid, methyl ester 23.861 4.76 
(E)-9-Octadecanoic acid, ethyl ester 24.648 1.79 
Octadecanoic acid, ethyl ester 25.181 22.52 
Eicosanoic acid, ethyl ester 27.551 4.07 
Heptadecanoic acid, ethyl ester 28.671 2.07 
Stigmasterol 35.383 3.03 
Gamma-sitosterol 37.253 8.03 
Total Identified Amount: 79.20% 
 
Table 3.3: Chemical constituents of EA 2 identified by GC-MS. 
Compounds Name Retention time Percentage (%) 
Pentadecanoic acid, metyl ester 19.519 1.12 
Ethyl 9-hexadecenoate 20.614 0.57 
Hexadecanoic acid, ethyl ester 21.121 5.82 
9,12-Octadecadienoic acid, methyl ester 23.254 9.16 
9-Octadecanoic acid (z), methyl ester 23.385 8.22 
Octadecanoic acid, methyl ester 23.867 0.35 
Linoleic acid methyl ester 24.693 38.84 
Ethyl oleate 24.824 33.38 
Octadecanoic acid, ethyl ester 25.180 2.28 
Total Identified Amount: 99.74% 
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Table 3.4: Chemical constituents of EA 3 identified by GC-MS. 
Compounds Name Retention time Percentage (%) 
Oxacycloheptadecan-2-one 19.726 0.29 
Tridecanoic acid 20.426 0.21 
9,12-Octadecadienoic acid, methyl ester 23.216 1.28 
912,15-Octadecatrienoic acid, methyl 
ester (z,z,z) 
23.354 3.11 
9,12-Octadecadienoic acid (z,z)- 24.298 5.42 
Linoleic acid ethyl ester 24.573 5.74 
9,12,15-Octadecatrienoic acid, ethyl 
ester, (z,z,z) 
24.730 12.44 
Decanedioic acid, bis(2-ethylhexyl) ester 34.939 0.14 
9,19-cyclolanost-24-en-3-ol, (3.beta.)- 42.432 0.52 
Total Identified Amount: 29.15% 
 
 
Table 3.5: Chemicals constituent of EA 4 identified by GC-MS. 
Compounds Name Retention time Percentage (%) 
n-Hexadecanoic acid 20.477 0.73 
9,17-Octadecadienal, (z)- 24.505 41.97 
2-Methyl-z,z-3,13-octadecadienol 25.706 6.65 
12-Methyl-E,E-2,13-octadecadien-1-ol 27.045 1.22 
9,12-Octadecadienoic acid (z,z)- 27.345 0.59 
2-Methyl-z,z-3, 13-octadecadienol 27.564 1.36 
2-Methyl-z,z-3,13-octadecadienol 27.864 0.96 
Cis-7, cis-11-Hexadecadienol-1-yl 
acetate 
31.273 0.08 
2-methyl-z,z-3,13-octadecadienol 33.494 0.22 
.gamma.-Tocopherol 38.279 0.32 
.gamma.-Sitosterol 41.864 7.10 
Total Identified Amount: 61.20% 
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3.3.3 Purification and identification of compound from EA 4  
 
EA 4 was subjected to another column chromatography, initially eluting with n-hexane 
and later with acetone to give twelve fractions. The sixth fraction [EA 4 (6)] was 
subjected to preparative thin layer chromatography yielding compound swietenolide (4).  
The eighth fraction [EA 4 (8)] was dissolved in methanol and stored in a refrigerator. A 
white solid was obtained after two days (1) and a second crop (2) was obtained after 
another two days. Recrystalization of the first (1) and second crop (2) from chloroform 
yielded colorless crystals namely diacetylswietenolide or 3,6-O,O-diacetylswietenolide 
(1) and swietenine (2). The ninth fraction [EA 4 (9)] was also dissolved in methanol and 
stored in refrigerator for three days until formation of white solid. Recystalization of 
crop from chloroform yielded 6-O-acetylswietenolide (8). The flow chart of purification 
procedure is show in Figure 3.19. 
 
The chemical structure of purified compounds were confirmed by comparison of 
obtained NMR data with published data as in tables listed below.The molecular weight 
of compounds was further confirmed by using GC-MS and fragmentation ions of 
compounds were shown in  Table 3.20.
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Figure 3.19 Flow chart of column chromatography isolation of compounds 1, 2, 4 and 8.   
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3.3.4 Purification and identification of compound from EA 5 
The EA 5 was subjected to preparative HPLC using 45% methanol: 55% water as the 
mobile phase and the compound known as 3-O-tigloylswietenolide (3) was obtained 
(Figure 3.20). The structures were confirmed by comparison of obtained NMR data 
with published literature data in Table 3.8 and 3.15. The structures were further 
confirmed using GC-MS Table 3.20. 
 
3.3.5 Purification and identification of compound from EA 7 
The EA 7 fraction of SMEAF was further fractionated using column chromatography, 
initially eluting with n-hexane and later with chloroform and finally increasing the 
mobile phase polarity using acetone until flushed out by using methanol. This gives six 
fractions. After evaluation using MTT assay for their cytotoxic activity, the most potent 
fraction EA 7(2) was subjected to preparative TLC (Figure 3.21 & Figure 3.22). This 
afforded the compound named hexadecanoic acid (5).  
 
3.3.6 Purification and identification of compounds from EA 8 
The EA 8 faction of SMEAF was subjected to column chromatography with hexane as 
initial eluting solvent and step-wise increasing polarities using acetone until flushed out 
using methanol. The column chromatography afforded us a total of ten fractions (Figure 
3.23) and all of them were evaluated for their cytotoxic activities. The IC50 of fractions 
EA 8 (1-10) were shown in Figure 3.24. The most potent faction was then subjected to 
preparative TLC and afforded compound Khayasin T (7). 
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3.3.7 Purification and identification of compound from EA 9 
The EA 9 fraction was separated using TLC (Figure 3.25). With the assistance of UV 
ray (254nm) we managed to purify out the compound known as proceranolide (6). The 
data of NMR spectra and GC-MS data were shown Table 3.10, 3.17 and 3.20.
 
 
114 
 
Ethyl acetate fraction 
(SMEAF) 
EA1 
EA2 
EA3 
EA4 
EA5 3-O-Tigloylswietenolide (3) 
Preparative HPLC 
EA6 
EA7 
EA8 
EA9 
EA10 
EA11 
C.C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20 Flow chart of column chromatography isolation of compound 3. 
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Figure 3.21 Flow chart of column chromatography isolation of compound 5. 
Ethyl acetate fraction 
(SMEAF) 
EA1 
EA2 
EA3 
EA4 
EA5 
EA6 
EA7 
EA7 (1) 
EA7 (2) 
Hexadecanoic acid 
(5) 
Preparative TLC 
EA7 (3) 
EA7 (4) 
EA7 (5) 
EA7 (6) 
C.C. 
EA8 
EA9 
EA10 
EA11 
C.C. 
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Figure 3.22 MTT cell viability assay evaluation on different fractions of EA 7 after 
chromatographed. The data represent mean ± S.E. of three independent experiments 
(n=9). 
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Figure 3.23 Flow chart of column chromatography isolation of compound 7.
Ethyl acetate fraction 
(SMEAF) 
EA1 
EA2 
EA3 
EA4 
EA5 
EA6 
EA7 
EA8 
EA8 (1) 
EA8 (2) Khayasin T (7) 
Preparative TLC 
EA8 (3) 
EA8 (4) 
EA8 (5) 
EA8 (6) 
EA8 (7) 
EA8 (8) 
EA8 (9) 
EA8 (10) 
C.C. 
EA9 
EA10 
EA11 
C.C. 
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Figure 3.24 MTT cell viability assay evaluation on different fractions of EA 8 after 
chromatographed. The data represent mean ± S.E. of three independent experiments 
(n=9). 
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Figure 3.25 Flow chart of column chromatography isolation of compound 6.
Ethyl acetate fraction 
(SMEAF) 
EA1 
EA2 
EA3 
EA4 
EA5 
EA6 
EA7 
EA8 
EA9 Proceranolide (6) 
Preparative 
TLC 
EA10 
EA11 
C.C. 
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3.3.8 Chemicals structures of purified compounds 
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Figure 3.26 Chemical structure of 3,6-O,O-Diacetylswietenolide (1). 
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Figure 3.27 Chemical structure of Swietenine (2). 
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Figure 3.28 Chemical structure of 3-O-Tigloylswietenolide (3). 
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Figure 3.29 Chemical structure of swietenolide (4). 
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Figure 3.30 Chemical structure of hexadecanoic acid (5). 
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Figure 3.31 Chemical structure of proceranolide (6).
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Figure 3.32 Chemical structure of khayasin T (7). 
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Figure 3.33 Chemical structure of 6-O-acetylswietenolide (8).
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3.3.9 Spectral data of purified compounds 
Table 3.6:  
1
H-NMR spectral data for diacetyl swietenolide (1). 
 
Position/type Chemical shift δ, ppm 
(400MHz, CDCl3) 
Literature
a
 δ, ppm 
(400MHz, CDCl3) 
H2, CH 3.13 (m) 3.14 (ddd) 
H3, CHOCOCH3 4.85 (d) 4.86 (d) 
H5, CH 3.38 (s) 3.40 (s) 
H6, CHOCOCH3 5.44 (s) 5.46 (s) 
H9, CH 2.08 (m) 2.08 (m) 
H11, CH2 1.74 (m) 
1.85 (m) 
1.16 (m) 
1.81 (m) 
H12, CH2 1.16 (m) 
1.80 (m) 
1.76 (m) 
1.89 (m) 
H15, CH2 3.43 (dt) 
3.66 (d) 
3.44 (dt) 
3.68 (d) 
H17, CH 5.58 (s) 5.60 (s) 
H18, CH3 1.02 (s) 1.04 (s) 
H19, CH3 1.13 (s) 1.15 (s) 
H21, olefinic CH 7.50 (s) 
 
7.52 (dd) 
(1.8, 1.0) 
H22, olefinic CH 6.43 (d) 6.45 (dd) 
H23, olefinic CH 7.40 (s) 7.43 (t) 
H28, CH3 1.05 (s) 1.07 (s) 
H29, CH3 0.83 (s) 0.85 (s) 
H30, CH2 2.08 (m) 
2.77 (dd) 
2.13(ddd) 
2.79 (dd) 
COOCH3 3.73 (s) 3.74 (s) 
6-OCOCH3 2.15 (s) 2.16 (s) 
H2’, COCH3 2.13 (s) 2.15 (s) 
 
 
 
 
 
 
 
 
 
 
 
 
 
125 
 
Table 3.7: 
1
H-NMR spectral data for swietenine (2). 
 
Position/type Chemical shift δ, ppm 
(400MHz, CDCl3) 
Literaturea δ, ppm 
(400MHz, CDCl3) 
H2, CH 3.53 (dd) 3.52 (ddd) 
H3, COH 4.64 (d) 4.64 (d) 
H5, CH 3.50 (br s) 3.50 (br s) 
H6, CHOC2H3=C2H4 4.56 (br s) 4.56 (br s) 
H9, CH 2.30 (dd) 2.30 (ddd) 
H11, CH2 1.81 (m) 
2.05 (dddd) 
1.81 (m) 
2.05 (qd) 
H12, CH2 1.45 (m) 
1.74 (m) 
1.46 (ddd) 
                 1.77 (m) 
H14, CH 2.22 (d) 2.23 (ddd) 
H15, CH2 2.85 (dd) 
2.79 (dd) 
2.83 (dd) 
2.76 (dd) 
H17, CH 5.55 (s) 5.54 (s) 
H18, CH3 0.97 (s) 0.97 (s) 
H19, CH3 1.45 (s) 1.45 (s) 
H21, olefinic CH 7.55 (s) 7.56 (dd) 
H22, olefinic CH 6.38 (d) 6.38 (dd) 
H23, CH3 7.45 (t) 7.45 (t) 
H28, CH3 1.12 (s) 1.12 (s) 
H29, CH3 0.89 (s) 0.89 (s) 
H30, olefinic CH 5.34 (dt) 5.34 (dt) 
COOCH3 3.76 (s) 3.76 (s) 
H2’-CH3, 2’-CH3 1.81 (br d) 1.82 (br s) 
H3’, olefinic CH 6.87 (dddd) 6.87 (qq) 
H3’-CH3, 3’H-CH3 1.74 (br dd) 1.74 (br d) 
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Table 3.8: 
1
H-NMR spectral data for 3-O-tigloylswietenolide (3). 
 
Position/type Chemical shift δ, ppm 
(400MHz, CDCl3) 
Literature
a
 δ, ppm 
(400MHz, CDCl3) 
H2, CH 3.22 (m) 3.21 (ddd) 
H3, CH 4.71 (d) 4.71 (d) 
H5, CH 3.38 (s) 3.38 (br s) 
H6, CH 4.56 (s) 4.56 (br s) 
H9, CH 2.12 (m) 2.11 (m) 
H11, CH2 1.74 (m) 
1.88 (m) 
1.76 (m) 
1.88 (m) 
H12, CH2 1.19 (m) 
1.74 (m) 
1.17 (m) 
1.74 (m) 
H15, CH2 3.28 (t) 
3.54 (d) 
3.25 (dt) 
3.54 (dt) 
H17, CH 5.43 (s) 5.43 (s) 
H18, CH3 0.99 (s) 0.99 (s) 
H19, CH3 1.43 (s) 1.43 (s) 
H21, olefinic CH 7.49 (s) 7.48 (dd) 
H22, olefinic CH 6.43 (t) 6.40 (dd) 
H23, olefinic CH 7.44 (s) 7.43 (s) 
H28, CH3 1.10 (s) 1.10 (s) 
H29, CH3 0.86 (s) 0.86 (s) 
H30, CH2 2.12 (m) 
2.68 (d) 
2.12 (m) 
COOCH3 3.86 (s) 3.86 (s) 
H2’-CH3, 2’-CH3 1.88 (s) 1.89 (t) 
(1) 
H3’, olefinic CH 6.93 (dd) 6.93 (qq) 
H3’-CH3, 3’-CH3 1.83 (d) 1.83 (dd) 
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Table 3.9: 
1
H-NMR spectral data for swietenolide (4). 
 
 
Position/type Chemical shift δ, ppm 
(400MHz, CDCl3) 
Literature
a
 δ, ppm 
(400MHz, CDCl3) 
H2, CH 3.02 (m) 3.04 (ddd) 
H3, CHOH 3.56 (d) 3.58 (d) 
H5, CH 3.23 (s) 3.25 (br s) 
H6, CHOH 4.51 (s) 4.54 (br s) 
H9,CH 2.04 (br d) 2.07 (br s) 
H11, CH2 1.73 (m) 
1.99 (m) 
1.14 (m) 
1.73 (m) 
H12, CH2 1.12 (dd) 
1.73 (m) 
1.78 (ddd) 
1.86 (ddd) 
H15, CH2 3.43 (dt) 
4.00 (d) 
3.46 (dt) 
4.03 (dt) 
H17, CH 5.45 (s) 5.47 (s) 
H18, CH3 0.97 (s) 0.99 (s) 
H19, CH3 1.38 (s) 1.40 (s) 
H21, olefinic CH 7.46 (s) 7.48 (dd) 
H22, olefinic CH 6.38 (d) 6.40 (dd) 
H23, olefinic CH 7.39 (s) 7.41 (t) 
H28, CH3 0.97 (s) 1.00 (s) 
H29, CH3 0.86 (s) 0.88 (s) 
H30,CH2 1.99 (dd) 
3.16 (dd) 
2.01 (ddd) 
                   3.19 (dd) 
COOCH3 3.81 (s) 3.82 (s) 
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Table 3.10: 
1
H-NMR spectral data for proceranolide (6). 
 
Position/type Chemical shift δ, ppm 
(400MHz, CDCl3) 
Literature
a
 δ, ppm 
(400MHz, CDCl3) 
H2, CH 3.03 (ddd) 3.04 (ddd) 
H3, CHOH 3.72 (d) 3.74 (d) 
H5, CH 3.23 (dd) 3.24 (dd) 
H6,CH2 2.34 (d) 
2.41 (d) 
2.34 (dd) 
 2.40 (dd) 
H9, CH 1.98 (m) 1.98 (m) 
H11, CH2 1.70 (m) 
1.77 (m) 
1.72 (m) 
1.80 (m) 
H12,CH2 1.04 (m) 
1.80 (m) 
1.03 (m) 
1.79 (m) 
H15, CH2 3.48 (dt) 
4.10 (dt) 
3.46 (dt) 
4.08 (dt) 
H17, CH 5.59 (s) 5.59 (s) 
H18, CH3 1.02 (s) 1.03 (s) 
H19, CH3 1.12 (s) 1.13 (s) 
H21, olefinic CH 7.49 (dd) 7.57 (dd) 
H22,olefinic CH 6.46 (dd) 6.49 (dd) 
H23, olefinic CH 7.37 (t) 7.39 (t) 
H28, CH3 0.72 (s) 0.72 (s) 
H29,CH3 0.80 (s) 0.81 (s) 
H30, CH2 1.95 (m) 
3.17 (dd) 
1.97 (m) 
3.19 (dd) 
COOCH3 3.69 (s) 3.70 (s) 
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Table 3.11: 
1
H-NMR spectral data for khayasin T (7). 
 
Position/type Chemical shift δ, ppm 
(400MHz, CDCl3) 
Literature
a
 δ, ppm 
(400MHz, CDCl3) 
H2, CH 3.23 (m) 3.23 (ddd) 
H3, CHO 4.83 (d) 4.85 (d) 
H5, CH 3.35 (dd) 3.37 (dd) 
H6, CH2 2.34 (m) 
3.38 (dd) 
2.37 (dd) 
2.42 (dd) 
H9, CH 2.01 (m) 2.01 (m) 
H11, CH2 1.74 (m) 1.73 (m) 
1.84 (m) 
H12, CH2 1.11 (m) 
1.82 (m) 
1.10 (m) 
1.83 (m) 
H15, CH2 3.23 (m) 
3.59 (br d) 
3.23 (dt) 
3.61 (dt) 
H17, CH 5.54 (s) 5.55 (s) 
H18, CH3 1.01 (s) 1.03 (s) 
H19, CH3 1.15 (s) 1.17 (s) 
H21, olefinic CH 7.56 (s) 7.57 (dd) 
H22, olefinic CH 6.45 (dd) 6.48 (dd) 
H23, olefinic CH 7.40 (t) 7.42 (t) 
H28, CH3 0.80 (s) 0.82 (s) 
H29, CH3 0.76 (s) 0.77 (s) 
H30, CH2 2.07 (m) 
2.64 (dd) 
2.08 (ddd) 
2.66 (dd) 
COOCH3 3.71 (s) 3.74 (s) 
H2’-CH3, 2’-CH3 1.88 (s) 1.89 (d) 
H3’, olefinic CH 6.95 (qq) 6.96 (qq) 
H3’-CH3, 3’-CH3 1.82 (dd) 1.83 (dd) 
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Table 3.12: 
1
H-NMR spectral 6-O-acetylswietenolide (8). 
 
Position/type Chemical shift δ, ppm 
(400MHz, CDCl3) 
Literature
a
 δ, ppm 
(400MHz, CDCl3) 
H2, CH 3.04 (m) 3.05 (ddd) 
H3, CHOH 3.60 (d) 3.62 (d) 
H5, CH 3.46 (s) 3.45 (br s) 
H6, CH 5.43 (s) 5.45 (br s) 
H9, CH 2.03 (m) 2.02 (m) 
H11, CH2 1.77 (m) 
1.88 (m) 
1.76 (m) 
1.89 (m) 
H12,CH2 1.13 (m) 
1.84 (m) 
1.15 (m) 
1.84 (m) 
H15, CH2 3.59 (d) 
4.01 (d) 
3.45 (dt) 
4.01 (dt) 
H17,CH 5.51 (s) 5.53 (s) 
H18, CH3 0.99 (s) 1.01 (s) 
H19, CH3 1.13 (s) 1.15 (s) 
H21, olefinic CH 7.51 (d) 7.54 (dd) 
H22, olefinic CH 6.45 (dd) 6.47 (dd) 
H23, olefinic CH 7.39 (t) 7.41 (t) 
H28, CH3 0.97 (s) 0.99 (s) 
H29, CH3 0.91 (s) 0.94 (s) 
H30, CH2 2.02 (m) 
3.13 (dd) 
2.00 (m) 
3.17 (dd) 
COOCH3 3.73 (s) 3.74 (s) 
6-OCOCH3 2.15 (s) 2.17 (s) 
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Table 3.13: 
13
C NMR spectral of diacetyl swietenolide (1). 
 
Position/type Chemical shift δ, ppm 
(400MHz, CDCl3) 
Literaturea δ, ppm 
C1, C=O 217.08 216.86 
C2, CH 47.91 47.86 
C3, CHOCOCH3 79.52 79.49 
C4, C quaternary 38.90 38.84 
C5, CH 44.43 44.40 
C6, CH 73.09 73.05 
C7, 6-COOCH3 171.33 171.26 
C8, C olefinic 127.66 127.61 
C9, CH 53.13 53.55 
C10, C quaternary 53.43 53.43 
C11, CH2 18.74 18.94 
C12, CH2 29.40 29.79 
C13, C quaternary 38.21 38.13 
C14, C olefinic 132.35 131.61 
C15, CH2 33.51 33.16 
C16, C=O 169.72 169.23 
C17, CH 80.91 81.11 
C18, CH3 18.06 18.04 
C19, CH3 16.81 16.71 
C20, C olefinic 120.56 120.53 
C21, C olefinic, CH 141.64 141.57 
C22, C olefinic,CH 109.94 109.88 
C23, C olefinic, CH 143.08 143.00 
C28, CH3 23.43 23.36 
C29, CH3 23.07 23.02 
C30, CH2 33.77 33.71 
COOCH3 52.25 53.35 
6-OCOCH3 169.85 169.71 
6-OCOOCH3 21.08 20.93 
C1’, 3-OCOCH3 170.23 170.23 
C2’, 3-OCOCH3 21.33 21.20 
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Table 3.14: 
13
C NMR spectral of swietenine (2). 
 
 
Position/type Chemical shift δ, ppm 
(400MHz, CDCl3) 
Literaturea δ, ppm 
C1, C=O 216.61 216.53 
C2, CH 48.93 48.95 
C3, COH 78.38 78.41 
C4, C quaternary 39.01 39.04 
C5, CH 45.43 45.47 
C6, CHOC2H3=C2H4 72.84 72.87 
C7,6- COOCH3 175.96 175.97 
C8, C olefinic 138.27 138.28 
C9, CH 57.52 57.56 
C10, C quaternary 50.36 50.39 
C11, CH2 21.24 21.28 
C12, CH2 34.60 34.64 
C13, C quaternary 36.69 36.73 
C14, CH 45.04 45.09 
C15, CH2 29.54 29.57 
C16, C=O 168.48 168.45 
C17, CH 76.71 76.71 
C18, CH3 21.24 21.28 
C19, CH3 16.52 16.53 
C20, C olefinic 121.33 121.38 
C21, C olefinic, CH 140.51 140.54 
C22, C olefinic, CH 109.21 109.24 
C23, C olefinic, CH 143.19 143.20 
C28, CH3 22.77 22.80 
C29, CH3 23.02 23.05 
C30, C olefinic, CH 123.60 123.66 
COOCH3 53.29 53.28 
C1’, CH 166.91 166.92 
C2’, C olefinic 127.73 127.77 
C3’, C olefinic, CH 139.02 139.02 
C2’-CH3 11.72 11.75 
C3’-CH3 14.63 14.64 
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Table 3.15: 
13
C NMR spectral of 3-O-tigloylswietenolide (3). 
 
Position/type Chemical shift δ, ppm 
(400MHz, CDCl3) 
Literaturea δ, ppm 
C1, C=O 218.01 217.95 
C2, CH 48.13 48.14 
C3, CH 80.55 80.57 
C4, C quaternary 39.16 39.17 
C5, CH 45.06 45.08 
C6, CH2O 73.33 73.36 
C7, 6-COOCH3 175.63 175.63 
C8, C olefinic 128.48 128.52 
C9, CH 53.52 53.55 
C10, C quaternary 53.43 53.43 
C11, CH2 18.91 18.94 
C12, CH2 29.76 29.79 
C13, C quaternary 38.10 38.13 
C14, C olefinic 131.59 131.61 
C15, CH2 33.19 33.16 
C16, C=O 169.27 169.23 
C17, CH 81.11 81.11 
C18, CH3 17.64 17.79 
C19, CH3 17.64 17.65 
C20, C olefinic 120.84 120.87 
C21, C olefinic, CH 141.05 141.06 
C22, C olefinic,CH 109.74 109.76 
C23, C olefinic, CH 143.11 143.12 
C28, CH3 23.09 23.11 
C29, CH3 23.73 23.75 
C30, CH2 34.05 34.07 
COOCH3 53.13 53.14 
C1’, CH 167.22 167.21 
C2’, C olefinic 129.03 129.06 
C3’, C olefinic, CH 138.99 138.98 
C2’-CH3 12.29 12.31 
C3’-CH3 14.59 14.60 
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Table 3.16: 
13
C NMR spectral of switenolide (4). 
 
Position/type Chemical shift δ, ppm 
(400MHz, CDCl3) 
Literaturea δ, ppm 
C1, C=O 219.8114 219.80 
C2, CH 50.0386 49.99 
C3, CHOH 78.6455 78.50 
C4, C quaternary 39.7590 39.66 
C5, CH 44.0701 44.00 
C6, CHOH 73.6637 73.57 
C7, 6-COOCH3 175.9240 175.83 
C8, C olefinic 129.1337 129.05 
C9, CH 53.0564 52.96 
C10, C quaternary 54.0720 53.99 
C11, CH2 18.8356 29.08 
C12, CH2 29.1919 18.71 
C13, C quaternary 37.9195 37.81 
C14, C olefinic 130.8695 130.75 
C15, CH2 33.8767 33.15 
C16, C=O 171.4308 171.43 
C17, CH 80.5903 80.51 
C18, CH3 17.9925 17.91 
C19, CH3 17.9925 17.91 
C20, C olefinic 120.9043 120.81 
C21, C olefinic, CH 141.1475 141.06 
C22, C olefinic,CH 109.9060 109.80 
C23, C olefinic, CH 142.9869 142.88 
C28, CH3 23.3000 23.22 
C29, CH3 23.7119 23.63 
C30, CH2 33.2539 33.80 
COOCH3 53.3726 53.23 
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Table 3.17: 
13
C NMR spectral of proceranolide (6). 
 
Position/type Chemical shift δ, ppm 
(400MHz, CDCl3) 
Literaturea δ, ppm 
C1, C=O 220.06 220.08 
C2, CH 50.13 50.15 
C3, CHOH 77.30 77.23 
C4, C quaternary 39.38 39.30 
C5, CH 39.38 39.30 
C6, CH2 33.63 33.54 
C7, 6-COOCH3 174.46 174.39 
C8, C olefinic 128.30 128.27 
C9, CH 51.90 51.76 
C10, C quaternary 53.69 53.61 
C11, CH2 18.83 18.74 
C12, CH2 28.69 28.56 
C13, C quaternary 38.01 37.88 
C14, C olefinic 131.43 131.20 
C15, CH2 33.17 33.06 
C16, C=O 171.60 171.73 
C17, CH 80.32 80.25 
C18, CH3 17.65 17.54 
C19, CH3 16.99 16.92 
C20, C olefinic 120.88 120.78 
C21, C olefinic, CH 141.80 141.71 
C22, C olefinic,CH 110.18 110.09 
C23, C olefinic, CH 142.72 142.62 
C28, CH3 20.25 20.17 
C29, CH3 23.92 23.90 
C30, CH2 33.39 33.33 
COOCH3 52.08 51.97 
 
 
136 
 
Table 3.18: 
13
C NMR spectral of Khayasin T (7). 
 
Position/type Chemical shift δ, ppm 
(400MHz, CDCl3) 
Literaturea δ, ppm 
C1, C=O 218.56 218.41 
C2, CH 48.30 48.30 
C3, CHO 79.35 79.28 
C4, C quaternary 38.80 38.73 
C5, CH 40.57 40.51 
C6, CH2 33.48 33.42 
C7, 6-COOCH3 174.36 174.28 
C8, C olefinic 127.87 127.80 
C9, CH 52.29 52.23 
C10, C quaternary 53.27 53.18 
C11, CH2 18.83 18.77 
C12, CH2 29.20 29.16 
C13, C quaternary 38.18 38.11 
C14, C olefinic 131.97 131.93 
C15, CH2 33.00 32.95 
C16, C=O 169.88 169.74 
C17, CH 81.00 80.92 
C18, CH3 17.34 17.29 
C19, CH3 16.79 16.72 
C20, C olefinic 120.86 120.81 
C21, C olefinic, CH 141.76 141.69 
C22, C olefinic,CH 110.05 109.98 
C23, C olefinic, CH 142.91 142.83 
C28, CH3 20.34 20.28 
C29, CH3 23.91 23.86 
C30, CH2 33.69 33.63 
COOCH3 52.18 52.09 
C1’,  C quaternary 167.49 167.41 
C2’, C olefinic 128.97 128.91 
C3’, C olefinic, CH 139.51 139.42 
C2’-CH3 12.46 12.40 
C3’-CH3 14.73 14.66 
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Table 3.19: 
13
C NMR spectral of 6-O-acetylswietenolide (8). 
 
Position/type Chemical shift δ, ppm 
(400MHz, CDCl3) 
Literaturea δ, ppm 
C1, C=O 219.00 218.83 
C2, CH 49.98 49.95 
C3, CHOH 77.31 78.37 
C4, C quaternary 40.08 39.84 
C5, CH 43.10 43.09 
C6, CHOCOCH3 73.62 73.60 
C7, 6-COOCH3 171.45 171.35 
C8, C olefinic 128.08 128.15 
C9, CH 52.67 52.68 
C10, C quaternary 54.38 54.11 
C11, CH2 18.65 18.62 
C12, CH2 28.84 28.85 
C13, C quaternary 34.08 37.96 
C14, C olefinic 130.55 131.77 
C15, CH2 33.21 33.16 
C16, C=O 171.45 171.35 
C17, CH 80.41 80.37 
C18, CH3 17.72 17.74 
C19, CH3 17.12 17.04 
C20, C olefinic 120.98 120.81 
C21, C olefinic, CH 141.60 141.54 
C22, C olefinic,CH 110.10 110.03 
C23, C olefinic, CH 142.88 142.82 
C28, CH3 23.23 23.21 
C29, CH3 23.63 23.60 
C30, CH2 33.69 33.65 
COOCH3 53.17 53.05 
6-OCOCH3 170.90 170.26 
6-OCOCH3 21.10 20.99 
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Table 3.20: Mass spectrum fragmentation of purified compounds. 
 
Compound (1) 3,6-O,O-Diacetylswietenolide: Colourless needles. EIMS m/z 570 (M
+
), 
510, 474, 446 (base peak), 439, 414, 386, 354, 326, 301, 283, 255, 207, 173, 137, 119, 
95.
 
 
 
Compound (2) Swietenine: Colorless needle. EIMS m/z: 568 (M
+
), 550 (M
+
-H20), 535 
(M
+
-H2O-H), 468, 451, 419, 283, 253, 207, 155 and 83 (C4H7CO
+
, base peak).  
 
Compound (3) 3-O-Tigloylswietenolide: Colorless needle. EIMS m/z: 568 (M
+
), 550 
(M
+
-H20), 535 (M
+
-H2O-H), 479, 444, 426, 355, 283, 255, 207, 119 and 83 (C4H7CO
+
, 
base peak).  
 
Compound (4) Swietenolide: Pale yellowish oil. EIMS m/z: 568 (M
+
), 550 (M
+
-H20), 
535 (M
+
-H2O-H), 468, 451, 419, 283, 253, 207, 155 and 83 (C4H7CO
+
, base peak).  
 
Compound (5) Hexadecanoic acid (C16:0). White coloured crystalline powder. MS m/z: 
256 (M
+
), 213, 185, 171, 157, 129, 115, 97, 83, 73 and 60.  
 
Compound (6) Proceranolide. Colorless needles. EISM m/z: 470 (M
+
), 452, 374, 346, 
318, 273, 246, 210, 189, 173, 149, 137, 119, 105 and 91. 
 
Compound (7) Khayasin T. EIMS m/z: 552 (M
+
), 456, 428, 356, 328, 313, 281, 256, 
207, 149, 119 and 83 (C4H7CO
+
, base peak). 
 
Compound (8) 6-O-acetylswietenolide. Colorless needles. EIMS m/z: 528 (M
+
), 528 
(M
+
), 468, 432, 404, 372, 344, 326, 301, 255, 207, 137, 119 and 95. 
 
 
 
 
 
 
 
 
 
 
 
 
139 
 
3.4 Evaluation of cytotoxic effects of compounds purified from SMEAF 
The purified compounds isolated from SMEAF were evaluated their cytotoxic effect on 
selected cancer cells using MTT assay. A 72h exposure to colon cancer cells HCT116 
particularly by 3-O-tigloylswietenolide (3), hexadecanoic acid (5), proceranolide (6) 
and khayasin T (7) led to significant reduction of cell viability. As shown in Table 3.21, 
the IC50 values of corresponding compounds were 40.06± 0.71 µg/ml, 21.34± 0.27 
µg/ml, 80.41± 1.79 µg/ml and 82.29± 3.67 µg/ml. This indicated the present of 
bioactive compounds in SMEAF that able to cause cytotoxic effect on HCT116 cell line. 
 
Moreover, those isolated compounds were also tested for their cytotoxic effects on HT-
29, KB, CasKi and MCF-7 cell lines. As indicated at Table 3.21, only hexadecanoic 
acid (5) and proceranolide (6) were active against all screened cell lines. Compound 3-
O-tigloylswietenolide (3) the strongest puried limonoid in this experiment on HCT116 
showed no effect on other cell lines except Caski where the IC50 value stand at 93.81 ± 
0.43 µg/ml. The four limonoids namely diacetylswietenolide (1), swietenine (2), 
swietenolide (4) and 6-O-acetylswietenolide (8) showed no cytotoxic effect at 
concentration up to 100 µg/ml. 
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Table 3.21: IC50 values (μg/ml) of purified compounds from SMEAF against different 
cell lines, calculated after 72 h exposure. 
______________________________________________________________________ 
Compounds                                                              Cell lines______________________ 
                                              HCT 116         HT-29           KB           CasKi         MCF-7                                      
Diacetylswietenoldie (1)         >100                 >100               >100            >100              >100 
Swietenine (2)                         > 100                >100               >100            >100              >100 
3-O-Tigloylswietenolide (3) 40.06±0.71        >100               >100          93.81±0.43     >100 
Swietenolide (4)                       >100                >100               >100             >100           >100 
Hexadecanoic acid (5)         21.34±0.27     18.86±0.28    18.08±0.30  41.06±1.42  30.61±3.51 
Proceranolide (6)                 80.41±1.79     67.63±1.39    38.69±1.18  70.85±0.96  61.85±2.04 
Khayasin T (7)                     82.29±3.67       >100             19.08±4.04        >100           >100 
6-O-acetylswietenolide (8)      >100              >100                 >100               >100           >100 
The data represent mean± S.E. of three independent experiments (n=9). 
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3.5 Swietenine derivative 
The chemical modification of swietenine into its derivative as described in section 2.2.7 
in methods was initiated with 81 mg starting material. After the reaction, the 
purification of the swietenine derivative was conducted using column chromatography 
with a constant gradient solvent system with 10% ethyl acetate increment in hexane was 
eluted. The fractionation of the chemical composition was determined by TLC. After 
concentrated under reduced pressure, pure form of swietenine derivative (60.2 mg) was 
obtained which represented 74.32% of total conversion.   The NMR spectrum data of 
swietenine derivative are shown on Table 3.22. As compared to the literature the 
swietenine derivative is known as swietenine acetate, which can be found in seeds of S. 
macrophylla (Taylor and Taylor, 1983b). 
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Figure 3.34 The structure of swietenine and its chemical-modified derivative or which 
known as swietenine acetate. 
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Table 3.22: The comparison of 
1
H and 
13
C NMR spectral of swietenine and its modified 
swietenine derivative (swietenine acetate). 
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3.6 Cytotoxic effect of swietenine acetate on HCT116 cell line 
Evaluation of the cytotoxic properties of swietnine acetate on HCT116 cell line was 
performed using MTT assay. Concentrations ranging from 3.125- 50 µg/ml of  the 
named compound were applied to cancer cells and the level of formed formazan was 
determined after 72 h of incubation period. As shown in  Figure 3.35 the increasing 
concentrations of treatment compound caused dose-dependent decrease in cell viability. 
The treatment of cells with 3.125 µg/ml of swietenine acetate caused the viability of 
cells to reduce to 94.03± 0.30%. Further increase in the concentrations of  6.25, 12.5, 25 
and 50 µg/ml resulted in the prominent decrease of viability percentage to 87.42± 0.90, 
77.43±1.05, 65.36±2.24 and 56.31±0.98 % respectively. This indicated the cell 
proliferation or growth was hindered when incubated with the presence of swietenine 
acetate.  
 
Figure 3.35 Effect of swietenine acetate on the viability of HCT 116 cells. HCT 116 
cells were treated with vehicle DMSO (control) or with increasing concentration (3.125-
50 µg/ml) of swietenine acetate for 72 h and then followed by measurement of cell 
viability using MTT assay. Results were expressed as mean percentage of cell viability 
(ratio of absorbance in treated cells to control cells) ± S.E. of three experiments. 
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3.7 Evaluation of apoptotic effect of swietenine derivative in HCT16 cells 
3.7.1 Morphological analysis of swietenine acetate treatment on HCT116 cancer 
cell line 
Swietenine, one of the purified limonoids from SMEAF has been shown to pose 
solubility problem as it crystalized shortly after treatment.  As indicated in Figure 3.36 
swietenine formed crystal structure after treatment on HCT116. There were no changes 
in the morphological appearances of the treated cells, reflecting the high possibility of 
null cytotoxic effects was due to the lack of contact between the compound and cells. 
 
A single dose 50 µM of swietenine acetate or derivative of swietenine treatment on 
HCT116 was evaluated. The nuclear changes of the cells exposed to swietnine acetate 
appeared to be shrinkage and condensed chromatin as evidence of the morphological 
hallmark of apoptotic nuclei. As compared to the switenine, swietenine acetate 
dissolved completely in aqueous solution and thereby exerting its effects on HCT116 
cells.  
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Figure 3.36 Effect of swietenine and its derivative (swietenine acetate) on morphological changes of HCT 116 cells. The figures showed cells were 
either treated with 25 µg/ml of swietenine or 50 µM of swietenine acetate for 48 h. the untreated cells represents HCT116 cells without treatment at 0 h. 
The cells were visualized under light microcope and photographed. Magnification: 200X 
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3.7.2 Hoechst-propidium iodide staining  
To gain further insight into the effect of swietenine acetate on nuclear and membrane 
alteration, treated cells were stained with Hoechst-propidium iodide stains. As shown in 
Figure 3.37, the cells underwent remarkable nuclear changes upon treatment. Control or 
untreated cells were uniformly stained with blue fluorescence Hoechts stain and were 
not stained with red-fluorescence propidium iodide indicating that the nuclei of cells 
and membrane of the cells were intact. When exposed to swietenine acetate HCT116 
cells showed an increase in intensity captured on blue and red fluorescence signals 
where the cells manifested two apoptotic morphological changes, namely nuclear 
condensation and alteration of cell membrane integrity.  
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                           Hoechst                               PI                              Hoechst & PI 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.37 Effect of swietenine acetate on HCT116 cells stained with Hoechst and 
Propidium iodide. Cells were incubated without or with 50µM of swietneine acetate 
for 48 h. At the indicated time, the cells were harvested and stained with Hoechst 
and Propidium iodide and visualized by fluorescence microscope and photographed. 
An intense blue and red fluorescence signals captured on SMEAF treated cells 
indicating condensation of cell nuclei and disruption of cell membrane integrity. 
 
 
 
 
 
 
Control 
48h 
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3.7.3 Detection of Reactive Oxygen Species (ROS) production induced by 
swietenine acetate 
ROS is known to play an important role in apoptosis induction (Simon et al., 2000). The 
formation of the intracellular ROS level upon the treatment of swietenine acetate was 
evaluated utilizing the sensitive probe known as DCFH-DA according to the method 
described earlier in Section 2.2.9.2. Intracellular ROS level was found to increase after 
swietenine acetate treatment for 4 h. Further analysis revealed the swietenine acetate 
caused up to 152.6 ± 6.7 fold ROS level increase in treated cancer cells compared to 
control cells. This indicated that swietenine acetate may cause treated HCT116 cells to 
undergo oxidative stress.  
 
 
 
Figure 3.38 Effect of swietenine acetate on intracellular ROS production in HCT 116 
cells. DCF-DA fluorescence probe was employed as described in material and methods. 
The black histogram represents the control, treated with vehicle (0.5 %, DMSO) and red 
histogram represents the treated HCT 116 cells with 50 µM of swietenine acetate.  
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3.7.4 Swietenine acetate depleted intracellular total glutahione (GSH) level 
 
The measurement of intracellular total GSH content was conducted by using a 
colorimetric quantitative method. As depicted in Figure 3.39, treatment of HCT116 
cells with swietenine acetate exhibited a time-dependent attenuation in the level of GSH. 
Compared to the control cells, a significant reduction in the intracellular GSH level in 
the treated cells was observed at all indicated time periods. Thus, treatment of HCT116 
cells with swietenine acetate caused the decrease of intracellular GSH from 27.4±2.14 
nmoles (control) to 13.38±1.55 nmoles (24h) 13.2±1.20 nmoles (48h) and finally, 12.42 
±1.34 nmoles (72h). 
 
 
             
Figure 3.39 Effect of swietenine acetate on intracellular total glutathione level of 
HCT116 cells at 24, 48 and 72 hours following treatment. The data represent mean± S.E. 
of three independent experiments (n=9). 
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3.7.5 Swietenine acetate dissipated mitochondrial membrane potential 
In an attempt to gain further insight whether swietenine acetate exposure in HCT116 
cells involved a change in mitochondrial membrane potential (Δψm), we measured the 
Δψm using the fluorescence probe JC-1. As shown in Figure 3.40 [A], most of the JC-1 
fluorescence appeared in the upper quadrant in the control cells. However, after 
exposure to swietenine acetate, there was a shift of fluorescence signal resulting in the 
treated cells having lower red fluorescence than the control cells. Intriguingly, the loss 
of red fluorescence was found intensified in a time-dependent manner. Based on the JC-
1 fluorescence ratio, swietenine acetate caused a substantial time-dependent reduction 
of red/green fluorescence (Figure 3.40 [C]).                                                                                             
 
[A]       [B] 
 
Figure 3.40 Effect of swietenine acetate on mitochondrial membrane potential (Δψm) 
of HCT 116 cells. HCT 116 cells were incubated in the absence (control) or 50 µM of 
swietenine acetate for 24 h, 48 h and 72 h. After treatment, the cells were stained with 
JC-1 and analysed with flow cytometer. Data presented are representative of means ± 
S.E. calculated from three individual experiments.  [A] Flow cytometry, fluorescence 
patterns analysis of JC-1 staining. [B] Bar charts showed the percentage in the 
distribution of HCT 116 cells in the upper and lower quadrants of intensity plot. 
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[C] 
    
Figure 3.40, continued [C] Bar charts showed the quantitative presentation of the data 
as red (585nm) / green (530 nm) fluorescence, expressed as percentage of control, 
indicated ratio high / low Δψm. Data presented are representative of means ± S.E. 
calculated from three individual experiments. The asterisk (*) represented significantly 
difference from control (* p < 0.05).  
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3.7.6 Swietenine acetate increased the expression of Bax, decreased the expression 
of Bcl-2 and augmented the ratio of Bax/Bcl-2 
The involvement of Bcl-2 family protein members in swietenine acetate induced 
apoptosis were examined using Q-PCR. As depicted in Figure 3.41, Bax expression 
increased slightly after 6 h and 12 h treatment. At 24 h, the expression level was found 
to be around 2 folds higher compared to control. Further investigation of the expression 
level of Bcl-2 revealed that swietenine acetate treatment eventually decreased the 
expression level of Bcl-2 significantly in time-dependent manner. The increase in Bax 
and decrease in Bcl-2 expression significantly elevated the Bax/Bcl-2 expression ratio, 
thus sensitizing the cells to apoptotic stimuli. Taken together, these results showed that 
swietenine acetate was able to induce apoptosis by altering the regulation of apoptotic 
genes particularly through up-regulation of Bax and down-regulation of Bcl-2. 
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         [A]                                                                               [B]                                                                                 [C] 
                         
Figure 3.41 Effect of SMEAF on gene expression level of Bax and Bcl-2 in HCT116 cells. Cells were treated with 50 µM of swietenine acetate 
for different time periods. After designated exposure times, cells were harvested and the total RNA was extracted. The RNA was subjected to q-
PCR analysis as described in methods. [A] The relative gene expression level of Bax was compared to control, [B] The relative gene expression 
level of Bcl-2 was compared to control which were normalized against PBGD expression using the formula 2
-∆∆CT
. [C] Values are means ± S.D. 
of three experiments. Asterisks indicate a significant difference between untreated and treated cells (*P < 0.05). 
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3.7.7 Bax and Bcl-2 proteins changes induced by swietenine acetate 
 
The intracellular immunofluorescence staining method by flow cytometry was 
performed to confirm the expression of Bax and Bcl-2 in individual cells. As seen in 
Figure 3.42, the Bax histogram showed a shift to the right while there was no shift in the 
Bcl-2 histrogram. Respectively, this reflected an increase of Bax and no change of Bcl-2 
associated immunofluorescence. The results for Bax were consistent with the Q-PCR 
results, however not in case of Bcl-2 where the Q-PCR expression was lower but not in 
its protein expression level. However, despite the null changes in Bcl-2, the high level 
of Bax expression is till noteworthy in delivering the notion that the swietenine acetate-
induced apoptosis in HCT 116 cells was mediated through mitochondrial pathway. 
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Figure 3.42 Effect of swietenine acetate on protein expression level of Bax and Bcl-2 in 
HCH116 cells. After treated with µM of swietenine acetate for different times, the cells 
were harvested and intracellular levels of Bax and Bcl-2 were determined as described 
in methods. Representative overlay of histrograms, showing Bax-associated 
immunofluorescence and Bcl-2-assiociated immunofluorescence. 
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3.7.8 SMAC protein elevated by treatment of swietenine acetate  
SMAC or also referred as second mitochondria-derived activator of caspases is a 
mitochondrial protein that participates in apoptotic cell death by means of sequestering 
a number of members of inhibitors of apoptosis proteins (IAPs) (Velazquez et al., 2007). 
The release of SMAC by mitochondria into cytosol promotes cytochrome-c dependent 
activation of caspases in apoptosis (Vucic et al., 2002). Swietenine acetate treatment 
was found to cause increased expression level of SMAC protein in a time-dependent 
manner detected in protein array analysis (Figure 3.43). The level of SMAC protein was 
found to increase more than four folds as compared to control cells, indicating the 
down-stream event after the release of cytochrome c in mitochondrial-mediated 
apoptosis. 
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[A] 
            
[B] 
 
Figure 3.43 Protein expression level of SMAC at 0 h (control), 6, 12 and 24 h exposure 
to 50µM of swietenine acetate in HCT116 cell line. [A] RayBiotech protein array 
analysis on control and treated cells photographed by GenePix 4000B. [B] Means of 
duplicates fluorescence signals of SMAC control (0 h), 6, 12 and 24 h swietenine 
acetate treated cells after subtracted with background and normalized against pre-coated 
positive control probes using Acuity 4.0 analysis software. 
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3.7.9 Caspase -3/7 and -9 involved in switenine acetate induced apoptosis 
Involvement of executioner Caspase -3/7 and initiator Caspase -9 were evaluated. The 
ability of swietenine acetate to activate the caspases was studied using fluorescence 
linked inhibitor of caspase -3/7 and -9. The HCT116 cells were incubated with 50 µM 
of swietenine acetate for 3, 6, 12 and 24 hours followed by addition of the fluorescent 
inhibitor and results of flow cytometer analysis were showed in Figure 3.44[A]From the 
histograms, the intensity of fluorescence signals of caspase -3/7 was detected to be 
higher throughout the treatment period. Meanwhile, evaluation of initiator caspase -9 
activity was shown in Figure 3.44[B]. There was a slight increase in caspase -9 activity 
at 3 and 6 h followed by a more pronounced augmentation at 12 and 24h of incubation 
periods.  Therefore, the results suggested that swietenine acetate was able to induce 
apoptosis through execution by caspase cascade especially through caspase -3/7 and -9. 
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[A] 
 
[B] 
 
 
Figure 3.44 Effect of swietenine acetate on caspase level of HCT 116 cell. The HCT 
116 cells were incubated in the absence (control) or 50 µM of swietenine acetate for 3 h, 
6 h, 12 h and 24 h. After treatment, the cells were stained with FAM-DEVD-FMK 
(Caspase -3/7) or FAM-LEHD-FMK (Caspase -9) and analysed with flow cytometer. 
Representative overlay of histrograms [A] showing Caspase -3/7- associated 
fluorescence signal, while [B] showing Caspase -9-assiociated fluorescence signal. 
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3.7.10 Swietenine acetate arrested cells in G1-phase and increased Sub-G1 
population 
Meanwhile, cell cycle analysis on HCT116 also showed arrest of G1 phase by the 
swietenine acetate treatment. As depicted in Figure 3.45, the percentage of G1 phase 
cells was shown to increase from 64.13 ±0.86% to 70.52±0.41% in 24 h treatment 
period. The prolonged treatment with  swietenine acetate for 48 h and 72 h showed an 
increase in Sub-G1 population up to 52.96 ±0.57% compared to control cells which was 
1.57 ±0.16% indicating a shift in arrested cells towards Sub-G1 population which is 
known as apoptotic population. This population of cells possess sub-diploid DNA 
content which is indicative of DNA fragmentation occurring during apoptosis (Raveh et 
al., 2001).   
[A] 
 
Figure 3.45 Effect of swietenine acetate on cell cycle and apoptosis of HCT 116 cells. 
The cells were treated with 50 µM of swietenine acetate for 24, 48 and 72 h. 
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[B] 
 
Figure 3.45, continued Effect of swietenine acetate on cell cycle and apoptosis of HCT 
116 cells. The cells were treated with 50 µM of swietenine acetate for 24, 48 and 72 h. 
The untreated corresponded to cells without swietenine acetate treatment at 0 h and 
similar results were obtained at other incubation time periods. After treatment, cells 
were harvested, fixed, stained with PI and analysed by flow cytometry as described in 
the  methods. [A] Representive histograms showed the cell cycle phase distribution. [B] 
Bar charts showed the percentage of cells in sub-G1, G1, S and G2/M phases of the cell. 
Results are mean value ± S.D. of three experiments.  
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3.7.11 Swietenine acetate induced changes in cell cycle regulatory genes 
Cell cycle analysis revealed the alteration in distribution of phases of HCT116 cells 
after exposure to swietenine acetate. In an effort to gain further insight into the 
molecular mechanisms affected by swietenine acetate in HCT116 cells, we profiled the 
expression of key pathways involved in cell cycle using human cancer pathway finder 
PCR array in swietenine acetate treated cells and control cells. Numerous key genes 
involved in cell regulatory pathways were altered in their expression levels, specifically 
CCNE1, CDC25A, CDK2, CDK4  and E2F1 were down regulated and detected by real-
time PCR as shown in Figure 3.46. In addition, the Q-PCR study conducted revealed the 
genes encoding p21 and p53 protein which are known as CDKN1A and TP53 
respectively, were up regulated. Besides, swietenine acetate exposure caused the down 
regulation of MDM2 gene which encodes the negative regulator of p53 was detected 
after the SMEAF treatment. These data indicated that SMEAF may cause the p53-p21 
activation and subsequently lead to cell cycle arrest in HCT116 cells and ultimately 
apoptosis.  
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                       [A]                                                                                            [B] 
Figure 3.46 The cells were treated with 50µM of swietenine acetate, harvested after 24 h incubation and the total RNA was extracted. The RNA was 
subjected to q-PCR analysis by using PCR array as described in methods. Analysis was done by using RT
2 
Profiler Data Analysis Excel platform. The 
gene expression was normalized against ACTB expression values. Values are mean ± S.D. of three experiments. [A] Effects of swietenine acetate 
treatment on cell cycle regulatory genes of HCT116 after 24h incubation period. [B] Effects of swietenine acetate on expression level of TP53 and 
MDM2 after 24h exposure period. Asterisks indicate a significant difference between expression level of TP53 and MDM2 of treated cells (*P < 0.05). 
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3.7.12 p53 and p21 protein expression level detection by using protein array 
Protein array analysis was utilized in the determination of protein expression of p53 and 
p21 proteins in HCT116 cells treated with 50 µM of swietenine acetate. Figure 3.47[A] 
and Figure 3.48[A], indicated the duplicates of experiments conducted on 0 h (control), 
6 h, 12 h and 24 h exposure to swietenine acetate particularly in HCT116. The 
photographs clearly showed that treatment with swietenine acetate at 6 h, 12h and 24 h 
caused an increase in the named protein levels as indicated by the sharper fluorescence 
signals. The fluorescent signals of each of the sample was subtracted with background 
fluorescent signal and further normalized against pre-coated positive control probes in 
arrays. Figure 3.47[B] and 3.48[B] showed the mean fluorescent signal of its duplicates. 
The 0 h or control samples fluorescence intensity for the p53 was shown to increase by 
~ 2 folds after a 24 h of swietenine acetate exposure. Meanwhile, p21 protein was found 
to peak at 12 h of incubation, approximately 4 fold increase as compared to the control. 
Taken together, these results indicated the possible involvement of p53-p21 proteins in 
cell cycle regulatory mechanism that resulted in apoptosis.  
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[A] 
 
 
[B] 
 
Figure 3.47 Protein expression level of p53 at 0 h (control), 6, 12 and 24 h exposure to 
50µM of swietenine acetate on HCT116 cell line. [A] RayBiotech protein array analysis 
on control and treated cells photographed by GenePix 4000B. [B] Means of duplicate 
fluorescence signals of p53 control (0 h), 6, 12 and 24 h in swietenine acetate treated 
cells after subtraction with background and normalized against pre-coated positive 
control probes using Acuity 4.0 analysis software. 
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[A] 
 
 
[B] 
 
Figure 3.48 Protein expression level of p21 at 0 h (control), 6, 12 and 24 h exposure of 
50µM of swietenine acetate in HCT116 cell line. [A] RayBiotech protein array analysis 
on control and treated cells photographed by GenePix 4000B. [B] Means of duplicate 
fluorescence signals of p21 control (0 h), 6, 12 and 24 h in swietenine acetate treated 
cells after subtraction with background and normalized against pre-coated positive 
control probes using Acuity 4.0 analysis software. 
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3.7.13 Caspase -8 and -10 involved in swietenine acetate-induced apoptosis 
To check whether swietenine acetate induced activation of initiator caspase -8 and -10 
fluorescence analysis detection by using flow cytometry was utilized. The ability of 
switenine acetate to activate the named caspases were studied using fluorescence linked 
inhibitor of caspase -8 and -10. The HCT116 cells were incubated with 50 µM of 
swietenine acetate for 3, 6, 12 and 24 hours followed by addition of the fluorescent 
inhibitor and the results of flow cytometer analysis were shown in Figure 3.49. From 
the histograms, the intensity of fluorescence signals of caspase -8 was found to be 
constant at 3 h of incubation period, the level was then increased further at 6 , 12 and 
also 24 h. The evaluation of caspase -10 activity is shown in Figure 3.49[B]. There was 
no change in activity level at 3 h, 6 h and 12 h of treatment periods. However, there was 
a marked augmentation in activity at 24 h incubation period. Therefore, the increased 
activities of caspase -8 and -10 activities results suggested swietenine acetate may also 
exert its apoptotic effects through extrinsic pathway.   
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[A] 
 
[B] 
 
Figure 3.49 Effect of swietenine acetate on the caspase levels in HCT 116 cells. HCT 
116 cells were incubated in the absence (control) or 50 µM of swietenine acetate for 3 h, 
6 h, 12 h and 24 h. After treatment, the cells were stained with FAM-LETD-FMK 
(Caspase -8) or FAM-AEVD-FMK (Caspase -10) and analysed by flow cytometry. 
Representative overlay of histrograms [A] showed Caspase-8-associated fluorescence 
signal, while [B] showed caspase-10-associated fluorescence signal. 
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3.7.14 Alteration of extrinsic apoptotic regulatory genes by swietenine acetate 
PCR array analysis also revealed alteration of numerous genes involved in extrinsic 
apoptotic pathway following treatment with swietenine acetate. The results showed that 
swietenine acetate exposure up-regulated genes encoding tumor necrosis factor receptor 
superfamily proteins such as TNFRSF1A, TNFRSF10B and also TNFRSF25. Besides, 
the CASP8 and FAS levels were up-regulated as well upon the treatment. These data 
suggested the role of swietenine acetate in modulating the expression of genes involved 
in extrinsic apoptotic pathway (Figure 3.50).  
 
Figure 3.50 The HCT116 cells were treated with 50µM of swietenine acetate, harvested 
after 24 h incubation and the total RNA was extracted. The RNA was subjected to q-
PCR analysis by using PCR array as described in methods. Analysis was conducted  by 
using RT
2 
Profiler Data Analysis Excel platform. The gene expression was normalized 
against ACTB expression values. Values are means ± S.D. of three experiments.  
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3.7.15 Swietenine acetate provoked the externalization of phosphatidylserine of 
HCT116 cells 
To further confirm the induction of apoptosis in HCT116 cells, the cancer cells were 
double stained with annexin V-FITC and PI and results were summarized in Figure 3.51 
According to Figure 3.51[A], the control cells were predominantly found in lower left 
quadrant of the dot plot, indicating the viable cells. After treatment with 50 µM of 
swietenine acetate for 24 h, the cells were progressively detected in the lower and upper 
right quadrants. The early apoptotic cells (annexin V+/PI-) began to appear as early as 
24 h of treatment, and were found to decrease from 18.57± 2.46% (24 h), 14.02±2.21% 
(48 h) and 7.05 ± 0.71% (72 h). On the other hand, the late apoptotic cells (annexin 
V+/PI+) were found to increase from 8.09±1.18% (24 h), 12.18±1.16% (48 h) and 
16.25±0.49% (72 h). However, there was no marked decrease of viable cell population 
throughout the treatment period in the control untreated cells.    
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[A] 
                   
[B] 
                    
 
Figure 3.51 Effect of swietenine acetate (50 µM) on the induction of phosphatidylserine 
externalization and cell membrane integrity in HCT116 cells undergoing apoptosis, 
measured using flow cytometry analysis. Histogram in [A] shows induction with dual 
parameters including V-FITC and PI for treatment period, 24, 48 and 72 h;  Histogram 
in [B] shows induction effects on HCT 116 cells at different stages of apoptosis.  The 
data represent mean± S.D. of three experiments. (n=3). 
 
 
173 
 
3.7.16 SDS-PAGE analysis of HCT116 cells lysate treated with swietenine acetate   
The cells treated with swietenine acetate were lysed by using Cytobuster solution and 
separated by using SDS-PAGE. The gel stained with bromophenol blue revealed a 
sharper and thicker protein band at ~70 KDa observed with increasing treatment period. 
The mentioned band was marked in red rectangular box shown in Figure 3.52, as 
evident, the band started to thicken particularly by 48 h and 72 h. 
 
 
Figure 3.52 HCT116 cells treated with 50 µM of swietenine acetate for different time 
periods were harvested and lysed. The lysates were subjected to SDS-PAGE analysis. 
The red rectangular box showed the sharper protein band detected with bromophenol 
stain. 
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3.7.17 LC-MS analysis of excised protein band 
LC-MS analysis was conducted in order to determine the protein presence in the band 
detected in the SDS-PAGE. As described in section 3.7.17, the excised protein band 
was treated and subjected to LCMS analysis. The result obtained are shown in the Table 
3.23 The detected proteins including heat shock 70kDa protein 1A/1B, Transketolase 
and X-ray repair cross-complementing protein 6. Recently, studies have shown that 
HSPs are involved in apoptosis regulation and HSP 70 is known to be one of the 
determinants of cell death which acts as anti-apoptotic protein (Helmbrecht et al., 2000; 
Jolly and Morimoto, 2000; Myung et al., 2004). Thus, we postulate that protein HSP 70 
may exert its anti-apoptotic effect in swietenine acetate-induced apoptosis in HCT116 
cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
175 
 
Table 3.23: Data showed the proteins detected after excised protein band subjected to LC-MS analysis. Accession numbers are from MASCOT 
database (http:// www.matrixcience.com). 
________________________________________________________________________________________________________________________P
rotein name                                                                      Accession           Theoretical      Theoretical         MASCOT            Queries           Sequence 
                                                                                             number               mass (Da)             Pl                     score                matched          coverage (%) 
 
Heat Shock 70kDa protein 1A/1B                                       P08107               70 009                  5.48                    548                    13                         17 
Transketolase                                                                       P29401               67 835                  7.58                    423                    7                           14                              
X-ray repair cross-complementing                                      P12956               69 799                   6.23                   237                    3                            8 
protein 6 
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3.7.18 HSP 70 protein detection by using protein array  
The expression level of the HSP 70 was confirmed in protein array analysis. As 
depicted in Figure 3.53, the expression level of HSP 70 was up-regulated after treatment 
with swietenine acetate. The HSP 70 fluorescence signals elevated for more than 2 folds 
as early as 6 h of swietenine acetate incubation and the level remained high after 12 h 
and 24 h.  
[A] 
 
[B] 
 
Figure 3.53 Protein expression level of HSP 70 at 0 h (control), 6, 12 and 24h exposure 
to 50µM of swietenine acetate in HCT116 cell line. [A] RayBiotech protein array 
analysis on control and treated cells photographed by GenePix 4000B. [B] Means of 
duplicate fluorescence signals of HSP 70 in control (0 h) and 6, 12 and 24 h swietenine 
acetate treated cells after subtracted with background and normalized against pre-coated 
positive control probes using Acuity 4.0 analysis software. 
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CHAPTER 4 
DISCUSSION 
One major goal of anticancer potential of any drug/naturally-derived agent is the 
induction of apoptosis in cancer cells (Denicourt and Dowdy, 2004). Apoptosis or 
programmed cell death is one of the most important targets for cancer treatment. It is 
characterized by membrane blebbing, cytoplasmic condensation, formation of apoptotic 
bodies, DNA fragmentation, alteration in membrane symmetry, activation of caspase 
cascade and loss of mitochondrial membrane potential (Kang et al., 2007). In the 
present study, cytotoxic potential of SMEAF was assessed by MTT assay against 
selected cancer cell lines (HCT 116, KB, Ca Ski and MCF-7). The assay is based upon 
reduction of yellow tetrazolium salt (MTT) by the reductase enzyme in metabolically 
active cells to a dark blue formazan (Loosdrecht et al., 1994), which has been employed 
by many workers to measure cytotoxicity to cells.  
 
Apart from preliminary screening on KB cells using the bark and leaf extracts 
(Camacho et al., 2003), to the best of our knowledge, this is the first study to show that 
S. macrophylla seeds were able to cause cytotoxicity towards cancer cells and induced 
apoptosis specifically in HCT-116  cells. The cytotoxicity effect of the crude ethanol 
extract of S. macrophylla seeds has demonstrated varying levels of cytotoxicity when 
screened against KB, CasKi, HCT 116, Hep G2 and MCF-7 cancer cell lines. Hence, 
the crude ethanol extract was further fractionated to yield hexane, ethyl acetate and 
aqueous fractions. The cytotoxicity effect was only observed in SMEAF treated cells 
and the lowest IC50 value was against HCT116.  Hexane and aqueous fractions were 
found to have no effect on all cell lines (IC50 > 200μg/ml in all cases). SMEAF did 
show higher values of IC50 compared to ethanol extract especially on CasKi and MCF-7 
but lower IC50 values were obtained on KB, Hep G2 and HCT-116 cells. Eventually, the 
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minimum IC50 value of 35.5μg/ml was obtained with the ethyl acetate fraction against 
HCT-116 cells.   Thus, it can be concluded that ethyl acetate fraction was selectively 
toxic against HCT116 cells and hence further investigations were carried out using 
HCT116 cell line.  
 
To investigate the mechanism of cell death induced by SMEAF in HCT116 cells, flow 
cytometric analysis by PI and annexin V-FITC labeling was conducted as a marker to 
confirm apoptosis (Kawamura and Kasai, 2007). During apoptosis, a number of changes 
occur in the cell surface markers that show affinity for PI and annexin V-FITC labelling 
(Vermes et al., 1995). The results in the present study indicated apoptotic induction by 
the S. macrophylla ethanol extract in a dose-and time-dependent manner. This was 
inferred on the basis of flow cytometric evidences, which showed an increment of 
apoptotic cell percentage in dose- and time-dependent manner by using Annexin V/PI 
staining.  
 
Another important characteristic of apoptosis induction is DNA fragmentation and 
measurement of DNA content makes it possible to identify apoptotic cells. TUNEL 
assay which measures DNA fragmentation or DNA strand breaks by the incorporation 
of Br-dUTP into the exposed 3’-OH DNA ends, followed by detection with 
fluorochrome-conjugated anti-BrdU antibody (Darzynkiewicz et al., 2008b) was 
performed to further confirm the potential of SMEAF to induce apoptosis in HCT-116 
cells. The results which showed increasing TUNEL positive cells at 24h, with 
increasing concentrations of SMEAF were found to be complementary with the results 
from Annexin V/PI. To recognize the cell cycle phase specificity and to quantify 
apoptosis, propidium iodide (PI) dye binds to DNA in cells at all stages of the cell cycle, 
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and the intensity with which a cell nucleus emits fluorescent light is directly 
proportional to its DNA content. 
 
Cell cycle analysis on a 24 h SMEAF treatment showed a significant increase in the 
percentage of G1-phase from 24.33% (control) to 55.34% of cells at the highest 
concentration of 1.0mg/ml suggesting that SMEAF arrested the cells at G1-S transition 
in a dose-dependent manner. To further confirm the involvement of cell cycle arrest in 
apoptosis, cells were subjected to different periods of incubation of 24, 48 and 72h). As 
depicted in Figure 4(B), there was a gradual increase in the percentage of Sub-G1 cells 
during prolonged induction by 0.05mg/ml of SMEAF at 24 h, 48 h and 72 h incubation 
periods. These results seem to suggest that the apoptosis occurred through G1 arrest in 
HCT-116.  
 
Generally, apoptosis is regulated through two distinct pathways: the cell surface death 
receptor and mitochondrial-mediated pathways (Darzynkiewicz et al., 2008b; Desagher 
and Martinou, 2000) and the  ΔΨm loss of MMP appears to be a critical event in 
apoptotic process  (Kroemer and Reed, 2000). In the present study, SMEAF treatment 
has induced ΔΨm loss in the period of 24h treatment performed by using JC-1 dye. The 
results demonstrated that concentration as low as 0.05mg/ml of SMEAF was able to 
induce disruption of mitochondrial membrane integrity of tested HCT-116 cells up to 
10.45%, while at the highest concentration of 1.0mg/ml, 53.69% of cells were affected.  
 
The investigation on intracellular total glutathione (GSH) level was performed to 
determine the involvement of oxidative stress in cell death. The depletion of GSH has 
been known to contribute to the onset of apoptosis, by rendering the cells more sensitive 
to apoptotic agents (Macho et al., 1997b). Heales and coworkers (1995) and Mithöfer 
 
 
180 
 
and coworkers (1992) have reported the importance of GSH in maintaining optimum 
mitochondrial functions and  the role of  ATP production in maintaining GSH level, 
indicating the correlation of GSH to MMP. Thus, the deficiency in the energy supplied 
by mitochondria is likely to affect the cellular turnover of GSH that protects the cells 
from oxidative stress and consequently apoptosis. Treatment with SMEAF at 
0.05mg/ml significantly depleted the level of GSH by as much as 49.56% (12.02±0.59 
nmoles) and showed ability in attenuating the GSH level in a dose-dependent manner. 
Based on these results, it is believed that SMEAF might cause cancer cells to undergo 
oxidative stress leading to the depletion of GSH and disruption of the mitochondrial 
membrane integrity and eventually leading to apoptosis.  
 
ROS generation in several anti-cancer therapies has been reported to contribute to their 
anti-cancer activities. Manipulation of ROS generation in cancer cells has also been 
reported to be a potential therapeutic strategy to enhance the cytotoxicity of drugs 
(Renschler, 2004; Wang and Yi, 2008). In this study, we found that treatment with 
SMEAF greatly increased ROS production and cytotoxicity in HCT116 cells. The 
increased oxidative stress has been shown to cause DNA damage, followed by cell cycle 
arrest (Stadtman & Berlett, 1998; Wang and Yi, 2008). An imbalance between the 
production of ROS and the ability to readily detoxify the reactive moieties in a 
biological system is known as oxidative stress. Severe effects of oxidative stress have 
been known to be involved in activating apoptosis responses in affected cell (Lu et al., 
2011). Intracellular glutathione level was shown to be decreased after treatment with 
SMEAF (Goh and Kadir, 2011) which was a sign of oxidative stress. These findings 
suggest the involvement of oxidative stress in SMEAF-induced cells with the detection 
of increment in intracellular ROS level. 
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Apoptosis is a gene-regulated phenomenon induced by many chemotherapeutic agents 
in cancer treatment (Gerl and Vaux, 2005; Ward et al., 2008) and well characterized by 
chromatin condensation, nuclear shrinkage, membrane blebbing, and oligonucleosomal 
DNA fragmentation (Green and Reed, 1998; Nesslany et al., 2009). Morphological 
observation of the SMEAF-treated HCT116 cells revealed that SMEAF induced cells to 
undergo apoptosis. As depicted in Figure 3.3, various morphological changes including, 
abnormal cell shape, nuclear condensation, cell detachment and membrane blebbing 
were observed and these characteristics implied the occurrence of apoptosis. Hoechst 
33342/PI is commonly used in differentiating the apoptotic versus normal cells and our 
findings confirmed the occurrence of apoptosis in SMEAF induced-cells which 
exhibited DNA condensation and alteration of plasma membrane permeability 
characteristics. This study indicated that SMEAF induced apoptotic cell death in 
HCT116 cells. 
 
This study addresses the induction of apoptosis and the underlying mechanisms of 
SMEAF-induced cell death in HCT116 cells. Apoptotic induction in tumor cells is 
considered to be very useful in the management, therapy, and prevention of cancer (Hu 
et al., 2007; Ram and Kumari, 2001). The present study revealed SMEAF-induced 
apoptosis in HCT116 cells in which the roles of caspase cascades, ROS production, and 
pathways involving Bcl-2 family, TP53 and MDM2 were to gain further insight into the 
molecular mechanisms of SMEAF in colon cancer. The present findings are consistent 
with earlier results in HCT116 cells, indicating that SMEAF possesses in vitro cytotoxic 
effect.  
 
To gain further insight into the potential mechanisms underlying the cytotoxicity effect 
of SMEAF, the expression of pro- and antiapoptotic proteins was investigated in the 
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present study. The Bcl-2 family, such as proapoptotic (Bid, Bax and Bcl-2-xs) and 
antiapoptotic (Bcl-2 and Bcl-xl), proteins plays an important role in induction of 
apoptosis in cancer cells (Cai et al., 2009; Gavathiotis et al., 2008). These pro- and 
antiapoptotic proteins have emerged as critical regulators of mitochondria-mediated 
apoptosis. An increase in the levels of pro-apoptosis proteins and/or a decrease in anti-
apoptosis proteins can lead to a decrease in mitochondrial membrane potential and an 
opening of mitochondrial permeability transition pores, leading to cytochrome c release 
from mitochondria into cytosol. In this study, we found that SMEAF increased the 
expression of the proapoptotic protein, Bax, and decreased the expression of anti-
apoptotic protein, Bcl-2, thus the Bax/Bcl-2 ratio was significantly elevated. Previous 
reports have shown that the ratio of Bax/Bcl-2 determines, in part, the susceptibility of 
cells to death signals [30]. This alteration may be responsible for the concomitant 
execution phase of apoptosis through the activation of caspase -9, caspase -3 and 
ultimately cell death. 
 
The level of Bax expression is an important determining index of apoptotic cell death, 
which also confirms that the mitochondrial signaling pathway is involved in SMEAF-
induced apoptosis in HCT116 cells. Once activated, Bax is inserted into the 
mitochondrial membrane to cause the dysfunction of mitochondria to increase 
membrane permeability (Green and Chipuk, 2008; Green and Reed, 1998), leading to 
the formation of the mitochondrial permeability transition pore (Bernardi et al., 2006). 
These findings seem to correlate with our previous results mentioned earlier on the 
SMEAF-induced loss of MMP (Goh and Kadir, 2011). Disruption of MMP is always 
accompanied by release of apoptogenic factors such as cytochrome c that forms a multi-
protein complex known as the apoptosome and initiates activation of caspase cascade 
effect by caspase-9 and which in turn cleaves and activates effector caspases such as 
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caspase-3 (Jin and Deiry, 2005). Thus detection of caspase activities was conducted 
using flow cytometric method, revealing the elevation of caspase -3/7 and -9 activities 
in HCT116 cells after exposure to SMEAF.  
 
TP53-regulated apoptosis involves activating the mitochondrial-mediated pathway by 
elevating expression of proapoptotic genes and suppressing the expression of 
antiapoptotic genes in the  Bcl-2 family (Fang et al., 2000; Green and Kroemer, 2004). 
Besides, the encoded p53 protein interacts with Bcl-2 family to enhance Bax-promoted 
outer-mitochondrial membrane permeabilization, and acts as a direct transcriptional 
activator of the Bax gene  (Toshiyuki and Reed, 1995). TP53 has been reported to 
induce apoptosis in various systems, as an example, TP53 activation can serve as an 
upstream cellular event that leads to mitochondrial membrane potential dissipation and 
caspase-3/7 activation, and may be responsible in executing the downstream process of 
apoptosis (Chen et al., 2009; Jin and Deiry, 2005).  
 
The MDM2 gene has been described as a negative regulator of TP53 as the 
amplification of MDM2 gene would lead to devoid of tumor-suppressor function of p53 
protein. Thus, overexpression of the MDM2 is oncogenic and inhibits upstream 
apoptosis pathways. Hence under expression of MDM2 may lend support for the 
acceleration of apoptosis (Arden et al., 2007). Whereas the presence of caspase-3/7 and 
-9 indicates that mitochondrial release of cytochrome-c has taken place. In the current 
study, SMEAF was found to upregulate the expression of TP53 up to ~ 2 folds as 
compared to the control cells. Interestingly, a concomitant decrease of MDM2 
expression was detected (~2 folds) in the SMEAF- treated cells. More interestingly, the 
upregulated expression of Bax and TP53 was accompanied by activation of caspase -3/7 
and -9 in cells treated with SMEAF, while Bcl-2 and MDM2 expression was down-
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regulated. Meanwhile, a marked increase in caspase-3/7 and -9 activities was detected 
when the HCT 116 cells were treated with SMEAF (Figure 3.14). These findings 
suggest that induction of apoptosis in SMEAF-treated HCT116 cells could be associated 
with a caspase-dependent cascade that involves the activation of the mitochondrial 
pathway through TP53 mediated, initiated by the suppression of Bcl-2 and the 
activation of Bax. This delivers the notion that inhibition of the p53-MDM2 interaction 
may be an important target in cancer therapy.  
 
The existence of the cell cycle checkpoints in cells is important, as it determines the 
survival of the cells and decreases the defected heritable genetic changes following 
exposure to DNA damaging agents (Kastan et al., 1992). The p53 is known to be 
associated to cell cycle regulatory process (Kastan et al., 1991). The presence of the 
wild type p53 is important in determining the arrest of cells that exhibited DNA damage 
in G1 phase (Kastan et al., 1992). Earlier in this study, p53 encoding gene TP53 was 
shown to be up regulated following treatment with SMEAF. In contrast, the negative 
regulatory protein gene MDM2 was shown to be down regulated. The protein array 
analysis confirmed the above finding particularly the p53 expression level was up 
regulated. Based on the results obtained an assumption can be made that the apoptosis 
induction of HCT116 cells was linked to p53 pathway.  
 
As indicated in the cell cycle analysis, SMEAF treated cells appeared to be arrested in 
G1 phase as the percentage of distribution increased in dose- and time-dependent 
manners. Extensive studies conducted on PCNA revealed a critical role in biological 
processes especially DNA metabolism whereby it serves as an accessory protein for 
DNA polymerases, required for chromosomal DNA synthesis and also shown to interact 
with cellular proteins involved in cell cycle regulation (Kelman, 1997). Thus, 
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expression of robust functioning PCNA encoded gene was evaluated using Q-PCR 
method. The analysis found that the expression level of PCNA gene decreased 
dramatically and significantly upon the SMEAF exposure. Therefore, these results 
suggested that the regulation and progression of the cell cycle might be affected by 
SMEAF in HCT116 cells.  
 
Next, the regulatory genes involved in cell cycle progression were then assayed using 
PCR array. Previous studies reported the importance and necessary existence of CDK2 
and CDK4 in permitting the transition of cells from G1 to S phase. Inhibition or down 
regulation  of CDK2 and CDK4 were then shown to increase in  cells arrested at G1 
phase (Carlson et al., 1996; Sherr, 1994). In the current study, Q-PCR analysis 
demonstrated reduction in expression level of CDK2 and CDK4. This may explain the 
observed G1 phase arrest in earlier analysis.  
 
In most organisms, the cell cycle machinery was known to rely on multiple cyclin-
CDKs (Roberts and Sherr, 2003). The CCNE1 or Cyclin-E1 was known to form a 
complex or worked as a regulatory subunit of CDK2 in G1/S transition state (Caldon 
and Musgrove, 2010); while rapid degradation of CDC25A or cell division cycle 25 
homolog A was reported to have blocked the entry into the S phase and DNA 
replication resulting in cells remaining in the G1 phase (Mailand et al., 2000). Thus, in 
order to strengthen the claim of G1 phase arrest in HCT116 cells by SMEAF, CCNE1 
and CDC25A expression was then assayed. The results indicated down regulation in the 
expression of both CCNE1 and CDC25A genes in HCT116 as a response to SMEAF 
exposure.  
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The gene CDKN1A encoded protein p21, a potent cyclin-dependent kinase inhibitor 
plays important roles in cell cycle progression and its expression is controlled by p53 
protein. The presence of p21 would directly inhibit the activity of Cyclin E/CDK2 
complexes and thus functions as a regulator of cell cycle process (Gartel and 
Radhakrishnan, 2005). In most of the cases, the arrest of cells by p21 was shown to be 
associated to p53 protein (Bunz et al., 1998; Waldman et al., 1995). Earlier analysis 
demonstrated tumor suppressor protein p53 expression was expressed in higher level as 
compared to control cells. In the current study, the gene and protein expression level of 
p21 was up regulated, thus this finding suggested that the arrest of cells may be 
sustained by p53-p21 dependent G1 arrest.  
 
Taken together, these findings suggested that there is a presence of bioactive 
compounds in SMEAF which are able to alter the molecular expression level and 
eventually lead to cell growth inhibition by arresting at G1 phase and activation of cell 
death pathway particularly through mitochondrial mediated apoptotic pathway.  
 
 
Figure 4.1 Summary of SMEAF apoptosis inducing effects on HCT116 cells. 
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Since time immemorial, exploration of nature by human in search of new drugs have 
resulted in the use of large number of medicinal plant in treating various diseases 
(Verpoorte, 1999). The advancement in modern scientific methods enables recent 
researchers to discover the bioactive chemicals and identify the secondary metabolites 
in plants that are responsible for their activities (Dong et al., 2011). Secondary 
metabolites are complex organic compounds that are produced by organisms and are not 
directly involved in the normal growth, development or reproduction of an organism 
(Fraenkel, 1959). The production of the secondary metabolites in plants was thought to 
be produced primarily as plant defense strategy against herbivores (Baldwin et al., 
2001). Some of the metabolites are designed to attract creatures for pollination or seed 
distribution, as pigments to protect from sun’s radiation so as regulatory hormone in 
response to environmental changes (Baldwin et al., 2001; Stepp, 2004).   
 
As discussed earlier, the molecular and cellular responses exerted by SMEAF on 
HCT116 are so dramatic and thus is crucial to identify and determine the bioactive 
constituents present. This will play an important role in the safe and effective use of 
SMEAF for therapeutic purpose. Therefore, the isolation and identification of the 
bioactive compounds were performed accordingly. 
 
Phytochemical investigation conducted previously on S. macrophylla have led to the 
isolation of structurally diverse secondary metabolites from the family of  limonoids 
(Chen et al., 2010). Naming a few of them, swietenolide, proceranolide, augustineolide, 
3β, 6-dihydroxydihydrocarapin, 7-deacetoxy-7-oxogedunin, andirobin, proceranolide, 
6-O-acetylswietenolide, 3,6,-O,O-diacetylswietenolide, khayasin T, and 
swietemahonins E-G,  2-hydroxyswietenine, and 6-deoxyswietenine (Mootoo et al., 
 
 
188 
 
1999), swietenine (Dewanjee et al., 2009a) and etc. The bioactivities possessed by S. 
macrophylla were associated to these limonoids as proven through numerous bioassays 
(Dewanjee et al., 2009b).  
 
In the current study we managed to purify eight compounds from this plant and 
identified using different spectroscopic analysis with further confirmation by using GC-
MS analysis. Cytotoxicity evaluation particularly on HCT 116 cells revealed the 
compounds namely, 3-O-tigloyswietenolide, hexadecanoic acid, proceranolide and 
khayasin T to possess cytotoxic effect (Table 3.21) particularly in HCT 116 cells. The 
results suggested that the purified compounds have a high probability of being the 
active principles that are responsible for the cytotoxicity and apoptosis inducing effects 
of SMEAF. 
 
The comparison in term of IC50 values revealed the purified compounds exhibiting 
higher IC50 value compared to SMEAF except for hexadecanoic acid. This is 
understandable, as in the mixture form, compounds may act synergistically to each 
other resulting in the stronger biological effect which is the situation commonly seen to 
happen in many studies (Lee et al., 2012; Lin et al.,  2005; Yee et al., 2004). However, 
no significant or clear cytotoxicity effect observed on any cancer cell lines particularly 
by swietenine aroused curiosity. As swietenine is sharing similar backbone structure 
with 3-O-tigloyswietenolide except for the difference in the orientation of the double 
bond particularly at C-8, C-14 for swietenine and C-8, C-30 corresponds to 3-O-
tigloyswietenolide. Previous study conducted particularly on antifungal activity 
concluded the position of this double bond did not affect its biological activity 
(Govindachari et al., 1999), but in the current cytotoxicity studies we postulated to be 
otherwise.  
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The observation on the swietenine treated cells found that the compound (Figure 3.36) 
was crystalized in the medium. Thus, an attempt was taken in re-analysing those 
purified limonoids especially diacetylswietenolide (1) and 6-O-acetylswietenolide (8). 
As expected those limonoids also presented similar condition, in which crystallization 
occurred in the medium (results not shown) when treated on cancer cells. Thus, it is 
believed that crystallization of the compounds would affect the results eventually, as 
there would not be direct contact between the cancer cells and the compounds.  Low 
solubility of natural product in water poses considerable problems in drug discovery. 
This factor has resulted in the demise of a number of promising leads, such as 
bruceantin and maytansine in cancer chemotherapy (Pavlik et al., 1983). Different co-
solvents, surfactants, emulsifiers such as ethanol (Sovova, 2001), acetone (Adams et al., 
1993), Tween 40 and 80 (O'Sullivan et al., 2004), polyethyl glycol 4000 (Honda and 
Magalhaesyô, 2004), Cremophor EL (Gelderblom et al., 2001) have been proven in 
previous studies to be capable in combating the solubility problems. However, all these 
previously stated methods were of no avail in encountering solubility problem with 
swietenine (2).  
 
Derivatization procedures have been shown to be able to improve solubility of 
compounds (Govindachari et al., 1999; Julka and Regnier, 2004; Zhang and James, 
2005). In the current study, acetylation procedure was performed on swietenine 
specifically aiming the 6-OH functional group on swietenine. The conversion efficacy 
was around 74% of the total amount of 81 mg obtained after purification of the end 
product from reaction mixture. Structural elucidation by utilizing numerous 
spectroscopy procedures revealed the derivative of swietenine known as swietenine 
acetate which is coincidently present in seeds of S. macrophylla. The spectral data are 
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also well correlated with the literatures (Narender et al., 2008; Taylor and Taylor, 
1983a).  
 
The cytotoxicity effect of swietenine acetate was conducted on HCT116 revealed that 
the compound was able to exert its proliferation inhibitory effect on the particular cell 
line. The microscopy observation showed that the compound did not experience 
solubility problems as what was experienced with swietenine (Figure 3.36). At 
concentration of 50 µM, swietenine acetate caused the cells to undergo apoptosis.  In 
Figure 3.36 the cells treated with 50 µM of swietenine acetate demonstrated the 
apoptotic features such as detachment from the culture surface, cell shrinkage and 
membrane blebbing which are signs of apoptosis (Kang et al., 2007). The apoptotic and 
non-apoptotic cells can be differentiated by exposure to Hoechst 33342 for a brief 
period followed by fluorescence intensity comparison (Dive et al., 1992).  In this 
experiment, the utilization of Hoechst/PI staining method revealed the cells treated with 
the 50 µM of swietenine acetate showing stronger blue fluorescence and also the 
presence of red fluorescence signals. This indicated that exposure to swietenine acetate 
caused the HCT116 cells to undergo apoptosis.  
 
In order to check whether the observed growth inhibition was associated with oxidative 
stress, the treated cells were stained by DCFH-DA stain. During the incubation with 
normal cancer cells, DCFH-DA diffused into the cells and hydrolyzed to DCFH and 
was thereby trapped within the cells. This was followed by the oxidation by ROS such 
as H2O2 or oxygen derivatives eventually formation of highly fluorescence compound 
DCF (Bass et al., 1983). Figure 3.38 showed the histrogram of ROS detection after 4 h 
treatment with swietenine acetate which remarkably shifted towards the right hand side, 
indicating an increase in intracellular ROS or sign of oxidative stress. 
 
 
191 
 
Confirmation of induced oxidative stress by swietenine acetate was assessed through 
intracellular GSH level. GSH is a cysteine-containing tripeptide or commonly known as 
cellular antioxidant which acts by protecting the cells from damaging effects of free 
radicals or ROS. In certain cases, high level of GSH has been shown to protect cells 
from apoptotic cell death induction (Chiba et al., 1996; Hedley and Chow, 1994). In the 
current study, treatment with swietenine acetate eventually down regulated the total 
intracellular glutathione level in a time-dependent manner which further reflected the 
oxidative stress induction on HCT 116 cells complementary with high level of ROS 
detection.  
 
The apoptotic inducing effect of swietenine acetate in colon cancer cells was further 
investigated by measuring the loss of Δψm, which is an apoptotic event (Zamzami et al., 
2007). Hence, the change of Δψm in treated cells was detected by using JC-1. In control 
untreated cells, JC-1 was in aggregate forms within the mitochondria resulting in higher 
level of red fluorescence, which corresponded to a polarized Δψm. In contrast, the 
treated cells, swietenine acetate dramatically reduced the formation of red fluorescent J-
aggregates, indicating disruption of Δψm in HCT 116 cells. The reduction of red/green 
fluorescence observed in the flow cytometry analysis proved that swietenine acetate 
evoked loss of Δψm in HCT116 cells, one of the hallmarks for apoptosis. 
 
The loss of MMP is normally associated with the release of cytochrome c. The released 
cytochrome c would bind with dATP to form apoptosome. The formation of 
apoptosome in turn binds and activates the procaspase -9 and subsequently activation of  
caspase -3/7 by caspase-9 (Jiang and Wang, 2004). In this study we examined the Bcl-2 
family proteins, particularly Bax and its antagonist protein Bcl-2 which are involved in 
the regulatory process of mitochondrial membrane integrity during apoptosis (Miyashita 
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et al., 1994). This finding showed that the swietenine acetate caused alteration in 
expression in favor of apoptosis, as it upregulated Bax (pro-apoptotic) and 
downregulated Bcl-2 (anti-apoptotic) protein. This explained the observed disruption of 
MMP in our earlier study. Besides, increased level of SMAC was detected after 
swietenine acetate exposure would further promotes apoptosis event in cells as it is 
known to promote the activation of caspase -9 through binding to inhibitor of apoptosis 
proteins (IAPs) (Tews et al., 2008). Activation of caspase-9 would subsequently 
upregulating caspase -3/7 activities which is consistent with our earlier findings 
suggesting that apoptosis may occur through mitochondrial-mediated pathway.  
 
Cell cycle analysis was performed as a mean to determine whether the apoptosis 
induction was associated with alteration of the cell cycle distribution. The rapid and 
accurate analysis using PI stain followed with flow cytometry analysis was performed 
(Riccardi and Nicoletti, 2006). After treatment with swietenine acetate, a conspicuous 
increase in G1-phase cell percentage was followed with sub-G1 percentage. These 
results seem to suggest that the cells were arrested in G1 phase and followed with the 
accumulation of fragmented cells with reduced DNA content. In order to evaluate the 
involvement of the cell regulatory proteins in cell cycle distribution, PCR array analysis 
revealed the cell regulatory proteins encoding genes were altered after treatment with 
swietenine acetate. The results showed that swietenine acetate exposure increased the 
expression of CDKN1A gene and its encoded p21 protein in HCT116 cells. Besides, 
numerous other genes including CDC25A, CDK2 and CDK4 that are important in 
regulating the progression of cell cycle were simultaneously downregulated. The ceased 
expression level of the CDC25A, CDK2 and CDK4 genes was shown to correlate with 
the arrest in the cell cycle (Ewen et al., 1995; Iavarone and Massagué, 1999; Neganova 
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et al., 2011; Wolter et al., 2001). These findings may explain the arrest of cells detected 
in cell cycle analysis. 
 
The expression level of p53 and its encoding gene TP53 was upregulated following 
exposure to swietenine acetate. Besides, the level of p21 expression was confirmed 
using protein array which showed a marked increase throughout the treatment period. It 
has reported that the elevation of p21 protein can be induced by modulation of p53 
protein which eventually contributed to the G1 phase arrest in cell cycle progression 
(Deiry et al., 1994). In our current study, p53 and p21 proteins were concurrently 
elevated suggesting that the arrest of the HCT116 cells by swietenine acetate might 
occur through p53-mediated upregulation of p21-induced cell cycle arrest pathway. 
 
Naturally occurring compounds have been found to cause apoptosis through intrinsic 
and also extrinsic pathways, for an example curcumin derived from turmeric that is 
capable in inducing the apoptotic effect through both pathways (Reuter et al., 2008). 
The extrinsic pathway is normally initiated by the interaction between specific ligands 
and surface receptors (Klein et al., 2005), such as CD95/Fas/Apo1, Tumor necrosis 
factor (TNF) receptor 1 (TNFR1), TNF receptor 2 (TNFR2) and death receptor 3-6 
(DR3-6) (Degterev et al., 2003). The interaction of signalling molecules with death 
receptors would result in translocation  of a death signal from the extracellular 
microevironment to the inner cytoplasm. This subsequently caused the recruit of 
initiator caspases such as caspase-8 and -10 followed by effector caspases -3 and -7 
(Klein et al., 2005).  
 
The utilization of flow cytometry detection method in determining caspase-8 and-10 
surprisingly showed an increase in both caspase enzyme activities. This provides clues 
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that the induction of apoptosis by swietenine acetate may also be associated to extrinsic 
apoptosis pathway. The involvement  of the extrinsic pathway was further confirmed 
with the detection of high expression level of genes such as TNFRSF1A, TNFRSF10B 
and also TNFRSF25 which are encoding genes for TNF family receptors.  
 
In normal cells, phosphatidylserine is normally confined to the inner leaflet of plasma 
membrane. However, it would be exported to the outer plasma membrane leaflet during 
apoptosis to serve as a trigger for recognition of apoptotic cells by phagocytes (Martin 
et al., 1996). Annexin V/PI stains utilized in this study demonstrated that treatment with 
swietenine acetate for 24 h caused an increase in the externalization of 
phosphatidylserine. Meanwhile, prolonged exposure to swietenine acetate did not 
significantly decrease the percentage of viable cancer cells but instead a significantly 
higher percentage of early apoptotic cells has entered the late apoptotic or dead stage. 
This phenomenon has raised question of the presence of any downstream signaling 
molecules that may have hampered the apoptotic activation pathway in HCT116 and 
thus an attempt was made in conducting further investigations. 
 
SDS-PAGE was performed on the lysates obtained from the cells treated with 
swietenine acetate. The result showed the increase level of a protein band particularly at 
around ~70KDa. The band was then excised, digested with enzyme and with the help of 
LC-MS/MS analysis enables us to detect the presence of HSP 70 protein. HSP70 is a 
major heat shock protein and known as an effective inhibitor of apoptosis. In a common 
pathway, disruption of MMP, release of cytochrome c from mitochondria, activation of 
caspase-3 and particularly with low HSP70 will eventually lead cells to apoptosis. 
However, it is shown to be otherwise if the cells are expressing high level of HSP70 
(Jäättelä et al., 1998; Mosser et al., 1997).  Protein array analysis confirmed this finding 
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where the expression level of HSP70 increased throughout the treatment period. Thus, 
we postulated that the apoptotic pathway induced by swietenine acetate may have been 
halted to a certain extent by HSP70 protein.  
 
 
Figure 4.2 Summary of swietenine acetate apoptotic inducing effects on HCT116 cells. 
 
Even though swietenine did not appear to be directly responsible for its bioactivities, the 
data generated in the present study may be applied towards the use of swietenine for the 
in vivo studies in the future. As studies have shown, diabetes is associated with a higher 
risk in developing cancer. Besides, reports have shown that individuals who suffer from 
both cancer and diabetes have a higher rate of mortality (Renehan et al., 2012; Yeh et 
al., 2012). Swietenine, a limonoid has been shown to be able to exert its hypoglycemic 
effects (Dewanjee et al., 2009a; Maiti et al., 2009) thus it would be very good if it can 
exert the growth inhibitory effect on colon cancer. In our current study we proved that 
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the acetylation of swietenine has resulted in a naturally occurring compound that is able 
to exert apoptotic inducing effect through intrinsic and extrinsic pathways. Thus, 
swietenine can be developed as a chemopreventive drug as acetylation is a very 
common metabolic reaction in human body. Acetylation can occur through the transfer 
of an acetyl group from acetyl-coenzyme A under catalysis of acetyltransferases 
enzyme  (Gennaro, 2000). This explained the potential use of swietenine as 
chemopreventive drug, as it can exploited as a new lead compound for prodrug therapy. 
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CHAPTER 5 
CONCLUSION 
In summary, the findings from the present study provided an insight into the cytotoxic 
effect of Swietenia macrophylla. Cytotoxicity studies of Swietenia macrophylla on 
different cancer cell lines and subsequent chemical purification of bioactive SMEAF 
have led to the isolation of eight compounds which were mostly limonoids, namely, 3,6-
O,O-diacetylswietenolide (1), swietenine (2), 3-O-tigloylswietenolide (3), swietenolide 
(4), hexadecanoic acid (5), proceranolide (6), khayasin T (7) and 6-O-
acetylswietenolide (8). Compounds 3, 5, 6 and 7 were shown to possess cytotoxic effect 
against HCT116 cells. Acetylation of swietenine produced swietenine acetate which 
with an enhanced bioactivity as compared to its parent compound. The exposure to 
SMEAF and swietenine acetate eventually altered the oxidative balance of HCT 116 in 
favor of oxidative stress through the increased level of ROS and attenuation of 
intracellular GSH level. The simultaneous arrest of the G1 phase with an increase in p53 
and p21 followed by a decrease in CDK2 and CDk4 may explain the inhibition of the 
cell cycle progression by SMEAF and swietenine acetate. Numerous apoptotic 
responses were identified, including cell shrinkage, chromatin condensation, DNA 
fragmentation, PS externalization, membrane blebbing and disruption of ∆ψm. The 
occurrence of mitochondrial-mediated apoptosis was further confirmed through the 
elevation of the Bax /Bcl-2 ratio and subsequent activation of caspase -3/7 and -9.  In 
the mean time, exposure to swietenine acetate caused an upsurge in the expression level 
of HSP 70 protein which is a well-known anti-apoptotic protein associated with 
diminished efficiency of anticancer drugs. This finding may impact the future of cancer 
treatment by providing another avenue for the discovery of a combined anticancer drug 
treatment that targets the impeding effect of HSP70 and thus promotes induced 
apoptosis. This may pave the way for a possible intervention through the use of 
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limonoid(s) in combination with a HSP70 inhibitor for therapeutic and chemopreventive 
applications. 
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APPENDIX 
 
 
 
 
 
 
Appendix 1 
1
H NMR spectrum of diacetyl swietenolide (1). 
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Appendix 2 
13
C NMR spectrum of diacetyl swietenolide (1). 
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Appendix 3 Mass spectrum of diacetyl swietenolide (1). 
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Appendix 4 
1
H NMR spectrum of diacetyl swietenine (2). 
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Appendix 5 
13
C NMR spectrum of swietenine (2). 
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Appendix 6 Mass spectrum of swietenine (2). 
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Appendix 7 
1
H NMR spectrum of 3-O-Tigloylswietenolide (3). 
 
 
 
 
 
206 
 
 
 
 
 
 
 
 
Appendix 8 
13
C NMR spectrum of 3-O-Tigloylswietenolide (3). 
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Appendix 9 Mass spectrum of 3-O-Tigloylswietenolide (3). 
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Appendix 10 
1
H NMR spectrum of swietenolide (4). 
 
 
 
 
 
 
209 
 
 
 
 
 
 
 
 
 
Appendix 11 
13
C NMR spectrum of swietenolide (4). 
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Appendix 12 Mass spectrum of swietenolide (4). 
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Appendix 13 
1
H NMR spectrum of proceranolide (6). 
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Appendix 14 
13
C NMR spectrum of proceranolide (6). 
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Appendix 15 Mass spectrum of proceranolide (6). 
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Appendix 16 
1
H NMR spectrum of Khayasin T (7). 
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Appendix 17 
13
C NMR spectrum of Khayasin T (7). 
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Appendix 18 Mass spectrum of Khayasin T (7). 
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Appendix 19 
1
H NMR spectrum of 6-O-acetylswietenolide (8). 
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Appendix 20 Mass spectrum of 6-O-acetylswietenolide (8). 
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Appendix 21 
1
H NMR spectrum of swietenine acetate. 
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Appendix 22 
13
C NMR spectrum of  swietenine acetate. 
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Appendix 23 DEPT NMR spectrum of swietenine acetate. 
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Appendix 24 HMBC NMR spectrum of swietenine acetate. 
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Appendix 25 HSQC NMR spectrum of swietenine acetate. 
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Appendix 26 NOESY NMR spectrum of swietenine acetate. 
 
 
 
 
 
 
 
 
 
 
225 
 
 
 
 
 
 
 
 
 
Appendix 27 COSY NMR spectrum of swietenine acetate. 
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Appendix 28  HRMS of swietenine acetate. 
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